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 In dairy cattle, insulin resistance of peripheral tissues during the transition 
from pregnancy to lactation is a normal adaptation to spare glucose for the gravid 
uterus and mammary gland.  Exaggerated insulin resistance, a potential factor in 
overfed dry cows, may contribute to excess mobilization of adipose tissue in early 
lactation.  The objectives were to determine the mechanism by which an insulin 
sensitizing agent (2,4-thiazolidinedione; TZD) and plane of nutrition (PON) can affect 
the metabolic health of transition cows.  In experiment one, plasma leptin and tumor 
necrosis factor-α, and adipose tissue peroxisome proliferator activated-γ (PPARγ) 
mRNA were increased by prepartum TZD administration.   The effects of PON and 
feed deprivation on insulin responses were measured in experiment two via glucose 
tolerance test (GTT) and hyperinsulinemic-euglycemic clamp (HEC) techniques.   
Cows subjected to high and low PON and then subjected to feed deprivation had 
different responses in glucose and lipid metabolism as measured by both GTT and 
HEC.  The effects of feed deprivation were much greater than PON.  Cows deprived 
of feed had much slower clearance of glucose during GTT, suggesting greater insulin 
resistance.  Following feed deprivation, cows had greatly attenuated insulin response 
to GTT.  In the final experiment, the effects of both PON and TZD were investigated 
using GTT, insulin challenge (IC), and adipose tissue mRNA analysis.  There were 
differential effects of PON on glucose and fatty acid metabolism such that cows fed a 
 lower PON had smaller glucose but larger NEFA responses following GTT. The only 
significant interactions of PON and TZD administration were that plasma NEFA 
responses were most dramatic for cows treated with TZD and fed lower PON.  While 
TZD administration or diet did not affect fatty acid synthase, leptin, TNFα, or 
adiponectin mRNA expression, the higher energy level diet increased mRNA of 
PPARγ and lipoprotein lipase.  It is possible that these effects and interactions of diet 
and TZD would be more dramatic closer to the time of calving.  Results from GTT 
and IC indicate that PON and insulin-sensitizing agents affect glucose and lipid 
metabolism during the dry period, which may have implications for the transition 
period.   
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CHAPTER 1: INTRODUCTION 
 
 The overall profitability and health of a dairy cow benefits from successful 
management during the transition period.  The metabolic adaptations that support the 
onset of lactation include increased mobilization of fatty acids from adipose tissue and 
increased hepatic gluconeogenesis (Bell, 1995).  Orchestration of nutrient partitioning 
is necessary to meet new metabolic demands coinciding with a simultaneous decrease 
in dry matter intake around calving, which requires mobilization of body fat reserves 
(Bauman and Currie, 1980).  These responses increase circulating non-esterified fatty 
acids (NEFA), which when taken up by the liver in excess generally result in 
triglyceride accumulation and increase the risk for fatty liver and other disorders such 
as ketosis, milk fever, retained placenta, and mastitis (Goff and Horst, 1997).   
 Insulin resistance during pregnancy and early lactation is a normal 
homeorhetic adaptation, the purpose of which is to spare glucose for the gravid uterus 
and mammary gland (Bauman and Currie, 1980).  While some mobilization of adipose 
tissue is necessary to support lactation, some animals will experience excessive 
mobilization which is detrimental to the metabolic health of dairy cattle, and is a major 
concern for the dairy industry (Drackley, 1999).  Cows that are overfed and gain 
excessive body condition during the dry period often experience prolonged negative 
energy balance in early lactation (Douglas et al., 2006; Dann et al., 2006).  
Additionally, overfed cows were also determined to have increased insulin resistance 
(Holtenius et al., 2003). 
 Although previous research has focused on the role of the liver during the 
transition period (Drackley et al., 2001), regulation of adipose tissue metabolism may 
be an appropriate approach to understanding transition cow metabolism.  It may be 
possible to regulate adipose tissue mobilization without compromising production.  
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Previous work has demonstrated that administration of insulin sensitizing agents to 
prepartum dairy cattle can have positive effects on transition cow metabolism (Smith 
et al., 2007; 2009).  The mechanisms of these responses are yet to be determined. 
 Therefore, one objective of this work was to further elucidate the role of 
insulin resistance in dry cows and its potential influence on transition cow metabolism.  
Furthermore, the influence of plane of nutrition on these responses was examined.  An 
additional objective was to determine potential mechanisms for the effects of insulin 
sensitizing agents observed in transition cows.  In order to meet these objectives, 
changes in glucose and fatty acid metabolism were investigated. 
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CHAPTER 2:  LITERATURE REVIEW 
THE ROLES OF PLANE OF NUTRITION, INSULIN SIGNALING, AND 
ADIPOSE TISSUE IN TRANSITION COW METABOLISM 
 
Introduction 
 
 The overall profitability and health of a dairy cow benefits from successful 
management during the transition period (Drackley, 1999).  The metabolic adaptations 
that support the onset of lactation include increased mobilization of fatty acids from 
adipose tissue and increased hepatic gluconeogenesis (Bell, 1995).  Orchestration of 
nutrient partitioning is necessary to meet new metabolic demands coinciding with a 
simultaneous decrease in dry matter intake around calving, which requires 
mobilization of body fat reserves (Bauman and Currie, 1980).  These responses 
increase circulating NEFA, which when taken up by the liver in excess generally 
result in triglyceride accumulation and increase risk for fatty liver and other disorders 
such as ketosis, milk fever, retained placenta, and mastitis (Goff and Horst, 1997).   
 Insulin is a protein hormone secreted by the β-cells of the pancreas which 
stimulates translocation of glucose transporters such as GLUT4, resulting in glucose 
uptake (Sasaki, 2002).  In ruminants, volatile fatty acids from the gastrointestinal tract 
are the major energy sources for oxidative metabolism and biosynthesis rather than 
glucose per se.  Thus, insulin plays a slightly different role in ruminants versus 
nonruminants, though many aspects of insulin function are the same.  Over the past 
two decades, the concept of insulin resistance has garnered much research attention 
with the increasing prevalence of obesity, Type II Diabetes, and metabolic syndrome 
in humans (Mokdad et al., 2003).  Insulin resistance can involve changes in sensitivity 
(the amount of hormone required to elicit a response) and/or responsiveness (the 
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maximum response to a hormone; (Kahn, 1978)).  As in humans, insulin resistance in 
ruminants is potentially related to changes in both sensitivity and responsiveness.  For 
the purpose of this review, the term insulin resistance will be used with the implication 
that the relative importance of sensitivity or responsiveness is not known in most 
cases. The role of insulin resistance in ruminants may prove to be an important 
metabolic regulator or potential intervention point for management. 
 Insulin resistance of peripheral tissues is a normal homeorhetic adaptation to 
late pregnancy and early lactation (Bauman and Currie, 1980; Vernon, 1989).  The 
purpose of insulin resistance of peripheral tissues is to spare glucose for the gravid 
uterus and eventually milk production (Bauman and Currie, 1980; Bell and Bauman, 
1997).  Early lactation is characterized by decreased lipogenesis and increased 
lipolysis in order to meet the needs for the rapid increase in milk production, which is 
in part controlled by insulin resistance of adipose tissue (Bauman and Currie, 1980; 
Vernon and Pond, 1997).  However, when excessive mobilization of adipose tissue 
occurs and the animal is in a period of prolonged negative energy balance, there can 
be negative effects on metabolic health (Drackley, 1999; Drackley et al., 2001)
 Excessive insulin resistance may help to explain why cows that enter the 
transition period have greater risk for metabolic disorders.  It has been shown that 
cows overfed during the dry period lose more body weight (BW), experience a more 
dramatic decrease in dry matter intake (DMI), and have higher circulating NEFA 
around calving (Douglas et al., 2006; Dann et al., 2006).  In cows fed at 178% of 
predicted energy requirements prepartum, Holtenius et al. (2003) implicated increased 
insulin resistance (as measured by decreased clearance rate of glucose following 
glucose infusion) as a mechanism for increased lipolysis resulting in greater NEFA 
and body condition score (BCS) loss post-calving.  Since these discoveries, research 
has concentrated on dietary strategies to mitigate transition cow problems potentially 
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related to insulin resistance (Dann et al., 2005; Douglas et al., 2006; Dann et al., 
2006).  It is clear that fundamentally different approaches to management focusing on 
the biology of the cow may be beneficial for improvement of transition cow health and 
performance related to nutrition during the dry period. 
 Modulation of insulin resistance in periparturient dairy cattle independent or in 
coordination with altered dietary energy has included the use of chromium as a dietary 
supplement (Spears, 2010).  Chromium supplementation has improved insulin 
sensitivity as measured by improved responses to glucose infusions, metabolic health 
and production variables (Yang et al., 1996; McNamara and Valdez, 2005; Spears et 
al., 2010; Spears, 2010).  More recently, the use of a pharmacological insulin 
sensitizer employed in human diabetes treatment has been investigated in ruminants 
(Kushibiki et al., 2001; Smith et al., 2007; Smith et al., 2009).  A pharmacological 
intervention used in humans to improve insulin resistance are the thiazolidinediones 
(TZD) (Yki-Jarvinen, 2004).  The overall mode of action of TZD is up-regulation of 
peroxisome proliferator-activated receptor-γ (PPARγ), which has been shown to be 
abundant in adipose tissue (Houseknecht et al., 2002; Hammarstedt et al., 2005).  The 
first use of the insulin-sensitizing agent TZD in ruminants was in steers with insulin 
resistance induced by administration of tumor necrosis factor-α (TNFα) (Kushibiki et 
al., 2001).  Subsequent studies in periparturient dairy cattle suggested potential for  
use of prepartum TZD treatment to improving insulin signaling (Smith et al., 2007; 
2009).   
 Adipose tissue plays an important role in metabolic regulation of the transition 
from late pregnancy to early lactation.  In addition to regulation of enzymes 
responsible for lipolysis and lipogenesis, adipose tissue hormones and cytokines such 
as leptin, adiponectin, TNFα, and others are secreted from the tissue and have 
metabolic effects throughout the body.  It is possible that these mechanisms are factors 
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in the apparent dysregulation that occurs in overfed or over-conditioned dry cows.  
Though much attention has been focused on liver and other tissues (Bell, 1995; 
Drackley et al., 2001), the role of adipose tissue in metabolic regulation of transition 
cows may be critically important. 
 Thus, questions still exist regarding the interactions of insulin resistance, the 
role of plane of nutrition, and adipose tissue during the dry and transition periods.  
How does metabolic regulation of each of these affect the success of an animal 
through calving and early lactation?  If these relationships can be more clearly 
defined, there may be potential to target the use of insulin-sensitizing agents during 
the transition period based on BCS, energy status, or other measures. 
 
Metabolic adaptation during the transition period 
 
 The transition period has been defined as the three weeks preceding and 
following calving (Grummer, 1993), but the implications from a management 
perspective begin well before that.  Once a cow is dried off, the process of preparing 
for the next lactation begins.  As the dry period progresses, the growing fetus will 
eventually increase metabolic demands on the dam.  The shifts in metabolic priorities 
and regulatory changes that occur during both pregnancy and the onset of lactation are 
examples of homeorhesis (Bauman and Currie, 1980).  In this manner, metabolic set 
points change and nutrient partitioning adjusts accordingly. 
 During the dry period, fetal growth is not a major nutrient drain until the third 
trimester during which mammary cell proliferation and differentiation is also at its 
peak (Bauman and Currie, 1980).  In animals carrying multiple offspring, this 
metabolic drain can be quite significant and results in metabolic disorders such as 
pregnancy toxemia in ewes (Vernon et al., 1981).  In dairy cattle, especially with 
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successful management of nutrition during the dry period, occurrence of metabolic 
disorders during late gestation is rare.  Instead, the dramatic increase in metabolic 
demand in dairy cattle occurs after calving when milk production doubles energy 
demands within a few days during the immediate periparturient period (Drackley et 
al., 2001).  
 Cows during the far-off dry period (generally considered to be from dry off at 
approximately 60 d before expected parturition until three to four weeks before 
expected calving) are experiencing relatively low metabolic demands as fetal growth 
is just beginning to accelerate and cows are no longer lactating.  However, it is known 
that glucose turnover is faster in pregnant ruminants (0.32 g/hr/kg3/4 for pregnant ewes 
vs. 0.24 g/hr/kg3/4 for nonpregnant ewes (Bergman et al., 1974)).  The bulk (86%) of 
the glucose turnover is accounted for by hepatic gluconeogenesis (Bergman et al., 
1974).  Fetal and uterine tissues are insulin-independent and so as energy demands 
increase with days of pregnancy, maternal peripheral tissues will need to become more 
insulin resistant, reducing dependence on glucose utilization in order to support fetal 
growth (Bell, 1995).  Investigation of mRNA levels for various glucose transporters 
correlate with these responses.  Insulin-independent GLUT1 is the major glucose 
transporter in the mammary gland, and its mRNA expression is increased significantly 
during lactation compared to the dry period (Komatsu et al., 2005).  GLUT1 mRNA 
decreases substantially in adipose tissue during peak lactation, while GLUT4 adipose 
tissue mRNA expression stays relatively constant throughout lactating and 
nonlactating periods (Komatsu et al., 2005).  Given these results, the authors 
concluded that insulin concentration and GLUT4 activation were important during 
lactation, but it would be interesting to speculate on the implications during the 
prepartum period (Komatsu et al., 2005).   These changes in the role of insulin likely 
have effects on energy metabolism in dry cows. 
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 Metabolic adaptations in periparturient dairy cattle become most obvious 
during the last three weeks prior to calving.  Adaptations include reduced glucose 
utilization by peripheral tissues and increased hepatic gluconeogenesis (Bell and 
Bauman, 1997). These adaptations occur in the face of potentially decreasing DMI 
(Ingvartsen and Andersen, 2000; Hayirli et al., 2002).  It is still unclear what the major 
factors regulating intake are during this time, but it is likely a combination of physical 
and metabolic signals.  Hayirli et al. (2002) summarized dry matter intake data from 
49 different diets within 16 experiments and determined that  56.1% of variation in 
DMI can be attributed to day of gestation.  As reviewed by Allen et al. (2005), there is 
evidence for increased propionate supply, increased concentrations of NEFA, and gut 
peptides that may serve to decrease DMI.  Increased propionate and fatty acid supply 
to the liver (such as when high starch diets are fed or when mobilization of adipose 
tissue is high) is thought to reduce intake through increased hepatic oxidation (Allen, 
2000; Oba and Allen, 2003).   Secretion of gut peptides may reduce gut motility or 
have indirect influence on insulin, reducing intake (Choi et al., 2000; Benson and 
Reynolds, 2001).  Though now thought to be previously overemphasized, physical fill 
was suggested to limit intake in late pregnancy in the transition cow (Stanley et al., 
1993; Ingvartsen and Andersen, 2000).  Based on more recent evidence, it appears that 
the coordination of oxidation of metabolic fuels coupled with signaling of other 
peptides result in central nervous system regulation of intake (Ingvartsen and 
Andersen, 2000).   
 Briefly, orchestration of nutrient partitioning is necessary to meet new 
metabolic demands.  Increased demands coupled with decreased DMI requires 
mobilization of body fat reserves (Bauman and Currie, 1980).  These responses 
increase circulating NEFA, which when taken up by the liver in excess of rates of 
oxidation and export as very-low density lipoproteins induce triglyceride accumulation 
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and increased risk for fatty liver and other disorders such as ketosis, retained placenta, 
and mastitis (Goff and Horst, 1997).  Additionally, a proportion of the rise in 
circulating NEFA may be independent of energy status (Bertics et al., 1992; Grummer, 
1995).  Bertics et al. (1992) determined that cows force-fed via rumen cannula in the 
days leading up to calving had lower liver triglycerides as well as increased milk yield 
during the first 28 d of lactation, thus underscoring the importance of maintaining 
adequate DMI during the prepartum period.  However, force-feeding did not entirely 
mitigate the rise in circulating NEFA observed during the transition period, suggesting 
additional mechanisms for NEFA responses (Bertics et al., 1992). 
 The shift in demand during late pregnancy and early lactation occurs via 
coordinated responses in different tissues.  These changes in tissue responses serve to 
spare glucose for the gravid uterus and eventually the mammary gland during early 
lactation (Bell and Bauman, 1997).  Tissues involved include the liver, adipose tissue, 
and muscle.  The end results are increased hepatic gluconeogenesis, increased NEFA 
mobilization from adipose tissue, and decreased use of glucose by peripheral tissues 
(Bell and Bauman, 1997).  Modulation of insulin pathways is a large factor in many of 
these adaptations. 
 Adaptations related to insulin include changes in plasma concentration as well 
as downstream effects.   Vernon et al. (1981) reported that both plasma insulin 
concentrations and the number of  insulin receptors on adipocytes were decreased as 
ewes exceeded 100 d of pregnancy.  These metabolic changes corresponded with loss 
of adipose tissue, which is consistent with the increased lipolysis that is greater during 
late pregnancy than early lactation in ewes.  Although the timing of adipose tissue 
mobilization relative to parturition differs in sheep and cattle, the mechanisms for 
regulation are likely to be similar.  As already mentioned, there are also tissue-
dependent changes in responses to insulin.  Figure 2-1 illustrates the coordinated 
 10 
 
regulation occurring during the transition period, and the role of insulin in many of 
these effects is notable. 
 
Insulin activity and peripheral tissues 
 Insulin action varies by tissue type.  Resistance of tissues to insulin can be 
attributed to changes in sensitivity, responsiveness, or both.  Decreased sensitivity 
occurs when a greater than normal concentration of hormone is required to elicit a 
normal response and is related to changes in receptor number (Kahn, 1978).  
Decreased responsiveness suggests changes in the maximal response to a hormone, or 
changes downstream of receptor-binding (Kahn, 1978).  Figure 2-2 from Kahn (1978) 
illustrates that the normal dose-response curve is shifted to the right in cases of 
reduced sensitivity, and shifted downward in the case of reduced responsiveness.  The  
distinction between changes in sensitivity and responsiveness is necessary to 
appropriately describe the mechanisms underpinning the changes in response to 
insulin, though at times the specific mechanisms are hard to distinguish from 
phenotypic responses.  Based on current literature, in ruminants it is often the case that 
the exact proportions of insulin resistance that can be allocated to differences in 
sensitivity or responsiveness is not known.  Therefore, unless data can prove 
otherwise, the general term “insulin resistance” is assumed to involve elements of 
both.    
 Additionally, tissues themselves may either be insulin-dependent or 
independent depending on the presence or absence of insulin-responsive glucose 
transporters.  For example, placental tissue contains insulin-independent glucose 
transporters GLUT1 and GLUT3 almost exclusively, and the mammary gland contains  
insulin-independent transporter GLUT1, meaning that glucose uptake by these cells 
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Figure 2-1.  Metabolic adaptation during the transition period. 
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Figure 2-2.  Types of resistance to hormone action.  From (Kahn, 1978).
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will not be mediated by insulin (Bell and Bauman, 1997).  Whole-body insulin  
resistance, therefore, depends on signaling within tissues that are responsive to insulin 
such as liver, skeletal muscle, and adipose tissue.  The term insulin resistance is 
further generalized at the whole-body level although quantitative aspects of resistance 
may be different within specific tissues. 
 In the liver, insulin inhibits gluconeogenesis and therefore the hypoinsulinemia 
characteristic of early lactation favors hepatic gluconeogenesis (Vernon, 1989).  This 
is another mechanism in order to ensure adequate glucose supply for the mammary 
gland.  Observed in nonruminants, insulin inhibits gluconeogenesis in the liver via 
suppression of phosphoenol pyruvate carboxykinase (PEPCK) and glucose-6-
phosphatase (Barthel and Schmoll, 2003).  Though the liver will increase its 
production of glucose in early lactation to increase glucose supply (Reynolds et al., 
2003), absorbed gluconeogenic precursors account for approximately 65% of average 
mammary glucose uptake  (Bell, 1995).  The remaining gluconeogenic precursors  are 
accounted for via mobilization of body tissue [adipose tissue and skeletal muscle; 
(Bell, 1995)].       
 In ruminants, changes in insulin resistance within skeletal muscle appear to be 
related to changes in levels of GLUT4 transporter (Petterson et al., 1993).  Regardless 
of mechanism, the result of having tissues such as the mammary gland insensitive to 
insulin while other insulin-dependent tissues (muscle, adipose) reduce sensitivity 
ensures that nutrients are properly partitioned to meet increased demands in late 
pregnancy and early lactation.   
  
 
 Insulin activity, fatty acid metabolism, and adipose tissue 
 Additional roles of adipose tissue in metabolic regulation during the transition 
period will be discussed in later sections while the specific relationship between 
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insulin signaling and adipose tissue is most relevant in this section.  Insulin promotes 
fatty acid synthesis and lipid accretion in adipose tissue.  In the transition from late 
pregnancy to early lactation, not only do circulating concentrations of insulin decrease,  
but adipocytes also become insulin resistant (Bell and Bauman, 1997).  The end 
results during the third trimester are increased transcription of enzymes such as 
lipoprotein lipase (LPL), acetyl CoA carboxylase, and increased activity of pyruvate 
dehydrogenase and stimulation of glucose transport (Vernon and Pond, 1997).  
Increased expression of hormone sensitive lipase (HSL) has also been observed in 
early lactation (Vernon et al., 1981).  Similarly, in humans with gestational diabetes 
there is reduced ability of insulin to suppress NEFA as gestation progresses (Catalano 
et al., 2002).  The end result is mobilization of body reserves and a rise in circulating 
NEFA.   
 While the overall effects of decreased lipogenic and increased lipolytic activity 
of adipose tissue are to supply milk fat precursors to the mammary gland and to 
provide oxidative fuels to tissues during negative energy balance (Pullen et al., 1989), 
there can be negative consequences throughout the body.  Primarily, the liver is 
affected if uptake of fatty acids exceeds the liver’s ability to oxidize them or export 
them in the form of very low density lipoproteins (Bobe et al., 2004).  The resulting 
accumulation of triglycerides in the liver, known as fatty liver, decreases the 
gluconeogenic capacity of the liver (Drackley et al., 2001; Bobe et al., 2004) .  There 
are several control points, as described by Drackley (1999), that result in fatty liver:  
delivery of NEFA to the liver, uptake of NEFA into mitochondria via carnitine 
palmitoyltransferase I (CPT-1), regulation of mitochondrial ketogenesis, regulation 
esterification steps, portioning of newly synthesized triglycerides between secretion 
and storage, and export of very low density lipoproteins. One way to improve the 
metabolic health of transition dairy cattle, and especially of those over-conditioned 
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during the dry period, would be to decrease the delivery of NEFA to the liver while 
maintaining milk production.  Modulation of insulin signaling could be a key factor.   
 An additional approach to decrease triglyceride accumulation in liver would be 
to improve the liver’s ability to oxidize or export liver triglycerides; several 
possibilities have been proposed in the literature.  Fatty acid oxidation in the liver is 
inhibited by propionate and insulin and stimulated by carnitine (Jesse et al., 1986a; 
Jesse et al., 1986b).  Limited choline supply reduces the liver’s ability to secrete fatty 
acids in the form of very low density lipoproteins (Santos and Lima, 2009).  Rumen 
protected choline has been used in an attempt to improve fatty liver in dairy cattle 
(Hartwell et al., 2000; Piepenbrink and Overton, 2003; Cooke et al., 2007).  
Pipenbrink and Overton (2003) reported that choline supplementation increased liver 
glycogen concentrations and decreased capacity for esterification of fatty acids in liver 
slices.  Cooke et al. (2007) determined that choline supplementation decreased liver 
triglycerides in cows with dietary-induced fatty liver.  However, Hartwell et al. (2000) 
observed that the effects of choline supplementation were dependent upon dietary 
rumen undegradable protein supply as well as BCS prepartum.  More recently, the use 
of clofibrate in liver slices from weaned calves suggested that the use of a PPARα 
agonist may decrease triacylglycerol content due increased expression of genes 
regulating fatty acid oxidation (Litherland et al., 2010). 
 Insulin may have greater influence on triglyceride accumulation in the liver 
through its ability to reduce fatty acid supply to the liver.  Andersen et al. (2002) 
subjected cows to hyperinsulinemic-euglycemic clamps (HEC) in order to determine 
the effects of insulin on hepatic lipidosis based upon stage of lactation.  Based on 
decreased plasma NEFA levels and lower triglyceride content of liver in cows 
administered insulin, the authors concluded that the anti-lipolytic effect of insulin on 
adipose tissue was more important than insulin’s ability to alter hepatic long-chain-
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fatty acid oxidation (Andersen et al., 2002).  This would support the concept that 
effects on transition cow health may be greater if efforts focused on adipose tissue 
metabolism and reducing the supply of NEFA to the liver. 
 Interestingly, cows with higher BCS prepartum experience more dramatic 
decreases in DMI during the transition period and thus have higher NEFA (Agenas et 
al., 2003; Dann et al., 2006). In a meta-analysis of over 5,000 cows, Garnsworthy 
(2006) determined that the optimal BCS at calving is 2.1-2.5 and that a BCS > 2.5 
results in greater loss in BCS post-calving.  Likewise, Bernabucci (2005) found that 
cows that calved at a BCS > 3.0 had higher NEFA and oxidative stress.   This provides 
support that it is the oxidation of fuels, and thus circulating levels of NEFA that are a 
regulator of intake and metabolism in transition dairy cattle.  In this manner, cows that 
have higher BCS at calving, have higher circulating NEFA concentrations and thus 
have a more dramatic decrease in intake resulting in further loss of body condition.  
Thus, many began investigating the role of plane of energy during the dry period on 
transition cow metabolic health, more examples of which are found in more detail in 
the next section. 
 
Effects of plane of nutrition during the dry period 
  
 The NRC determines energy requirements during the dry period based on 
maintenance and pregnancy requirements (NRC, 2001).  Energy for maintenance is 
defined as 0.08 Mcal/kg BW0.75(NRC, 2001).  Energy requirements for pregnancy in 
late gestation are assumed to be dependent mostly on day of gestation (and efficiency 
of energy use by the gravid uterus) but also calf birth weight (Bell, 1995; NRC, 2001).   
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The equation for calculated energy requirement for pregnancy is: 
Term B (NEL/day) = [(0.00318 x day – 0.0352) x (calf birth weight/45)] 
            0.218 
Therefore, the final energy requirement during pregnancy is the sum of both the 
energy required for maintenance (Term A) and the energy requirement of pregnancy 
(Term B).  Animals consuming energy above and beyond that necessary to support 
maintenance and pregnancy could be consuming excess energy, are overfed, or at a 
high plane of nutrition. 
 In the past ten years researchers have become increasingly aware of the effect 
of feeding management during the dry period on transition dairy cattle.  Management 
involves not only monitoring intake and energy level of the diet, but the timing of 
different nutritional strategies during the dry period.  Historically, many believed 
energy intake should be maximized during the dry period (NRC, 2001).  Curtis et al. 
(1984; 1985) reported improved performance and decreased correlation with 
metabolic disorders in cows fed higher planes of nutrition prior to calving.  However, 
the idea that cows should be fed a high energy “steam-up” ration just prior to calving 
has slowly begun to lose ground (Drackley et al., 2006).   
 It was shown that cows fed high energy diets during the dry period are more 
likely to have fatty liver after parturition, experience a more dramatic decrease in 
intake after calving, and have higher incidences of metabolic disorders in early 
lactation (Rukkwamsuk et al., 1998; Rukkwamsuk et al., 1999a; Agenas et al., 2003; 
Dann et al., 2006).  Furthermore, Dann et al. (2006) determined that dietary energy 
level during the far-off dry period has a significant effect on metabolism during the 
transition period regardless of close-up dry cow nutrition.  In cows that were fed a far-
off dry cow diet that met 80%, 100% or 150% of NRC energy requirements and were 
then switched to a close-up diet fed at ad libitum or restricted levels, the cows that 
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were overfed during the far-off period had higher NEFA and lower DMI postpartum 
independent of close-up diet (Dann et al., 2006).  Furthermore, cows that were 
restricted to only 80% of predicted NEL in their close-up diets had higher NEFA 
prepartum but higher energy balance in the first 56 days in milk (Dann et al., 2006).  
Many of these responses are likely related to changes in insulin signaling. 
 
Insulin resistance as a potential mediator 
 The mechanism for the effects of dry period nutrition on the metabolic health 
of cows as they approach calving and early lactation needs investigation.  Analysis of 
adipose tissue collected from cows fed at restricted and excessive energy levels during 
the dry period revealed that adipose tissue from overfed cows had higher rates of 
esterification (Rukkwamsuk et al., 1999b).  Overfed cows also had greater rates of 
lipolysis post-calving than those fed restricted diets (Rukkwamsuk et al., 1999b).  
They concluded that adipose tissue from overfed cows had a lower basal lipolytic rate 
prior to parturition and a higher rate postpartum compared to cows fed diets at 
restricted amounts (Rukkwamsuk et al., 1999b).  As in dairy cattle, there is a decline 
in the ability of insulin to suppress NEFA during late gestation in humans (Catalano et 
al., 2002).  Interestingly enough, the ability is more severely depressed when 
individuals have gestational diabetes.  These humans with gestational diabetes also 
have decreased activation of PPARγ, and greater NEFA concentrations (Catalano et 
al., 2002).   
 Overfed cows (consuming 178% of calculated energy requirements for eight 
weeks prior to calving) also had increased insulin responses to glucose challenge three 
weeks prior to calving, suggesting that overfed cows are more insulin resistant 
(Holtenius et al., 2003).  Additionally the overfed cows had a 20% slower glucose 
clearance rate measured three weeks postpartum.  This implicates postpartum insulin 
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resistance which the authors suggest contributed to these cows having higher NEFA 
and greater BCS loss postpartum (Holtenius et al., 2003).  Likewise, over-conditioned 
ewes had decreased insulin sensitivity as measured by the HEC technique (Bergman et 
al., 1989).  Dann et al. (2006) determined that cows fed 150% of NRC energy 
requirements during the far-off dry period had higher NEFA and β-hydroxybutyrate 
(BHBA) and lost more body weight postcalving despite having higher insulin levels 
during the dry period. In this way, the adipose tissue of overfed cows is geared up for 
lipogenesis in the dry period and will switch to excessive rates of lipolysis post-
calving.  Higher rates of lipolysis lead to higher circulating NEFA and eventually fatty 
liver (Van den Top et al., 1995).  Additionally, higher NEFA serve as an additional 
signal to decrease DMI in early lactation, further driving down negative energy 
balance (Emery et al., 1992; Allen, 2000).     
 It is also likely that increased adipose deposition in ruminants results in 
changes in regulation of adipose tissue hormones related to insulin resistance such as 
leptin, TNFα, adiponectin, and others.  For example, Holtenius et al. (2003) reported 
that overfed cows had higher circulating levels of leptin, which is a regulator of energy 
metabolism and feed intake.  Briefly, but to be discussed in further detail, leptin serves 
as signal of adiposity in many species, and does so via activation of the central 
nervous system (Vernon et al., 2001; Ingvartsen and Boisclair, 2001).  Also to be 
discussed are the potential positive effects of adiponectin on insulin action, as well as 
the negative effects of TNFα on insulin action (Arner, 2003; Kadowaki et al., 2006).  
An additional factor from adipose tissue in ruminants is resistin.  Resistin increases 
insulin resistance and it was shown by Komatsu et al. (2003) that lactating animals 
have 13-fold greater resistin mRNA expression in adipose tissue versus non-lactating 
animals.  These adipokines may serve as links between overfed cows, insulin 
resistance, and metabolic disorders.   
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The use of insulin-sensitizing agents 
 
 Many of the effects discussed related to oxidative metabolism, intake 
regulation, and overall metabolic health are related to insulin action.  Chromium 
deficiency has been linked to insulin resistance and treatment of cows with chromium 
may be a mediator of insulin resistance during the transition period (Hayirli et al., 
2001; Sumner et al., 2007; Spears, 2010).  Lower plasma insulin concentration 
following a glucose tolerance test (GTT) suggested that growing heifers were more 
insulin sensitive when they were fed diets supplemented with chromium propionate 
(Spears et al., 2010).  The effects of chromium on insulin sensitivity are partially 
mediated through increased sensitivity of adipose tissue resulting in greater lipogenic 
rates and a tendency for decreased lipolysis (McNamara and Valdez, 2005).  
Chromium propionate supplementation was shown to increase lipogenesis in adipose 
tissue and reduce lipolysis in periparturient dairy cattle (McNamara and Valdez, 
2005).  In growing heifers, chromium propionate supplementation increased basal 
glucose concentrations and decreased basal insulin and NEFA concentrations, as well 
as increased glucose clearance rate following GTT (Sumner et al., 2007).  Older cows 
with higher BCS were shown to benefit from chromium supplementation as measured 
by decreased circulating BHBA and NEFA, which the authors concluded may result in 
lower rates of metabolic disorders (Yang et al., 1996).  There may be opportunity to 
explore additional insulin-sensitizing agents. 
 The period of mild to moderate insulin resistance during late pregnancy in 
dairy cattle may not be unlike humans in late gestation (Catalano et al., 2002).  
Insulin-sensitizing agents have been used for the treatment of Type II diabetes in 
humans for a number of years (Hammarstedt et al., 2005).  In Type II diabetes, rather 
than an inability to properly produce insulin, individuals have tissue resistance to 
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insulin resulting in a higher concentration of insulin required to elicit a normal 
response.  Common drugs used are those in the family of TZD (Guo and Tabrizchi, 
2006).  The TZDs are synthetic ligands for PPARγ; natural ligands include unsaturated 
fatty acids and eicosanoids (Stienstra et al., 2006).  In general, PPARs are ligand-
activated transcription factors which are involved in energy status and also modulate 
inflammatory responses (Yki-Jarvinen, 2004).  Abundant in adipose tissue, PPARγ is 
a major regulator of adipogenesis (Stienstra et al., 2006).  It has been characterized 
and found to be highly expressed in adipose tissue of ruminants as well (Sundvold et 
al., 1997; Harvatine and Bauman, 2007).   
 When a ligand binds to PPARγ, heterodimerization with retinoid X receptor 
occurs and there is a conformational change that leads to repressor release and 
activator binding which then allows PPARγ to interact with several transcription 
factors (Hammarstedt et al., 2005; Guo and Tabrizchi, 2006).  Example transcription 
factors that bind PPARγ include CAAT/enhancer binding protein responsible for  
PPARγ’s role in adipocyte differentiation and sterol response-element binding protein 
1 responsible for changes in fatty acid metabolism (Hammarstedt et al., 2005).  Within 
adipocytes, PPARγ activation upregulates fatty acid-binding protein, acyl-CoA 
synthase, and LPL and represses TNFα, leptin, and other genes implicated in insulin 
resistance (Guo and Tabrizchi, 2006).  Upregulation of PPARγ has several effects, as 
shown in Table 2-1, which ultimately lead to an overall increase in insulin sensitivity. 
 Thus, it is clear that TZD-effects on insulin sensitivity can be attributed to 
direct [i.e., improved β-cell function; (Gastaldelli et al., 2007)] or indirect mechanisms 
(i.e., adipose tissue remodeling and altered levels of adipokines).   Treatment of 
nonruminants with TZD caused a restructuring of adipose tissue such that there were a 
greater number of smaller adipocytes that are more insulin-sensitive (Arner, 2001).  
Related effects of this remodeling are changes in adipokine secretion and activity.  For 
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Table 2-1.  Effects of PPARγ upregulation. 
Adapted from (Picard and Auwerx, 2002) 
Increased adipogenesis and adipose tissue remodeling: Additional effects:
  Increases in lipogenic genes (LPL, PEPCK)   Increased intake
  Decreases in lipolysis   Decreased circulating NEFA
  Increase in small adipocytes   Inhibition of TNFα, leptin, resistin
  Decreased visceral adipose tissue   Increased adiponectin
  Increased mitochondrial mass in adipocytes   Improved pancreatic β-cell function
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instance, PPARγ activation increases adiponectin expression, and adiponectin is 
known to be lower in individuals who are Type II Diabetic (Maeda et al., 2001).  
Administration of TZD in humans increased mRNA for adiponectin by 1.72-times, 
decreased resistin by almost half, and decreased leptin by 28% in adipose tissue 
(Tonelli et al., 2004).   Response to TZD treatment also varies based on specific 
adipose tissue depots.  For example, visceral adipose tissue depots are decreased or not 
changed with TZD treatment while subcutaneous depots increase (Yang and Smith, 
2007).  Additionally, response to TZD treatment both in vivo and in vitro is greater 
when the ratio of visceral fat to subcutaneous adipose tissue is reduced (Yang and 
Smith, 2007).  This is due to TZD’s ability to increase adiponectin secretion from 
visceral fat (even when the volume of visceral adipose tissue deposits may be 
reduced), it’s ability to control adipocyte cell size and distribution, and control 
lipolytic and lipogenic genes (Yang and Smith, 2007) .    
 It has been shown that the main effects of TZD treatment on insulin resistance 
are related to fatty acid esterification (Tordjman et al., 2003a).  In rats, 
glyceroneogenesis accounts for 75% of the TZD-effect (Tordjman et al., 2003a).  
Through activation of this pathway, release of fatty acids to circulation is decreased 
since they are essentially now trapped in adipose tissue via upregulation of the 
cytosolic form of PEPCK.  There may be additional positive effects of TZD-treatment 
during pregnancy.  TZD treatment was shown to reduce the incidence of diabetes in 
women with a history of gestational diabetes as well as slow decline in β-cell function 
(Xiang et al., 2006).  The positive impact TZD treatment has on fatty acid metabolism, 
as illustrated in applications such as gestational diabetes, suggests that it could serve 
as a potential therapy in transition cows. 
 Treatment with TZD also has been shown to have effects on energy balance.  
In a study of 20 males, energy balance for those receiving placebo was 72% of those 
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treated with TZD (Joosen et al., 2006) .  Larsen et al. (2003) reported  increased intake 
and feed efficiency resulting in increased weight gain in rats treated with TZD.  Some 
of the effects of TZD on energy balance may be indirect, such as its effect on 
adipokine circulation.  Type II diabetics treated with TZD experience increased body 
mass index concurrent with increased hunger (Shimizu et al., 1998).  These same 
subjects had decreased circulating leptin (Shimizu et al., 1998).  Though increased 
weight gain might not be desirable in the situation of human therapy, improved energy 
status might be beneficial in the transition dairy cow in early lactation.  
 
 
2, 4-thiazolidinedione treatment in ruminants 
 The first group to treat ruminants with TZD used it to reverse TNFα-induced 
insulin resistance (Kushibiki et al., 2001).  After treating steers with TNFα, the treated 
animals had smaller glucose area under the curve (AUC) in response to an insulin 
challenge and insulin AUC was smaller following a glucose challenge suggesting that 
steers treated with TNFα were insulin resistant (Kushibiki et al., 2001).  Treatment 
with TZD partially reversed the insulin resistance caused by TNFα administration as 
demonstrated by lower glucose and insulin responses to glucose and insulin challenges 
(Kushibiki et al., 2001).  This paper illustrated the potential use of TZD in ruminants 
to alter insulin resistance.  Additionally, TZDs appeared to enhance peripheral tissue 
sensitivity to insulin without dramatically affecting circulating levels of insulin. 
 In the first study with transition dairy cattle, cows were treated once daily from 
25 d before expected parturition until parturition (Smith et al., 2007).  The results of 
this initial trial indicated that cows treated prepartum with TZD had decreased 
circulating NEFA concentrations during the pre and peri-partum periods and increased 
DMI during the post-partum period (Smith et al., 2007).  Additionally, cows in this 
study were administered an insulin challenge at two doses (0.8 µg/kg of BW and 2.4 
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µg/kg BW) both pre- and postpartum.  There were no differences in responses to the 
insulin challenges based on TZD dose as measured by glucose and insulin AUC, 
which the authors attributed to a lack of effect of TZD treatment on glucose utilization 
in skeletal muscle as expected (Smith et al., 2007).  The results of this study suggested 
the potential for the use of TZD in transition dairy cattle to mitigate the dramatic 
decrease in intake and concurrent rise in NEFA that occurs postcalving.   
 In a second study in transition dairy cattle, cows were treated with two levels 
of TZD (0, 2.0 and 4.0 mg/kg of BW) prepartum and followed through early lactation 
(Smith et al., 2009).  As in the first TZD-transition cow study, plasma NEFA were 
lower in the postpartum period in TZD-treated cows and there was increased DMI in 
the cows during the peripartum period (Smith et al., 2009).  There were also linear 
decreases in postpartum liver triglycerides and glycogen (Smith et al., 2009).  
Administration of TZD linearly increased BCS postpartum, suggesting more favorable 
energy balance in TZD-treated cows (Smith et al., 2009).  As described, the results in 
this study are likely an effect of both direct and indirect effects of TZD administration.  
For instance, increases in DMI can not only be attributed to PPARγ activation, but 
also decreased NEFA.   
 The first published study involving ruminants and TZD administration 
illustrated the potential effects on insulin resistance in ruminants in general (Kushibiki 
et al., 2001).  The second and third studies from our laboratory suggested the potential 
applied application of TZD administration in transition dairy cattle (Smith et al., 2007, 
2009).  The reason that TZD administration might be beneficial for transition dairy 
cattle is related to the changes in insulin signaling that occur during the transition 
period, as already described.  Evidence that insulin resistance occurs in transition dairy 
cattle, especially those overfed during the dry period, in combination with results from 
ruminant TZD trials suggests opportunity for further exploration of the role of insulin 
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resistance in metabolic disorders.  Furthermore, there may be opportunity to use TZDs 
to treat or prevent disease in these animals.  Upregulation of PPARγ likely has its 
greatest effects in adipose tissue, and thus there is opportunity to explore the specific 
roles of adipose tissue in these situations.  
 
The role of adipose tissue 
 
 Excessive adiposity has been linked strongly with Type II Diabetes and 
metabolic syndrome (Stienstra et al., 2006).  Additionally, the location of adipose 
tissue depots is correlated with insulin resistance.  Visceral (vs. subcutaneous) adipose 
tissue depots release more NEFA, with more direct access to the liver, and secrete 
more adipokines (Arner, 2003; Sharma and Staels, 2007).  In 18 non-pregnant, non-
lactating cows fed either low or moderate levels of energy for 56 d, cows that were fed 
the moderate energy level had upwards of 75% increase in omental and mesenteric 
adipose tissue despite no significant differences in BCS (Nikkhah et al., 2008).  This 
suggests that rather than changes in BCS alone, changes in adipose tissue depot size 
and architecture may be factors in overfed cows.  Adipocyte size also appears to relate 
to insulin resistance in that large adipocytes are more insulin resistant, release more 
inflammatory cytokines, less adiponectin, and are found in higher proportion in 
insulin-resistant individuals (Yang and Smith, 2007).  Many of the genes involved in 
fatty acid metabolism as well as the hormones secreted from adipose tissue have 
already been discussed as being implicated in insulin resistance.  What additional roles 
does adipose tissue play in the development of insulin resistance, especially in 
transition dairy cattle? 
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 Regulation of lipolysis and lipogenesis 
 There are a few major genes implicated in regulation of fat metabolism in 
adipose tissue of dairy cattle.  Lipoprotein lipase is the rate-limiting factor in fatty acid 
uptake the endothelium from very low density lipoproteins and chylomicrons.  Cows 
and ewes that were feed-restricted and then refed had large responses in LPL (19-25-
fold increase) and fatty acid synthase (FAS; 6-8-fold increase) mRNA levels after 
refeeding, but less dramatic responses in hormone sensitive lipase (HSL; slight 
increase in feed-restricted cows, no effect in ewes) (Bonnet et al., 1998).  Activity of 
LPL is highly correlated with mRNA level, though the relative activity is much lower 
than in nonruminant species (Hocquette et al., 1998).  Treatment with TZD increases 
LPL expression in white adipose tissue of mice and humans (Kageyama et al., 2003; 
Bogacka et al., 2004).  Fatty acid synthase, involved in de novo fatty acid synthesis, 
also is increased by TZD administration (Bogacka et al., 2004).  It is not surprising 
that key genes involved with fat storage are regulated by TZDs, given the responses 
seen in fat metabolism and the reduction of circulating fatty acids.      
 The balance of lipolysis versus lipogenesis in adipose tissue is a large factor in 
regulating circulating NEFA levels.  Expression of HSL mRNA in adipose tissue 
increases with the onset of lactation and is a key enzyme involved in fat mobilization 
(Sumner and McNamara, 2007).  Lipogenic rates in adipose tissue of dairy cattle in 
early lactation can be almost 40 times lower than rates in mid to late lactation while 
lipolytic rates are also lower (McNamara and Hillers, 1986a; McNamara and Hillers, 
1986b).  Furthermore, effects on lipogenic rates are more related to energy balance 
whereas lipolytic rates seem to vary more based on level of milk production 
(McNamara and Hillers, 1986a; McNamara and Hillers, 1986b).   More recently, cows 
fed moderate versus low levels of dietary energy has higher expression of genes 
related to lipolysis such as HSL (Ji et al., 2010).  Insulin activates enzymes involved in 
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lipid synthesis (LPL, FAS) and downregulates those related to lipolysis (HSL), which 
corresponds with decreased concentration of insulin in ruminants in early lactation 
(Vernon et al., 1981).  Resistance of adipose tissue to insulin therefore removes the 
negative signals insulin has upon lipolytic genes and the result is release of NEFA.  
Thus the relationship of adipose tissue lipogenesis and lipolysis and regulation via 
alteration in response to insulin is a potential area of research.   
 Adipose tissue also has an indirect effect on perpetuating insulin resistance 
through the release of these NEFA (Guo and Tabrizchi, 2006).  Most importantly, 
excess NEFA from adipose tissue further increases insulin resistance.  NEFA enter the 
cell via fatty acid transport proteins and result in increased fatty acid metabolism 
through fatty acyl-CoA and diacylglycerol (Morino et al., 2006).  These changes 
upregulate protein kinase C, and the serine/threonine kinases.  More serine/threonine 
phosphorylation of insulin receptor substrate (IRS) reduces activity, reducing the 
activity of PI3 kinase activity.  With less PI3 kinase activity, glucose uptake is slowed, 
resulting in insulin resistance (Petersen and Shulman, 2006).  Additionally, the excess 
NEFA from adipose tissue results in increased liver triglycerides, reducing the 
gluconeogenic capacity of the liver (Petersen and Shulman, 2006).  Women with 
gestational diabetes had decreased IRS-1 as well as PPARγ (Catalano et al., 2002).   
 The same result of high NEFA is seen in dairy cattle.  Dairy cattle with 
elevated NEFA in response to a 48-h fast had decreased response to glucose infusion 
and reduced rates of glucose clearance were reported (Pires et al., 2007a).  The cattle 
with high NEFA were compared to cows that were treated with nicotinic acid in order 
to reduce plasma NEFA, and the nicotinic acid-treated cows appeared to be more 
insulin sensitive as  measured by improved glucose clearance rates (Pires et al., 
2007a).  Furthermore, cows that were infused with tallow emulsion in order to induce 
hyperlipidemia also had increased insulin resistance as measured by impaired glucose 
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clearance during GTT (Pires et al., 2007b).  This implicates high levels of NEFA 
during early lactation as a cause for more severe insulin resistance.  
 Excessive NEFA from adipose tissue as a result of insulin resistance can also 
have effects on insulin resistance of peripheral tissues.  Increased circulating NEFA 
result in increased fatty acid oxidation by muscle and thus inhibits glucose metabolism 
(Schinner et al., 2005).  Thus, in humans there is emphasis on alleviating excess fatty 
acids as a means of reducing insulin resistance (Delarue and Magnan, 2007).  There 
may also be effects on glucose uptake via impairment of IRS and PI3 kinase or 
increased serine phosphorylation (Schinner et al., 2005).  In this manner, there is 
cross-talk between adipose tissue (more specifically, excessive lipolysis) and 
peripheral tissues upsetting normal glucose and fatty acid homeostasis.  
 Excessive lipolysis in adipose tissue also may have direct effects on the 
pancreas.  In starved cows, there is noted absence of the normal biphasic insulin 
secretion in response to a glucose challenge, and an overall attenuated insulin response 
(Hove, 1978).  Similarly, in ketotic cows, GTT administration resulted in lower insulin 
responses versus non-ketotic cows (Sakai et al., 1996).  In ketotic cows subjected to 
both glucose and insulin challenges, there were effects of long-term hyperketonemia 
on insulin secretion and metabolism (Kerestes et al., 2009).  Finally, in cows with 
metabolic acidosis achieved through adjustment of the dietary cation-anion difference, 
glucose utilization as measured by as reduced insulin response to GTT is altered 
(Bigner et al., 1996).   
 Much of the discussion has already focused on regulation of lipolysis and 
lipogenesis as it is relates to situations of over-feeding during the dry period.  As 
stated, cows that are overfed during the dry period have altered adipose tissue 
metabolism causing them to eat less and lose more body condition post-partum.  Much 
of this is linked to the imbalance of lipolysis vs. lipogenesis described above, and the 
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effects of high concentrations of NEFA on other tissues.  Additional factors include 
hormones released from adipose tissue depots. 
  
Leptin and other adipokines 
 The role of adipose tissue in relation to insulin during the transition periods has 
already been discussed; the effects of additional hormones and cytokines secreted 
from adipose tissue also play important roles during the transition period.  The 
molecules include but are not limited to: leptin, adiponectin, TNFα, and resistin.  
While some hormones secreted from adipose tissue such as leptin serve as a marker of 
energy status and intake control, others such as adiponectin can have direct and 
indirect effects on insulin signaling. 
 Leptin and its role in ruminant metabolism has received much attention in 
recent years (Chilliard et al., 2001; Ingvartsen and Boisclair, 2001; Chilliard et al., 
2005). Known as a signal of adiposity in many species, leptin has the ability to 
increase energy expenditure and protect tissues from accumulation of excess lipid 
(Vernon et al., 2001).  It does so via activation of the central nervous system as 
mediated by cytoplasmic tyrosine kinase Janus kinase-2 (Jak2), IRS-I, the mitogen-
activated protein kinase (MAPK) pathway, and the signal transducer and activator of 
transcription-3 (STAT3), all of which are related to insulin signal transduction 
(Ingvartsen and Boisclair, 2001).   
 In dairy cattle, leptin decreases as much as 50% less than two weeks prior to 
calving and remains low throughout early lactation (Block et al., 2001; Liefers et al., 
2003).  If the negative energy balance seen during early lactation is prevented by not 
milking cows, plasma leptin concentrations are twice that of cows in early lactation 
(Block et al., 2001).  Plasma leptin has been shown to be responsive to periods of 
negative energy balance and refeeding  (Chelikani et al., 2004).    
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 A major factor regulating leptin during the transition period is likely to be 
insulin (Block et al., 2003).  If insulin is a positive regulator of leptin, this may 
partially explain the consequent decrease in plasma leptin and insulin during the late 
prepartum period in dairy cattle (Block et al., 2003).  Additionally, it appears that 
during the negative energy balance experienced during early lactation, the effects of 
leptin may be more on energy conservation than regulation of DMI (Leury et al., 
2003).  Furthermore, the ability of insulin to regulate leptin is decreased in early 
lactation as compared to late pregnancy (Leury et al., 2003).  Leptin mRNA in 
adipocytes is decreased by TZD treatment (Hammarstedt et al., 2005).  Leptin may 
therefore be a key hormone in the regulation of insulin resistance in transition cows 
with or without TZD administration. 
 Another adipokine implicated in insulin resistance is TNFα.  Tumor necrosis 
factor-α is mainly secreted by macrophages but also by other tissue types including 
adipose tissue, and is involved in the acute phase response of inflammation (Carswell 
et al., 1975).  The effects of  increased TNFα are decreased lipogenesis, increased 
lipolysis, and increased circulating leptin concentrations (Arner, 2003).  Additionally, 
TNFα also increases oxidative species in the pancreas and has negative effects directly 
on β-cell function (Greenberg and McDaniel, 2002).  Tumor necrosis factor-α has 
been shown to be higher in cows with greater insulin resistance and fatty liver 
(Ohtsuka et al., 2001).  As already mentioned, steers treated with TNFα had smaller 
glucose AUC in response to an insulin challenge, and insulin AUC was smaller 
following a glucose challenge suggesting  insulin resistance (Kushibiki et al., 2001).  
The TZDs have been shown to affect TNFα activity by decreasing its circulating 
levels, antagonizing TNFα inhibition of insulin signaling, and reducing TNFα 
stimulation of lipolysis (Arner, 2003).  The effects of TZD treatment on TNFα levels 
in dairy cattle are not known. 
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 Adiponectin, which increases insulin sensitivity, is increased by TZD-
treatment (Hammarstedt et al., 2005).  Administration of TZD has also been shown to 
mitigate the reduction in plasma adiponectin that occurs prepartum in transition dairy 
cattle (Kim et al., 2008).  Adiponectin is considered to be an insulin sensitizer because 
it activates pathways related to insulin sensitivity and also inhibits hepatic 
gluconeogenesis, resulting in reduced glucose concentrations (Kadowaki et al., 2006).  
Circulating concentrations of adiponectin were shown to be reduced in women with 
gestational diabetes (Ranheim et al., 2004).  Though not studied extensively in 
ruminants, adiponectin receptors were reported by Lemor et al. (2009) to be decreased 
in dairy cattle post-calving while adiponectin mRNA was not different.  More research 
is required for the full characterization of adiponectin in transition dairy cattle and the 
potential relationship with insulin resistance.     
 An additional factor from adipose tissue in ruminants is resistin, which is 
shown to have greater mRNA expression in lactating versus non-lactating dairy cattle 
(Komatsu et al., 2003).  However, the cows in this study were low in number (4 per 
group) and had large variation in period of time during the dry period (3 to 10 weeks).  
Originally identified as being overexpressed in obese mice, resistin is also 
downregulated by the insulin sensitizing TZDs (Steppan et al., 2001), though the data 
in mouse models has been contradictory (Way et al., 2001).  More recently, 
researchers failed to find a link between resistin and insulin resistance in a group of 
humans despite obese individuals having higher circulating levels of the protein 
(Owecki et al., 2010).  Further work in both ruminants and nonruminants is necessary 
to determine the true relationship between resistin and insulin resistance. 
 Finally, perilipin may be another factor related to adipose tissue metabolism 
and the transition cow.  Phosphorylation of perilipin is necessary for HSL to interact 
with lipids (Shen et al., 2009).  Recently, it has been hypothesized that 
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phosphorylation of perilipin may be an important regulator in both lipolysis occurring 
in early lactation as well as basal lipolysis in late lactation (Sumner and McNamara, 
2007; Elkins and Spurlock, 2009).  Sumner and McNamara (2007) reported increased 
perilipin mRNA in lactation (90 DIM).  Elkins and Spurlock (2009) did not observe 
differences in either mRNA or protein level in early (5-14 DIM) versus later (176-206 
DIM) lactation, though they did report increases in phosphorylation of perilipin.  The 
roles of leptin, adiponectin, TNFα, and other proteins secreted from adipose tissue in 
metabolic regulation of insulin resistant ruminants require further investigation.    
 
Integration of plane of nutrition and insulin-sensitizing agents 
 
 As outlined above, characterization of the effects of plane of nutrition and 
insulin-sensitizing agents on insulin resistance in periparturient ruminants has been 
limited.  Furthermore, interactions of plane of nutrition and administration of these 
agents also have not been investigated.  In order to properly measure effects on insulin 
signaling, however, the appropriate method for evaluating insulin resistance should be 
selected.  As described, insulin resistance includes a combination of both sensitivity 
and responsiveness and if possible, experimental methods chosen must attempt to 
distinguish between the two.  However, practicality of experimental procedures also 
need be considered as well.  Throughout the literature, there are three major methods 
for evaluating insulin resistance:  the hyperinsulinemic-euglycemic clamp (HEC), the 
intravenous glucose tolerance test (GTT), and an intravenous insulin challenge (IC).  
There is only one steady-state calculation-based measure of insulin sensitivity that has 
been used in ruminants and that is the revised quantitative insulin sensitivity check 
index (RQUICKI) (Holtenius and Holtenius, 2007).   
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 The HEC is known in medical fields as the “gold standard” for measuring 
insulin resistance (DeFronzo et al., 1979; Muniyappa et al., 2008).  The reason it is 
considered the “gold standard” is because of its ability to measure effects of elevated 
levels of insulin without the interference of altered glucose concentrations (Trout et 
al., 2007).  During the HEC, insulin is infused at a constant rate and glucose is infused 
simultaneously at variable rates in order to maintain euglycemia.  The goal is to raise 
plasma insulin levels to a plateau, and maintain the animal at those elevated insulin 
levels while maintaining glucose levels at basal concentration +/- 10% (DeFronzo et 
al., 1979; Griinari et al., 1997).  Blood is sampled frequently and analyzed for glucose 
immediately so that the rate of glucose infusion can be adjusted accordingly.  Thus the 
rate of glucose required to maintain euglycemia is essentially an estimate of whole-
body glucose disposal rate given that the greater concentration of insulin should, in 
theory in nonruminants, suppress hepatic glucose production (Muniyappa et al., 2008).  
Accordingly, an individual that requires more glucose to maintain euglycemia is more 
insulin sensitive as they have a greater glucose disposal rate.   
 Short-term clamps that last one and one-half to a few hours (of plateau or 
steady-state) in duration are used to measure changes in insulin resistance while 
longer-term clamps (generally 96 h in the case of ruminants) are used to measure 
longer-term regulation of insulin on metabolism.  The HEC technique has also been 
used to compare differences in insulin sensitivity of fatty acid metabolism in lactating 
versus nonlactating sheep (Faulkner and Pollock, 1990) and in lactating versus 
nonlactating dairy cattle (Andersen et al., 2002).  As described, the assumptions for 
the HEC must be as follows:  1.  Steady-state conditions are achieved, 2.  Hepatic 
glucose production is completely suppressed, and 3.  Steady-state is achieved within 
an insulin concentration where glucose disposal rate can vary based on insulin 
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sensitivity (Muniyappa et al., 2008).  Only when these three criteria are met can one 
be confident in the conclusions drawn from an HEC about relative insulin sensitivity. 
 The GTT, though much easier to administer than the HEC, has results that 
must be interpreted indirectly.  During the GTT, an intravenous dose of glucose is 
given and rapid blood samples are taken in order to determine the time response of 
plasma glucose and insulin.  It is an indirect measure of insulin response since there is 
the added complication that there is a proportion of glucose clearance that is related to 
direct glucose effects (glucose effectiveness) (Bergman et al., 1979; Bergman et al., 
1981).  It gives an overall comparison of insulin sensitivity, glucose effectiveness, and 
β-cell function.  Furthermore, responses in circulating fatty acids can be used to 
evaluate insulin action on fatty acid metabolism (Sumner et al., 2004; Moate et al., 
2007; Boston et al., 2008).   
 If a bolus insulin injection is given shortly after the glucose bolus, there is 
opportunity to make calculations based on the minimal model developed by Bergman 
(1979).  However, if the objective is to measure responses in fatty acid metabolism to 
GTT, it has been observed that adipose tissue will be nonresponsive to exogenous 
insulin given within 20 minutes of the glucose infusion due to hyperinsulinemia 
caused by the response to glucose (Sumner et al., 2004).  Therefore, in terms of 
measuring responses in fatty acid metabolism, it would be beneficial to not include the 
insulin infusion, or wait until endogenous insulin has begun to decline following GTT.  
 Unlike the HEC, steady-state is never reached and thus the GTT model has the 
following assumptions:  1.  Instantaneous distribution of the glucose dose, 2.  Glucose 
disappearance is assumed to occur at a monoexponential rate, 3.  Glucose 
concentration at the end of the GTT is assumed to be identical to that at the beginning, 
4.  Insulin is assumed to act extravascularly to promote glucose disappearance, and 5. 
The effects of insulin to promote glucose disposal and suppress hepatic glucose 
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production are lumped together (Muniyappa et al., 2008).  If a GTT alone, without 
simultaneous insulin infusion and minimal model analysis is completed, it can be 
thought of as an evaluation of “glucose tolerance”, not necessarily insulin sensitivity 
(Bergman et al., 1979; Bergman et al., 1981).  Additionally, hyperglycemia has also 
been found to have direct effects on fatty acid metabolism in dogs (Park et al., 1990). 
During GTT, it may be possible to make relative comparisons of peak concentration of 
glucose relating to insulin responsiveness as well as glucose clearance rate reflecting 
insulin sensitivity (Kahn, 1978).  The GTT may be a more appropriate measure of 
insulin resistance in non-lactating animals as lactating animals have the large non-
insulin dependent glucose utilization by the mammary gland (Bossaert et al., 2009).  
 Finally, the IC is a measure of insulin responsiveness as long as the dose of 
insulin given is large enough.  In the IC, a bolus dose of insulin is given intravenously 
and rapid blood samples are collected in order to determine changes in plasma glucose 
and insulin over time.  The rate and magnitude of decline of plasma glucose following 
the insulin infusion provides an estimate of insulin sensitivity (Muniyappa et al., 
2008).  Disadvantages of IC are that it may induce a state of hypoglycemia which may 
cause counterregulatory mechanisms and confound insulin sensitivity estimates 
(Muniyappa et al., 2008).  Responses in fatty acid metabolism to IC can be observed, 
as long as the animal is not already in a hyperinsulinemic state (Sumner et al., 2004). 
 The RQUICKI is a relative measure of insulin sensitivity based on basal levels 
of insulin, glucose, and NEFA.  Although used extensively in human medicine where 
steady-state glucose metabolism is relatively common, it is used less in ruminant 
species (Holtenius and Holtenius, 2007).  However, the measure has been tested and 
used in ruminant animals on a few occasions (Holtenius and Holtenius, 2007; Kerestes 
et al., 2009; Bossaert et al., 2009).  The calculation for RQUICKI is as follows: 
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RQUICKI  = 1 / [log(Gb) + log(Ib) + log(NEFAb)] 
Where 
Gb = Basal glucose (mg/dL) 
Ib = Basal insulin (µU/mL) 
NEFAb = Basal NEFA (mmol/L) 
 
The nature of RQUICKI is such that a lower RQUICKI suggests greater insulin 
resistance.  Accordingly, obese cows are found to have lower RQUICKI than those 
with adequate body condition (Holtenius and Holtenius, 2007).  The limitations of 
RQUICKI are that it is more applicable in nonruminants where steady-state (fasting) is 
commonly achieved and that it is a single-point-in-time calculation.  Its robustness as 
a relative measure needs further testing in ruminant animals. 
 
Summary and major research questions 
  
 As outlined in this review, though much is already known about transition cow 
metabolism, the mechanistic details of many aspects have yet to be explored.  It is 
clear that insulin plays a major role in many of the metabolic adaptations that occur 
during the transition period.  The concept of insulin resistance in humans is much 
more thoroughly studied and thus it has been beneficial to turn to research in human 
medicine to make applicable assumptions in dairy cattle.  Most interesting has been 
the correlations with obesity and Type II diabetes and how that metabolic situation 
may relate to dairy cattle.  This is not unlike the situation we see in overfed dry cows.  
The nature of this dysregualtion likely stems from fatty acid metabolism and the roles 
of adipose tissue.  Early work in dairy cattle using an insulin-sensitizing agent that 
also serves to target adipose tissue had desirable results and it will beneficial to pursue 
future application.  The exact mechanism of how TZDs affect transition cow 
metabolism would help target the use of such a therapy.  Finally, because energy 
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status plays a large role in insulin signaling, there is opportunity to explore the 
potential interaction of TZD and plane of nutrition.  The major research questions 
sought to be answered with this series of experiments include: 
1. What are the potential metabolic outcomes for the use of insulin-sensitizing 
agents in transition cows? 
2. Do changes in insulin resistance underpin changes in metabolism during 
situations of modified energy status in dairy cattle during late gestation? 
3. Do the effects of TZD administration depend upon plane of energy intake in 
dry cows? 
 It is hypothesized that TZD administration will affect various metabolic 
outcomes in transition cows, which may include changes in plasma leptin, TNFα and 
adipose tissue gene expression.  Furthermore, it is thought that plane of nutrition will 
impact insulin resistance in dairy cattle, responses to negative energy balance, and that 
these responses may interact with TZD administration. 
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CHAPTER 3:  EFFECTS OF PREPARTUM 2,4-THIAZOLIDINEDIONE ON 
INSULIN SENSITIVITY,  PLASMA CONCENTRATIONS OF ADIPOKINES, 
AND ADIPOSE TISSUE GENE EXPRESSION1 
 
Abstract 
 
 Administration of thiazolidinediones (TZD), which are potent ligands for  
peroxisome proliferator-activated gamma (PPARγ), to prepartum dairy cattle has been 
shown to improve dry matter intake (DMI) and reduce circulating non-esterified fatty 
acids (NEFA) around the time of calving.  The objective of this experiment was to 
further elucidate the mechanisms of TZD action in transition dairy cattle via 
investigation of plasma leptin, tumor necrosis factor alpha (TNFα), the revised 
quantitative insulin sensitivity check index (RQUICKI), and adipose tissue gene 
expression of leptin, peroxisome proliferator activated receptor-gamma (PPARγ), 
lipoprotein lipase (LPL) and fatty acid synthase (FAS).   Holstein cows (n = 40) 
entering second or greater lactation were administered 0, 2.0, or 4.0 mg TZD/kg BW 
by intrajuglar infusion once daily from 21 d before expected parturition until 
parturition. Plasma samples collected daily from 22 d before expected parturition 
through 21 d postpartum were analyzed for glucose, NEFA, and insulin. Plasma 
samples collected on d -14, -3, -1, 1, 3, 7, 14, and 49 relative to parturition also were 
analyzed for leptin and TNFα. Data from 40 cows were used for prepartum analyses  
 
 
 
1Research material published in part as abstracts in 2008 and 2010 (Schoenberg et al., 
2008; 2010) 
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and 31 cows were used for peripartal (d -7 to +7) and postpartum analyses. Adipose 
tissue was collected by tissue biopsy on d -7 prior to expected parturition from a 
subset of cows and adipose tissue gene expression was examined via quantitative real-
time polymerase chain reaction.  There was a tendency for a treatment by time effect 
on plasma leptin prepartum such that values were similar on d -14 but cows receiving 
2.0 mg/kg BW of TZD tended to have lower circulating leptin as calving approached. 
Leptin tended to be increased linearly (2.3, 2.4, 2.5 ng/ml) during the postpartum 
period in cows treated with TZD prepartum.  Plasma TNFα also increased linearly 
(0.56, 0.67, 0.70 pg/mL) in response to TZD treatment and decreased through the first 
week postpartum.  RQUICKI was calculated (RQUICKI = (1/[log(glucose) + 
log(insulin) + log(NEFA)])) for 21 d pre- and post-calving and there was an effect of 
day on RQUICKI.  During the peripartal period there was a trend for a quadratic effect 
of TZD administration on RQUICKI (0.77, 0.75, 0.80), suggesting increased insulin 
sensitivity in cows administered TZD. Administration of TZD increased adipose tissue 
expression of PPARγ mRNA (11.0, 13.3, 12.8).  There was a quadratic effect of TZD 
on adipose tissue gene expression of leptin (16.2, 10.7, 17.4).  There were no effects of 
TZD-administration on adipose tissue gene expression of LPL or FAS.  Results 
implicate altered expression and plasma concentrations of leptin, plasma TNFα, 
potential changes in insulin resistance, and changes in expression of PPARγ but not 
LPL or FAS in adipose tissue as potential mechanisms for the effect of TZD 
administration on transition dairy cattle. 
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Introduction 
 
 The overall profitability and health of a dairy cow benefits from successful 
management during the transition period (Drackley, 1999).  The metabolic adaptations 
that support the onset of lactation include increased mobilization of fatty acids from 
adipose tissue and increased hepatic gluconeogenesis (Bell, 1995).  Orchestration of 
nutrient partitioning is necessary to meet new metabolic demands corresponding with 
a simultaneous decrease in DMI around calving, which requires mobilization of body 
fat reserves (Bauman and Currie, 1980).  These responses increase circulating NEFA, 
which when taken up by the liver in excess predispose cows to accumulate triglyceride 
in liver and increase risk for fatty liver and other disorders such as ketosis, milk fever, 
retained placenta, and mastitis (Drackley et al., 2001). 
 Although much research has focused on the ability of the liver to process these 
excess fatty acids (Bobe et al., 2004), there also may be potential to reduce the fatty 
acid load to the liver by modulating the spike in circulating NEFA that occurs during 
the immediate peripartal period.  Part of the homeorhetic adaptation that occurs from 
late pregnancy to early lactation is insulin resistance of peripheral tissues, including 
adipose, in order to spare glucose for the mammary gland (Bell and Bauman, 1997).  
Although this is beneficial to support lactation, excessive insulin resistance of adipose 
tissue likely results in disproportionately high NEFA levels (Vernon, 2005).  Whether 
or not cows experience excessive adipose tissue mobilization postpartum may be 
related to plane of nutrition during the dry period.  Cows that were overfed to 150% of 
energy requirements during the dry period lost more body weight (BW) and had 
higher circulating NEFAs despite higher circulating levels of insulin (Dann et al., 
2006).  Additionally, cows that are overfed during the dry period were suggested to be 
more insulin resistant as measured by reduced insulin responses to glucose challenge 
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(Holtenius et al., 2003).  These observations combined suggest changes in insulin’s 
ability to stimulate glucose uptake and attenuate lipolysis, as well as changes in insulin 
release in response to glucose.  Especially in relation to altering the influence on 
lipolysis, opportunities to target adipose tissue in order to mediate potential insulin 
resistance might be beneficial to transition dairy cows. 
 The use of insulin-sensitizing agents has been used for the treatment of Type II 
diabetes in humans for a number of years (Hammarstedt et al., 2005).  Popular drugs 
used are those belonging to the TZD family of synthetic PPARγ ligands (Guo and 
Tabrizchi, 2006).  PPARs in general are ligand-activated transcription factors that are 
involved in energy status and also modulate inflammatory responses (Yki-Jarvinen, 
2004).  PPARγ is a major regulator of adipogenesis and is most abundant in adipose 
tissue (Stienstra et al., 2006).  It has been characterized and determined to be most 
abundant in adipose tissue of ruminants as well (Sundvold et al., 1997; Harvatine and 
Bauman, 2007). 
 The first group to treat ruminants with TZD used it to reverse TNFα-induced 
insulin resistance in steers (Kushibiki et al., 2001).  Treatment with TZD partially 
reversed the insulin resistance caused by TNFα administration as demonstrated by 
decreased response of plasma insulin to glucose infusion, and reduced response in 
plasma glucose to insulin challenges (Kushibiki et al., 2001).  This paper illustrated 
the potential use of TZD in ruminants to alter insulin resistance.  Additionally, TZDs 
appeared to enhance peripheral tissue sensitivity to insulin without dramatically 
affecting circulating levels of insulin. 
 In the first study with transition dairy cattle, cows were treated with either 0 or 
4 mg/kg BW of TZD by intravenous infusion once daily from 25 d before expected 
parturition until parturition (Smith et al., 2007).  The results of this initial experiment 
indicated that cows treated prepartum with TZD had decreased NEFA during the pre 
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and peri-partum periods and increased DMI  in the post-partum period (Smith et al., 
2007).  This suggested the potential for the use of TZD in transition dairy cattle to 
mitigate the dramatic decrease in intake and concurrent rise in NEFA that occur post-
calving.   
 The results discussed below are a follow-up from a second study in transition 
dairy cattle (Smith et al., 2009).  Similar to the first TZD-transition cow study, plasma 
NEFA were lower in the post-partum period in TZD-treated cows and peripartal DMI 
was higher (Smith et al., 2009).  There were also linear decreases in post-partum liver 
concentrations of triglycerides and glycogen (Smith et al., 2009).   Based on these 
results, it was of interest to further explore potential mechanisms for these beneficial 
effects of TZD administration on transition cow metabolism.  The objectives of this 
study were to determine the effect of prepartum TZD administration on plasma leptin, 
plasma TNFα, a calculated index of insulin sensitivity, and adipose tissue mRNA 
abundance for genes involved in lipid metabolism. 
 
Materials and methods 
 
 All procedures involving animals were approved prior to the onset of the 
experiment by the Cornell University Institutional Animal Care and Use Committee.  
This experiment was part of a larger experiment that commenced in September 2006 
and was completed in March 2007 (Smith et al., 2009).    Detailed Materials and 
Methods can be found in previously published work (Smith et al., 2009).  In brief, 
Holstein cows (n = 40) entering second or greater lactation that had been dried off at 
approximately 60 d before expected calving were selected from the Cornell Teaching 
and Research Center dairy herd and moved to individual tie stalls at approximately 32 
d before expected calving. 
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 Cows were fitted with a single indwelling jugular catheter (Micro-Renathane® 
Implantation Tubing, 2.03 mm o.d. x 1.02 mm i.d.; Braintree Scientific Inc., Braintree 
MA) 23 d before expected calving date.  At 21 d before expected parturition, cows 
were assigned to one of three treatments in a completely randomized design and 
administered TZD at one of two doses (2.0 or 4.0 mg/kg BW) or saline (control) by 
intrajugular infusion once daily at 1200 h until parturition.  TZD was obtained as 2,4-
thiazolidinedione from Sigma Chemical Co. (St. Louis, MO).  Cows were assigned to 
treatments by balancing for BCS and previous calculated 305-d mature equivalent 
milk yield.  Cows were fed a common TMR for ad libitum intake during each of the 
pre- and postpartum periods formulated to meet or exceed predicted requirements for 
energy, protein, minerals, and vitamins (NRC, 2001).   
 Body weights and BCS were recorded once weekly beginning the week prior 
to treatment initiation until the end of the study.  Body condition scores were assigned 
using a five-point system and the scores of two individuals were averaged as the value 
assigned to each cow (Wildman et al., 1982). 
 
Plasma and tissue analyses   
 Blood samples were collected immediately prior to treatment administration 
once daily at 1200 h via jugular catheter from 22 d prior to expected parturition to 
parturition.  A sterile solution of sodium heparin (200 IU/mL of saline) and Naxcel® 
(4 mg/mL of saline; Pfizer Inc.; New York, NY) filled the catheter after sampling to 
prevent blood coagulation and bacterial growth.  Following parturition, blood samples 
were collected daily via venipuncture of the coccygeal vessels until 21 d postpartum 
and then twice per week from wk 4 through 9 of lactation.  Blood samples were 
transferred into glass test tubes containing sodium heparin (100 IU/mL blood).  
Plasma was harvested following centrifugation (2,800 x g for 15 min at 4°C), snap-
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frozen in liquid N2, and stored at -20°C until analyses for metabolites.  Plasma 
concentrations of glucose were determined by enzymatic analysis (glucose oxidase) 
using a commercial kit (kit 510-A; Sigma Chemical).  Plasma concentrations of NEFA 
also were analyzed by enzymatic analysis (NEFA-C; WAKO Pure Chemical 
Industries; Osaka, Japan) with modifications described by McCutcheon and Bauman 
(1986).  Intra- and interassay coeffiecients of variation for plasma glucose and NEFA 
assays were as described previously (Smith et al., 2009).  All spectrophotometric 
measurements were conducted using a Versamax tunable microplate reader (Molecular 
Devices, Sunnyvale, CA).  Plasma concentrations of leptin on d -14, -3, -1, 1, 3, 7, 14, 
and 49 relative to parturition were determined by double-antibody radioimmunoassay 
(Ehrhardt et al., 2000).  Intra- and interassay coefficients of varation for plasma leptin 
were 3.9 and 9.7%, respectively.  Plasma TNFα concentrations from d -14, -3, -1, 1, 3, 
7, 14, and 49 relative to parturition were determined in the laboratory of Dr. Barry 
Bradford (Kansas State University, Manhattan. KS) by enzyme-linked immunosorbent 
assay (ELISA) (Farney et al., 2010). 
 Adipose tissue was collected from a subset of cows prior to initiation of 
treatments and again seven d prior to expected calving date (and thus after 
approximately 14 d of TZD administration).  Six cows were from the group 
administered saline, five cows were administered 2.0 mg/kg BW TZD and four were 
administered 4.0 mg/kg BW TZD.  Days prior to actual calving date averaged 5.8 +/- 
3.8 d and ranged from 1 to 13 days prior to actual calving date.  During biopsies, the 
area was brushed and clipped to remove excess hair and prepared with betadine 
surgical scrub [Betadine Surgical Scrub (7.5% povidone-iodine); Purdue Frederick; 
Stamford, CT] and 70% ethanol in water.  Cows were administered 20 mg of the 
sedative zylazine hydrochloride (Rompun 2%, Bayer Inc., Sarnia, Ontario, Canada).   
A local anesthetic (Lidocaine HCL; 2%; Butler Animal Health; Dublin, OH; 18 cc) 
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was injected subcutaneously around the biopsy site.  The area below the spinal 
processes between the hips and the pins of the cow was palpated to locate an area with 
sufficient subcutaneous fat, a 4-8 cm incision was made with a scalpel blade, and a 
small biopsy (0.5-1.5 g) was removed using sterile forceps and scalpel.  The incision 
was closed with 6-12 surgical skin staples (3MTM PreciseTM Vista Disposable Skin 
Stapler; 3M; St. Paul, MN) and treated with a topical antiseptic (BluKoteTM aerosol 
spray; H.W. Naylor Co.; Morris, NY).  Adipose samples were washed with sterile 
saline, cut into aliquots and placed into sterile and RNAse-free vials, and quenched in 
liquid N2. 
 
Quantitative RT-PCR 
 Analysis of gene mRNA expression was done via quantitative real-time 
polymerase chain reaction (RT-PCR).  RNA was isolated from 150-200 mg of adipose 
tissue using the RNAeasy mini kit (Qiagen; Valencia, CA) and on-column DNase 
digestion with the RNase-free DNAse set (Qiagen; Valencia, CA) after 
homogenization in 1.0 mL of Qiazol (Qiagen; Valencia, CA) reagent.  RNA 
concentration and integrity was determined using an Agilent 2100 BioAnalyzer 
(Agilent Technologies; Santa Clara, CA).  Total RNA was reverse-transcribed using 
ABIs High Capacity cDNA reverse transcription kit with RNAse Inhibitor (Applied 
Biosystems; Foster City, CA).    PCR reactions were carried out using Power SYBR 
Green (Applied Biosystems; Foster City, CA), 25 ng total RNA (or 5 ng total RNA for 
18S) and 400 nmol/L gene-specific forward and reverse primers in a 25 µl reaction 
volume using a 2-step program (95°C for 15 seconds followed by 60°C for 60 
seconds) on an ABI PRISM 7000 sequence detection system (Applied Biosystems; 
Foster City, CA).  Expression of 18S mRNA was used as a housekeeping gene.   
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Primers used were published previously (Thorn et al., 2006; Harvatine et al., 2009).  
Table 3.1 details the primer sequences used.   
 
 
Calculations 
 RQUICKI, the relative insulin sensitivity measure used in ruminants was 
calculated as the following (Holtenius and Holtenius, 2007): 
RQUICKI  = 1 / [log(Gb) + log(Ib) + log(NEFAb)] 
Where 
Gb = Basal glucose (mg/dL) 
Ib = Basal insulin (µU/mL) 
NEFAb = Basal NEFA (mmol/L) 
such that a lower RQUICKI suggests greater insulin resistance. 
 
 
Statistical analysis 
 Statistical analyses were conducted as analysis of variance (ANOVA) on 
measures conducted over time (plasma concentrations, BCS) using the PROC MIXED 
procedure of SAS (2001) for a completely randomized design with repeated measures.  
Nine cows were removed from the dataset for peri- and post-partum data as detailed in 
Smith et al. (2009).  The statistical model included fixed effects of covariate, 
treatment, time and the interaction of treatment and time.  The random effect was cow 
nested within treatment.  For each variable, six covariance structures were evaluated 
(first-order autoregressive, heterogeneous first-order autoregressive, compound 
symmetry, heterogeneous compound symmetry, first-order ante-dependence, and 
unstructured) and the structure with the smallest Akaike’s information criterion was 
selected.  The method of Kenward-Rogers was used for calculation of denominator 
degrees of freedom.  Covariates were dropped from the statistical model if P > 0.15 
 
 
 
 
 
 
 
 
Table 3-1. Primer sequences for adipose tissue gene expression. 
 
 
 
 
48 Target Forward Primer Sequence Reverse Primer Sequence Source
PPARγ AAGAGCCTTCCAACTCCCTCA CCGGAAGAAACCCTTGCAT (Harvatine et al., 2009)
Leptin TCACCAGGATCAATGACATCTCA ACCAGTGACCCTCTGTTTGGA (Harvatine et al., 2009)
Lipoprotein lipase (LPL) GAACTGGATGGCGGATGAAT GGGCCCCAAGGCTGTATC (Harvatine and Bauman, 2006)
Fatty Acid Synthase (FAS) CTGATGAGCTGACGGACTCCA GCGATTGGGCAGGGCT (Harvatine and Bauman, 2006)
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and the data were reanalyzed.  In all cases, prepartum (d -21 to -1; or -14 and -3 d in 
the case of plasma leptin), peripartum (d -7 to +7), and postpartum data were analyzed 
separately, consistent with Smith et al. (2009).  Gene expression data were analyzed 
using the MIXED procedure of SAS including the effects of treatment.  Day relative to 
actual calving date and BCS were evaluated for significance as covariates 
and removed if P > 0.15.  Expression data were evaluated relative to reference gene 
(18S) expression and with expression from a covariate sample as a covariate in the 
statistical model. 
 
Results 
  
 Plasma 
  Results related to daily plasma values and production levels were reported 
previously (Smith et al., 2009).  As reported, TZD administration during the 
prepartum period resulted in a quadratic effect in prepartum plasma NEFA such that 
cows receiving 2.0 mg TZD/kg of BW had higher NEFA than either the control cows 
or those receiving 4.0 mg TZD/kg of BW.  While there were no effects on plasma 
NEFA during the peripartum period, prepartum TZD linearly decreased plasma NEFA 
during the postpartum period.  Administration of TZD prepartum resulted in higher 
glucose concentrations for cows administered 4.0 mg TZD/kg of BW during the pre- 
and peripartum periods.  There was no effect of TZD administration on plasma insulin 
concentrations in these cows.   
 Figure 3-1 illustrates the trend for treatment by day interaction (P = 0.09) of 
prepartum plasma leptin such that cows receiving 2.0 mg TZD/kg of BW prepartum 
had the lowest concentration of plasma leptin as calving approached.   There was no
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 Figure 3-1.  Prepartum plasma leptin.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Data shown are plasma values 
 from d 14 and 3 prior to expected calving date.  Values are least squares means 
 with error bars representing SEM; n = 13 for Control, n = 13 for 2.0 mg 
 TZD/kg BW, n = 14 for 4.0 mg TZD/kg BW.  The P value for treatment by 
 day interaction was 0.09 and effect of day was 0.04.   
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treatment effect on plasma leptin (P = 0.76) during the peripartum period, but plasma 
leptin decreased as calving approached and remained low through d +7 (Figure 3-2; P 
< 0.0001).  Postpartum plasma leptin tended (P = 0.14) to increase linearly in response 
to TZD-treatment as shown in Figure 3-3.  Plasma TNFα was also increased linearly 
during day -14 through day +49 relative to calving date (P = 0.01; Figure 3-4) in 
response to TZD-treatment and decreased (P = 0.001, Figure 3-5) during the first 
week post-partum.   
 As shown in Figure 3-6, there was a trend (P = 0.09) for an interaction of TZD 
administration and day during the peripartum period such that cows receiving 2.0 mg  
TZD/kg of BW had lower RQUICKI prepartum while cows receiving 4.0 mg TZD/kg 
of BW had higher RQUICKI closer to calving.  Additionally, there was a main effect 
of day (P < 0.0001) such that RQUICKI is lowest around the time of calving.  
Postpartum RQUICKI was not affected by prepartum TZD administration (P = 0.54).   
 
 
 Adipose tissue gene expression 
 Cows that were administered TZD had greater adipose tissue expression of 
mRNA for PPARγ than control cows (P = 0.01; Figure 3-7).  There was a quadratic 
effect of TZD (P = 0.04, Trt; P = 0.07, Quad; Figure 3-8) on adipose tissue gene 
expression of leptin such that cows administered 2.0 mg TZD/ kg of BW had the 
lowest leptin mRNA expression.  There were no effects of TZD-administration on 
adipose tissue gene expression for either LPL or FAS (Figures 3-9, 3-10).   
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 Figure 3-2. Peripartal plasma leptin.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Data shown are plasma values 
 from d -3 through d +7 relative to calving date.  Values are least squares means 
 with error bars representing SEM; n =31.  Only the main effect of day is shown 
 as effect of TZD was not significant (P = 0.76).  The P value for effect of day 
 was < 0.0001. 
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 Figure 3-3. Postpartum plasma leptin.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Data shown are average plasma 
 values from d +1 through d +49 relative to calving date.  Values are least 
 squares means with error bars representing SEM; n = 13 for Control, n = 13 for 
 2.0 mg TZD/kg BW, n = 14 for 4.0 mg TZD/kg BW.  The P value for effect of 
 day was 0.008; the P value for linear effect of treatment was 0.14. 
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 Figure 3-4. Pre- and postpartum plasma TNFα.   Cows were administered 
 increasing amounts of TZD during the prepartum period.  Data shown are 
 plasma values from d -14 through d +49 relative to calving date.  Values are 
 least squares means with error bars representing SEM; n = 12 for Control, n = 
 10 for 2.0 mg TZD/kg BW, n = 9 for 4.0 mg TZD/kg BW.  The P value for 
 effect of treatment was 0.03; the P value for linear effect of treatment was 
 0.01; the P value for effect of day was 0.001; the P value for the interaction of 
 treatment and day was 0.68. 
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 Figure 3-5. Peripartal plasma TNFα.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Data shown are plasma values 
 from d -14 through d +49 relative to calving date.  Values are least squares 
 means with error bars representing SEM; n = 31.  Treatment effects are 
 illustrated in Figure 3-4.  The P value for effect of day was 0.001; the P value 
 for the  interaction of treatment and day was 0.68. 
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 Figure 3-6. Peripartal RQUICKI. Cows were administered increasing 
 amounts of TZD during the prepartum period.  RQUICKI was calculated 
 (RQUICKI = (1/[log(glucose) + log(insulin) + log(NEFA)])) for 7 d pre- and 
 post-calving.  Values are least squares means with error bars representing 
 SEM; n = 12 for Control, n = 10 for 2.0 mg TZD/kg BW, n = 9 for 4.0 mg 
 TZD/kg BW.  The P value for effect of treatment was 0.38, for effect of day 
 was < 0.0001; P value for interaction of treatment by day was 0.09. 
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 Figure 3-7. PPARγ mRNA expression.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Adipose biopsies were 
 conducted 7 d prior to expected calving date.  Values are least squares means 
 of arbitrary units in reference to a reference  gene (18S) with error bars 
 representing SEM; n = 6 for Control, n = 5 for 2.0 mg TZD/kg BW, n = 4 for 
 4.0 mg TZD/kg BW.  The P value for effect of treatment was = 0.01. 
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 Figure 3-8. Leptin mRNA expression.  Cows were administered increasing 
 amounts of TZD during the prepartum period.  Adipose biopsies were 
 conducted 7 d prior to expected calving date.  Values are least squares means 
 of arbitrary units in reference to a reference  gene (18S) with error bars 
 representing SEM; n = 6 for Control, n = 5 for 2.0  mg TZD/kg BW, n = 4 for 
 4.0 mg TZD/kg BW.  The P value for effect of treatment was 0.04; the P value 
 for quadratic effect of treatment was 0.07. 
 
0
5
10
15
20
25
1
Le
pt
in
  m
R
N
A
 (a
rb
itr
ar
y 
va
lu
e)
Control
2.0 mg TZD/kg BW 
4.0 mg TZD/kg BW 
 59 
 
 
 
 
 
  
 
 
 
 
 
 
 Figure 3-9. Lipoprotein lipase (LPL) mRNA expression. Cows were 
 administered increasing amounts of TZD during the prepartum period.  
 Adipose biopsies were conducted 7 d prior to expected calving date.  
 Values are least squares means of arbitrary units in reference to a reference 
 gene (18S) with error bars representing SEM; n = 6 for Control, n = 5 for 2.0 
 mg TZD/kg BW, n = 4 for 4.0 mg TZD/kg BW.  The P value for effect of 
 treatment was not significant (0.20). 
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 Figure 3-10. Fatty acid synthase (FAS) mRNA expression.  Cows were 
 administered increasing amounts of TZD during the prepartum period.  
 Adipose biopsies were conducted 7 d prior to expected calving date.  
 Values are least squares means of arbitrary units in reference to a reference 
 gene (18S) with error bars representing SEM; n = 6 for Control, n = 5 for 2.0 
 mg TZD/kg BW, n = 4 for 4.0 mg TZD/kg BW.  The P value for effect of 
 treatment was not significant (0.21). 
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Discussion 
 
 Dynamic metabolic changes occur around the time of parturition in dairy cattle 
(Bell, 1995).  These changes include altered levels of plasma hormones such as leptin, 
changes in insulin resistance, and regulation of adipose tissue gene expression. In this 
study prepartum TZD administration increased peripartal DMI and decreased 
postpartum plasma NEFA indicative of improved  metabolic health (Smith et al., 
2009).  The results reported herein indicate additional effects on plasma leptin, relative 
changes in insulin sensitivity, and lesser effects on adipose tissue mRNA expression of 
key genes involved in lipid metabolism. 
 Known as a signal of adiposity in many species, leptin has the ability to 
increase energy expenditure and protect tissues from accumulation of excess lipid 
(Vernon et al., 2001).   Plasma leptin decreases substantially as calving approaches  
and remains low throughout early lactation (Block et al., 2001; Liefers et al., 2003).  
During the prepartum period, cows treated with the 2.0 mg TZD/kg BW dose had the 
most substantial decrease in plasma leptin and cows treated at the highest dose 
remained at a similar level to Control cows (Figure 3-1).  Leptin mRNA in adipocytes  
has shown to be decreased by TZD (Hammarstedt et al., 2005), so the reason for 
differential effects based on treatment in this case are unclear.  Although insulin was 
reported to increase plasma leptin during the transition period (Block et al., 2003), 
changes in insulin are not likely to be a factor here as circulating insulin levels 
prepartum were not different in these cows (Smith et al., 2009).  Prepartum energy 
balance, calculated as net energy balance according to the NRC, was reported 
previously as 150% for Control cows, 154% for 2.0 mg TZD/kg BW cows, and 162% 
for  cows receiving the highest dose despite no significant differences in prepartum 
DMI  (Smith et al., 2009).  It is possible then that there is some interaction prepartum 
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with energy balance and TZD administration, though energy balance differences here 
might not be significant.  During the peripartum period, effects of treatment were not 
significant, but the effect of day illustrates the normal plasma leptin response reported 
during this period (Block et al., 2001), the effects of which may overshadow treatment 
effects (Figure 3-2). 
 Although there was no effect of TZD administration on plasma leptin during 
the peripartum period, there were differences in plasma leptin in the postpartum 
period.  The linear increase in postpartum plasma leptin for TZD-treated cows (Figure 
3-3) also may be related to energy balance and BCS.  Figure 3-11 shows plasma leptin 
plotted with postpartum BCS.  Circulating leptin has been shown to be higher in cattle 
with higher body condition score (Ehrhardt et al., 2000).  It is possible then, that the  
higher plasma leptin is manifested through indirect effects that TZD administration 
had on energy balance.  This may also explain in part how TZD administration 
prepartum can have lasting effects through early lactation.  Further discussion 
regarding indirect effects on leptin is relevant to changes in adipose tissue gene 
expression discussed in future sections. 
 Another potentially relevant adipokine is TNFα.  Thiazolidinediones have been 
shown to decrease TNFα circulation and activity (Arner, 2003).  In this study,  
however, TZD administration increased plasma TNFα (Figure 3-4).  The relationship 
of TZD administration on TNFα in ruminants has not been determined and TNFα 
itself remains relatively unstudied in dairy cattle.  It has been implicated in insulin 
resistance and fatty liver in transition cows (Ohtsuka et al., 2001), as well as during 
acute mastitis challenges in cows in early lactation (Blum et al., 2000).  Interestingly, 
circulating concentrations of TNFα did decrease based on day relative to parturition 
and were relatively higher prepartum versus postpartum, as depicted in Figure 3-5.  
Increased circulating levels of TNFα have been associated with increased circulating 
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 Figure 3-11. Postpartum plasma leptin and BCS.  Cows were administered 
 increasing amounts of TZD during the prepartum period.  Data shown are 
 average plasma values from d +1 through d +49 relative to calving date and the 
 average BCS from two scorers, based on a 5-point system (Smith et al., 2009). 
 Values are least squares means with error bars representing SEM (0.02); The P 
 value for linear effect of treatment was 0.14 for plasma leptin and 0.001 for 
 BCS.   
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levels of leptin (Arner, 2003), and so it is not surprising that we see similar 
relationships over time.  It is worth noting that the TNFα analysis completed here was 
completed with a relatively new assay designed to detect much lower levels of TNFα 
than previously measured by bioassay and radioimmunoassay (Blum et al., 2000; 
Ohtsuka et al., 2001).  Basal levels of TNFα are relatively low with the absence of 
 infection (Blum et al., 2000).  As few studies have been able to examine the patterns 
of TNFα at these lower levels, the pattern shown around the time of calving is worth 
further investigation. 
 A lower RQUICKI value has implications of greater insulin resistance 
(Holtenius and Holtenius, 2007).  In this study, RQUICKI values decreased as calving 
approached and then increased again slightly through early lactation (Figure 3-6).  
This is in agreement with past statements regarding increased insulin resistance in the 
late prepartum period, as well as RQUICKI calculations in transition cows (Kerestes et 
al., 2009).  Regarding the effects of TZD administration on RQUICKI, RQUICKI was 
highest around calving for cows administered the 4.0 mg TZD/kg of BW dose of TZD 
and lowest precalving for cows receiving the 2.0 mg TZD/kg of BW dose (Figure 3-
7). Although RQUICKI has been associated with changes in BCS, further research is 
required to confirm that cows with lower RQUICKI do indeed have greater insulin 
resistance.  Authors of a previous paper attempted to correlate RQUICKI results with 
those during GTT or IC and concluded that RQUICKI is a poor indicator of insulin 
resistance, especially in cows experiencing poor metabolic health (Kerestes et al., 
2009).  Given the nature of the calculation, changes in plasma NEFA are likely to 
drive changes in RQUICKI.  We would expect changes in plasma NEFA to have 
direct and indirect effects on insulin resistance already, so RQUICKI may be an 
applicable relative measure of insulin resistance.  It would be premature to use 
RQUICKI to quantitatively measure insulin resistance in cows under different 
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physiological states or management strategies, but its future as a general indicator is 
still unknown. 
 Although TZD is a known ligand for PPARγ (Houseknecht et al., 2002), this is 
the first evidence that TZD administration causes upregulation of mRNA expression 
for  PPARγ in dairy cattle (Figure 3-7).  In addition to altering the expression of 
PPARγ mRNA, TZD had a significant effect on leptin mRNA (Figure 3-8).  Although 
the reasons for the differential leptin expression based on level of TZD treatment are 
not apparent, it is very interesting to note that patterns of mRNA expression are in 
agreement with prepartum plasma leptin (Figure 3-1).  Adipose tissue gene expression 
may have been affected by actual day relative to calving when biopsies were taken, as 
well as BCS.   Because adipose tissue samples were taken at d -7 relative to expected 
calving date, there was quite a bit of variation in actual day relative to calving that 
adipose tissue was collected.  Day of adipose tissue biopsy relative to actual calving 
ranged from 2 to 13 d.  Especially for leptin, this is a period of dynamic change and in 
the span of one or two days the major regulatory signals could be very different.  For 
PPARγ mRNA, BCS was determined to be a significant covariate (P = 0.02), and 
therefore included in the statistical model whereas day relative to actual calving date 
was not (P = 0.79).  For leptin expression, although day prior to actual calving date 
was a factor initially (P = 0.11), it was not significant in the final model (P = 0.16), 
and so was eventually dropped.  Body condition score was not a significant covariate 
(P = 0.28) for statistical analysis of leptin expression.  So although it was 
hypothesized that body condition score and day relative to actual calving date may be 
clouding treatment effects, in almost all cases the influence did not reach levels that 
were statistically significant. 
 There were no effects of TZD administration on expression of either LPL or 
FAS in this study.  Although TZD has been shown to increase expression of both of 
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these genes in nonruminants  (Kageyama et al., 2003; Bogacka et al., 2004), its effects 
in ruminants are not yet known.  Because both of these genes have been implicated in 
changes in lipid metabolism occurring during milk fat depression (Harvatine et al., 
2009), it was hypothesized that they may play roles in changes in insulin resistance 
mediated by TZD administration.  In this case, however, effects of treatment were not 
significant.  For the case of LPL, it may not be a large factor in early lactation but 
instead may play a greater regulatory role in mid to late lactation (McNamara et al., 
1987).  Other factors besides LPL and FAS appear to be altering lipid metabolism in 
response to TZD administration.  Other potential targets may include HSL or PEPCK.  
The cytosolic form of PEPCK has been shown to be increased with TZD, resulting in 
decreased fatty acid release (Tordjman et al., 2003b).  This effect is likely a major 
factor in TZD’s effect on insulin resistance and is a logical next step in exploring 
regulation of fatty acid metabolism during insulin resistance and potential mediation 
by TZD.  There is also potential to explore how additional adipokines besides leptin 
and TNFα are affected by TZD administration in dairy cattle.  One example would be 
adiponectin, which has been shown in humans to be increased by TZD (Tonelli et al., 
2004), and may be an important regulator in the transition to early lactation (Lemor et 
al., 2009).  Furthermore, TZD treatment has been shown to attenuate the prepartum 
decrease in plasma adiponectin (Kim et al., 2008). 
    
Conclusions 
 
 Prepartum administration of TZD in transition dairy cattle has been shown to 
improve DMI and metabolic health (as measured by attenuated loss in BCS post-
calving and reduced days to first ovulation) (Smith et al., 2007; Smith et al., 2009).  
Results shown here add to these previous bodies of work.  Expression of PPARγ 
mRNA was upregulated by TZD administration.  Additional results reported herein 
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illustrate that TZD directly or indirectly alters leptin mRNA expression in adipose 
tissue and its circulating peripartal concentrations.  Plasma concentrations of TNFα 
were increased linearly by TZD administration, in patterns potentially opposite to 
results shown in nonruminants.  Although there were no significant effects of TZD on 
RQUICKI, RQUICKI did vary based on day relative to parturition. The relationship of 
RQUICKI and day relative to calving is consistent with timing of insulin resistance 
and TNFα concentration around the time of calving, suggesting that RQUICKI might 
have potential as a qualitative measure of insulin resistance in dairy cattle.  Given 
mixed results in this experiment and others reported, there is need to further evaluate 
RQUICKI before it is used regularly as a measure of insulin resistance in ruminants.  
There were no effects of TZD administration on expression of genes involved in lipid 
metabolism, LPL and FAS.  This study suggests that additional factors than leptin, 
TNFα, LPL and FAS activity play a role in the effects of TZD administration on the 
metabolic health of transition dairy cows.  It does, however, illustrate the importance 
of leptin, TNFα, and insulin sensitivity in temporal changes in the periparturient dairy 
cow. 
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CHAPTER 4:  EFFECTS OF PLANE OF NUTRITION AND FEED DEPRIVATION 
ON INSULIN RESPONSES IN DAIRY CATTLE DURING LATE GESTATION1 
 
Abstract 
 
 Nonlactating Holstein cows (n = 12) in late pregnancy were used to determine 
effects of plane of nutrition followed by feed deprivation on metabolic responses to 
insulin.  Beginning 48 +/- 4.5 d prepartum, cows were fed either a High or Low diet to 
meet 143 and 88% of calculated energy requirements, respectively.  Cows were 
subjected to an intravenous glucose tolerance test in the fed state [GTT; 0.25 g 
dextrose/kg of body weight (BW)] on d 14 of treatment and a hyperinsulinemic-
euglycemic clamp in the fed state (HEC; 1µg/kg of BW/h) on d 15.  Following 24 h of 
feed removal, cows were subjected to a second GTT on d 17 and a second HEC on d 
18 after 48 h of feed removal.  During the feeding period, plasma NEFA 
concentrations were higher for cows fed the Low diet versus those fed the High diet 
(163.6 vs. 73.1 µEq/L), whereas plasma insulin was higher for cows fed the High diet 
during the feeding period (11.1 vs. 5.2 µIU/mL).  For cows assigned to both treatment 
groups, plasma glucose concentrations were lower after 48 versus 24 h of feed 
deprivation (54.6 vs. 67.6 mg/dL) but plasma NEFA concentrations were higher 
(792.6 vs. 219.3 µEq/L).  Glucose area under the curve (AUC) during both GTT were 
higher for cows fed the Low diet than cows fed the High diet (4213 vs. 3750 mg/dL x 
60 min) and was higher during the GTT in the feed deprived state (4878 vs. 3085  
 
1Research material published in part as an abstract in 2009 (Schoenberg et al., 2009)  
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mg/dL x 60 min) than the fed-state GTT, suggesting slower clearance of glucose 
during negative energy balance either pre- or post-feed deprivation.  This 
corresponded with a higher dextrose infusion rate during the fed-state HEC than the 
feed deprived-state HEC (203.3 vs. 90.1 ml/h; P < 0.001).  Plasma NEFA decreased at 
a faster rate following GTT during feed deprivation compared to the fed state (8.7 vs. 
2.9%/min).  NEFA suppression was highest for cows fed the High diet during the feed 
deprived-state GTT, and lowest for cows fed the High diet during the fed-state GTT 
(68.6 vs. 50.3% decrease from basal).  Cows fed the Low diet had greater NEFA AUC 
than those fed the High diet (-19044 vs. -12055 µEq/L x 60 min), as did cows during 
feed deprivation versus the fed state (-25238, -6258 µEq/L x 60 min).  Plasma insulin 
responses to GTT were affected dramatically by feed deprivation such that cows had 
much lower insulin response to GTT by 24 h after feed removal (995 vs. 3957 µIU/mL 
x 60 min).  During the fed-state HEC, circulating concentrations of NEFA were 21% 
below basal for cows fed the High diet and 62% below basal for cows fed the Low 
diet; during feed deprivation NEFA were 79 and 59% below basal for the High and 
Low diets, respectively (diet x HEC).  These results suggest that cows fed below 
energy requirements or feed-deprived have slower clearance of glucose and larger 
NEFA responses to glucose challenge.  Additionally, feed deprivation had a large 
effect on insulin secretion.  Overall, effects of feed deprivation were larger than prior 
plane of nutrition.   
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Introduction 
 
 Cows during the early far-off dry period are experiencing relatively low 
metabolic demands as fetal growth is just beginning to accelerate and cows are no 
longer lactating.  Fetal and uterine tissues are insulin-independent and so as energy 
demands increase with days of pregnancy, maternal peripheral tissues will become 
more insulin resistant in order to support fetal growth (Bell, 1995).  These changes in 
the role of insulin have effects on energy metabolism in dry cows. 
 Much of the work in far-off dry cows has investigated the effect of dry cow 
diets on subsequent health and performance during the transition period and early 
lactation.  Researchers have sought to determine why cows that are over-fed during 
the dry period have more severe decreases in peripartal DMI and higher postpartum 
concentrations of NEFA and β-hydroxybutyrate (BHBA) during the transition period 
(Agenas et al., 2003; Holtenius et al., 2003; Dann et al., 2005; Douglas et al., 2006; 
Dann et al., 2006).  It is our hypothesis that increased body condition, or at least 
increased dietary energy level, makes cows more insulin resistant, leading to abnormal 
metabolic regulation.  Cows fed 178% of calculated energy requirements during the 
entire dry period had greater insulin responses to glucose challenge, indicative of 
increased tissue resistance to insulin (Holtenius et al., 2003). Likewise, ewes that are 
over-conditioned have decreased insulin sensitivity as measured by the 
hyperinsulinemic-euglycemic clamp technique (Bergman et al., 1989).   
 Dann et al. (2006) reported that cows fed diets to achieve 150% of NRC 
requirement for energy during the far-off dry period had higher circulating 
concentrations of NEFA and BHBA and greater loss of BW during the postpartum 
period despite higher insulin levels when consuming the higher energy level diets.  
These results provide further evidence for effects of diet on insulin resistance in 
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adipose tissue.  Overfeeding during the dry period resulted in increased esterification 
rates in adipose tissue prepartum (concurrent with higher circulating insulin) and 
greater lipolytic rates (and thus higher NEFA) postpartum (Rukkwamsuk et al., 
1999b).  The practical outcome is that cows overfed during the dry period lose more 
body condition postpartum (Agenas et al., 2003) and that these alterations in metabolic 
signaling have carryover effects that persist into early lactation.   
 The transition period is one of dynamic changes in metabolic regulation.  It 
may be beneficial then to study changes in insulin resistance independent of additional 
adaptation occurring around the time of calving.  In this case, it was our desire to 
measure the effects of plane of nutrition on metabolism during the dry period.  In 
addition to changes in insulin resistance based on dietary energy level, it is of interest 
to determine how plane of nutrition interacts with subsequent negative energy balance.  
Rather than employ means such as infusion of fats in order to increase plasma NEFA 
(Pires et al., 2007b), a short-term feed deprivation was the approach selected to 
increase plasma NEFA to levels similar to that of early lactation. 
 Therefore, the overall objective of this experiment was to further characterize 
adaptation in response to various states of energy balance occurring during the dry 
period.  Specifically, what effects would overfeeding have on glucose, insulin, and 
fatty acid metabolism and how might that be altered when the same cows are exposed 
to acute negative energy balance?  The hypothesis was that plane of nutrition would 
impact insulin resistance as well as metabolic responses to negative energy balance. 
 A secondary objective for this experiment was to evaluate the use of HEC and 
GTT in measuring metabolic responses related to glucose, insulin, and fatty acid 
metabolism in dry cows.  How might results obtained from HEC and GTT compare?  
Although the HEC is considered the “gold standard” for measuring changes in insulin 
sensitivity, it requires greater resources and the concurrent administration of large 
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amounts of glucose to maintain euglycemia (DeFronzo et al., 1979).  Although the use 
of GTT during lactation is complicated due to the large insulin-independent glucose 
uptake by the mammary gland through GLUT1 and GLUT3 transporters (Bauman and 
Currie, 1980; Bell and Bauman, 1997), it can and has been used as a relative measure 
of changes in insulin resistance in calves and dry cows (Bauman and Currie, 1980; 
Pires et al., 2007b; Bossaert et al., 2009).  Our hypothesis was that changes in insulin 
resistance would be reflected in both the HEC and GTT.  
 
Materials and methods 
 
Animals, treatments, and daily sampling 
  All procedures involving animals were approved prior to the onset of the 
experiment by the Cornell University Institutional Animal Care and Use Committee.  
The animal phase of this experiment took place from August through November 2008.  
Nonlactating Holstein cows (n = 12) entering second or greater lactation that had been 
dried off at approximately 50 d (48 +/- 4.5 d) before expected calving were selected 
from the Cornell Teaching and Research Center dairy herd and transported to the 
Large Animal Research and Teaching Unit (LARTU) and housed in individual tie 
stalls.  Cows were assigned randomly to one of two treatments:  those fed a high plane 
of nutrition (High) or those fed a low plane of nutrition (Low).  Ingredient and nutrient 
content of the diets are described in Table 4-1.  Samples of concentrate mixtures and 
TMR were obtained weekly throughout the experiment, and DM content was 
determined by drying at 55°C until a static weight was observed.  Dry matter contents 
of the TMR were used in calculating DMI for the corresponding week.  The weekly 
TMR samples were composited into 4-wk composite samples and submitted (3 each 
for both High and Low diets) to a commercial laboratory for wet chemistry analysis  
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 Table 4-1.  Experimental diet ingredients and chemical composition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ingredient (% , DM basis) High Low
Corn silage, processed 17.4         6.2        
Wheat straw  20.3       51.0        
Soybean hulls   18.75       12.88      
Wheat mids     5.17         3.55      
AminoPlusTM 1    19.62        13.48     
Soybean meal     8.03        5.52    
Calcium Carbonate     2.88        1.98    
Molasses     3.02        2.08    
Salt 0.27    0.18    
Magnesium Oxide 0.74    0.51    
Trace mineral premix 0.07    0.05    
Vitamin A, D, E premix2 0.07    0.05    
Dicalcium phosphate 0.87    0.60    
Calcium Sulfate 1.74    1.19    
Vitamin E premix3 1.00    0.69    
Nutrient High Low
NEL (Mcal/kg)5      1.35                     1.21             
CP (%)  23.3 (5.16)     16.2 (0.42)  
Soluble protein, % of CP 21.3 (0.58)     21.0 (3.00)  
ADF (%) 26.4 (0.57)    36.3 (0.81)  
NDF (%) 44.0 (1.45)    56.7 (1.34)  
Ca (%) 2.30 (0.33)   1.50 (0.28)
P (%) 0.50 (0.05)   0.40 (0.06)
K (%) 1.50 (0.11)   1.20 (0.24)
Mg (%) 0.70 (0.06)   0.40 (0.07)
Na (%) 0.20 (0.02)   0.10 (0.02)
S (%) 0.60 (0.02)   0.40 (0.05)
1Rumen undegradable protein supplement; AGP® Inc., Omaha, NE
2Contained 37, 113 IU/kg of vitamin A, 7, 216 IU/kg vitamin D, and 72, 165 IU/kg of vitamin E
3Contained 499,400  IU/kg of vitamin E
Chemical Composition4 (DM basis, ± SD) of experimental diets.
4Calculated by Dairy One Cooperative (Ithaca, NY) using NRC (2001) equations from three 
composite samples of each diet
5Estimated from CNCPS (v. 6.1)
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(Dairy One Cooperative Inc., Ithaca, NY).  Samples were analyzed for DM (method 
930.15; (AOAC, 2000)), crude protein (CP) (method 990.03; AOAC, 2000), acid 
detergent fiber (ADF) and neutral detergent fiber (NDF) (Van Soest et al., 1991), and 
macro- and microminerals (Sirois et al., 1994).  Both diets were fed for ad libitum 
intake, split between feedings that occurred at approximately at 1000 and 1600 h.  On 
d 11-15 of the experiment, an additional feeding occurred at 1200 h in order to 
maintain more regular feeding intervals prior to the first GTT and HEC. 
 Body weights were determined for all cows before beginning the feeding 
period, on d 7 of the experiment, and on d 11, 12 and 13 of the experimental period.    
Two individuals recorded BCS for all cows prior to the start of the experiment, one 
week into the experiment, and again at the conclusion of the trial [(1.0 to 5.0 scale, 
(Wildman et al., 1982)].  The average BCS for both individuals was recorded as the 
BCS for each cow at a given time period.   
 Daily blood samples (10 ml) were collected via coccygeal venipuncture in 
order to determine baseline plasma glucose, insulin, and NEFA concentrations.  The 
overall study design is depicted in Figure 4-1.   
 
Glucose tolerance tests and hyperinsulinemic-euglycemic clamps 
 Cows were non-surgically fitted with two indwelling jugular catheters into 
each jugular vein one day prior to the GTT (on d 13).  Catheters (Micro-Renathane® 
Implantation tubing, 2.03 mm o.d. x 1.02 mm i.d.; Braintree Scientific Inc., Braintree, 
MA) were inserted in conscious cows by percutaneous venipuncture.   
Prior to insertion, the area on the neck was clipped to remove the hair, cleaned 
aseptically using Betadine scrub [Betadine Surgical Scrub (7.5% povidone-iodine); 
Purdue Frederick, Stamford, CT] and 70% ethanol in water.  The jugular vein was  
  
 
Figure 4-1.  Study design.  Figure represents overall study layout, by day.
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punctured using a 12g MedicutTM  (12g, 2” Medicut intravenous cannula; Tyco 
Healthcare; Gosport, UK) needle and catheter insertion sleeve.  Once the needle was 
removed, approximately 30 cm of sterile catheter was inserted through the Medicut  
sleeve into the jugular vein.  The catheter was checked for proper function and the 
Medicut sleeve was removed.  The catheter was flushed with sterile saline and 
left filled with sterile saline containing 200 U/mL heparin and secured to the skin of 
the neck using a butterfly and tag cement, placed within bandages, and the entire neck 
was wrapped with Optiplaste (Optiplaste 4”; BSN Medical Ltd.; Brierfield, England) 
and CoFlex (Coflex 4”; Andover Healthcare; Salisbury, MA) bandages to prevent the 
cow from dislodging the catheter.  Patency of the catheters was maintained with 
regular flushing with heparinized saline (10 U/ml for frequent sampling; 100-500 
U/ml otherwise). 
 On d 14 of the experimental period, all cows were subjected to an intravenous 
GTT similar to those described previously (Pires et al., 2007b).  Feed was removed at 
approximately 0800 h.  Briefly, 0.25 g/kg of body weight of glucose i.v. (dextrose 
50% wt/vol) was administered over an average of 6.7 minutes from multiple 60 mL 
syringes approximately two hours after feed removal.  Blood samples (10 ml) were 
collected -120, -15, -5, 0, 3, 6, 9, 12, 15, 20, 25, 30, 45, 60, 90, 120, 150, and 180 min 
relative to the glucose infusion from the catheter.    The “-120”, “-15”, and “-5” min 
samples were taken relative to the beginning of the glucose infusion. The “0” sample 
was taken concurrently from the opposite jugular vein upon complete infusion from 
the final 60 mL syringe and the rest of the samples taken relative to the completion of 
the infusion. 
 On the following day (d 15), a HEC was performed on all cows.  Procedures 
were similar to those described previously (Petterson et al., 1993; Blum et al., 1999).  
Briefly, insulin (1µg/kg of body weight; 27 IU/mg; at a rate of 9.0 ml/hr) was infused 
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into one jugular catheter.  Insulin infusates were prepared using a 1 mg/mL bovine 
insulin (Insulin from bovine pancreas; ≥27 USP units/mg; Sigma Aldrich; St. Louis, 
MO) stock solution, sterile saline, and plasma harvested from each animal the day 
before at a final concentration of 2.5% of total infusate.  The concentration of insulin 
required to maintain a 1 µg/kg of BW dose was based on the average of three weights 
taken on d 11, 12 and 13 of the experiment.  Insulin solution was infused using the 
Macro XL Plum Pump (Abbott Laboratories; Bedford, MA) with a Lifeshield Primary 
IV Plum Set insert (#1642-48; Hospira; Lake Forest, IL).  A priming dose of 1.5 mL 
of insulin infusate was delivered at the onset of the HEC.  Blood samples were taken 
from the catheter contralateral to the infusion lines for frequent (every 5 min until 
steady-state concentrations of whole-blood glucose were reached; every 20 min 
thereafter) cow-side glucose measurements to enable glucose infusion adjustments to 
maintain euglycemia.  Cow-side glucose measurements were conducted on whole 
blood using a handheld blood glucose meter (Precision Xtra; NDC 57599-8814-1; 
Abbott Laboratories; Bedford, MA).  Euglycemia was determined as ±10% of baseline 
whole-blood glucose concentrations (the average of samples collected -15 and -5 
minutes from the start of the HEC).  Glucose (dextrose, 50% wt/vol) was infused i.v. 
from sterile bags via syringe pump (NE-300; New Era Syringe Pump Systems, Inc.; 
Farmingdale, NY) for at least 120 min until steady state was maintained.  Parameters 
measured included plasma glucose, insulin, and NEFA concentrations determined as 
described below. Cows were considered “clamped”, or at steady-state plasma glucose 
for an average of 86 min.  If two steady-states were reached during the duration of the 
HEC, the second steady-state was considered the clamped values for an individual 
cow.  
 Beginning on d 16 of the experimental period, feed for all cows was removed 
for a total of 56 h beginning at 0900 h.  During feed deprivation, cows were 
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supplemented daily with NRC (NRC, 2001) requirements for vitamins and minerals 
with wheat middlings as a carrier (1 kg/d). Water was available to all animals for ad 
libitum consumption.  During feed restriction, blood samples (10 ml) were collected 
via catheters twice daily at 0900 and 1600 h.  After two days of feed restriction, all 
cows were subjected to a second GTT (d 18) followed 24 h later by another HEC as 
described above.  At the conclusion of the second HEC, all cows were refed the Low 
diet for ad libitum intake until returning to the Dairy T&R within three days. 
 
 Plasma analyses   
 Blood samples, regardless of collection methods, were transferred into glass 
test tubes containing sodium heparin (100 IU/mL blood).  Plasma was harvested 
following centrifugation (2,800 x g for 15 min at 4°C), snap-frozen in liquid N2, and 
stored at -20°C until analyses for metabolites and insulin.  Plasma concentrations of 
glucose were determined by enzymatic analysis (glucose oxidase) using a commercial 
kit (kit 510-A; Sigma Chemical).  Intra- and interassay coefiecients of variation (CV) 
were 5.0% and 8.9% respectively.  Plasma concentrations of NEFA were also 
analyzed by enzymatic analysis (NEFA-C; WAKO Pure Chemical Industries; Osaka, 
Japan).  Intra- and interassay CVs were 3.8% and 12.8% respectively.  All 
spectrophotometric measurements were conducted using a Versamax tunable 
microplate reader (Molecular Devices, Sunnyvale, CA).  Plasma concentrations of 
insulin were determined by double-antibody radioimmunoassay (Ehrhardt RA et al., 
2001).  Intra- and interassay CVs were 14.8% and 16.5% respectively.   
  
 Calculations 
 Energy balance was calculated using Cornell Net Protein and Carbohydrate 
System v. 6.1 (Tylutki et al., 2008).   
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 RQUICKI, the relative insulin sensitivity measure used in ruminants was 
calculated as the following (Holtenius and Holtenius, 2007): 
RQUICKI  = 1 / [log(Gb) + log(Ib) + log(NEFAb)] 
Where 
Gb = Basal glucose (mg/dL) 
Ib = Basal insulin (µU/mL) 
NEFAb = Basal NEFA (mmol/L) 
such that a lower RQUICKI suggests greater insulin resistance. 
 Responses to GTT and HEC were measured as area under the curve (AUC), 
calculated using incremental change and trapezoidal rule via SAS (v. 9.2).  Additional 
responses such as clearance rates, half-life, and time to reach basal concentrations 
were estimated using Proc NLIN of SAS (v. 9.2).  The following represents an 
example of the SAS code used to generate estimated parameters: 
 
Data GTTnlin8095fed; 
INPUT Cow diet$ group time glc; 
DATALINES; 
8095 low 1 a 0 170  
8095 low 1 a 3 158.4  
8095 low 1 a 6 158.1  
8095 low 1 a 9 153.3  
8095 low 1 a 12 147.1  
8095 low 1 a 15 145.7  
8095 low 1 a 20 140.1  
8095 low 1 a 25 125.3  
8095 low 1 a 30 123.8  
8095 low 1 a 45 113.6  
8095 low 1 a 60 98.6  
run; 
proc nlin data = GTTnlin8095fed; 
parms A =   170 
           k = -1 to 1 
   ; 
   model glc = A * exp(-k*time); 
   output out=p p=predict; 
   run; 
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Parameter A represents a starting value for maximum plasma concentration, as entered 
from analyzed results.  Clearance rate (CR) was estimated using the slope of the line 
(for the first 30 min for responses in plasma glucose, the first 60 min for plasma 
NEFA) generated by estimated values from SAS.   
 
Time to reach half maximal concentration was calculated as: 
{[ln(2)]/CR}x100; 
 
 Time to reach basal concentration was calculated as: 
 {(ln[ta] – ln[tb])/CR} x100;  
where ta and tb are the concentration in plasma at times a and b respectively. 
 
Statistical analysis 
 Statistical analysis was performed as analysis of variance (ANOVA) on 
measures conducted over time (plasma concentrations) using the MIXED procedure of 
SAS (2001) for a completely randomized design with repeated measures where 
appropriate.  The statistical model included fixed effects of covariate, treatment, time 
and the interaction of treatment and time.  The random effect was cow nested within 
treatment.  For each variable, six covariance structures were evaluated (first-order 
autoregressive, heterogeneous first-order autoregressive, compound symmetry, 
heterogeneous compound symmetry, first-order ante-dependence, and unstructured) 
and the structure with the smallest Akaike’s information criterion was used for further 
analysis.  The method of Kenward-Rogers was used for calculation of denominator 
degrees of freedom.  Covariates were dropped from the statistical model if P > 0.15 
and the data were reanalyzed.  Significance was declared as P values ≤ 0.05; trends as 
0.15 ≥ P ≥ 0.05. 
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Results 
 
Daily intake and plasma 
  Figure 4-2 illustrates the patterns of DMI throughout the trial.  There was a 
significant diet by day interaction (P = 0.03) such that cows fed the low diet consumed 
less DM than cows fed the high diet (10.9 vs. 18.5 kg DMI/d).   Table 4-2 shows the 
average plasma metabolite concentrations for each treatment during the first 13 d of 
the experimental period and after 24 and 48 h of feed deprivation.  There was no effect 
of treatment on plasma glucose for the first 13 d of the trial (66.8 for low vs. 66.4 
mg/dL for high; P = 0.84).  During the first 13 d of the experiment, cows fed the Low 
diet had higher plasma NEFA (164 vs. 73 µEq/L; P < 0.01) and lower plasma insulin 
(5.2 vs. 11.1 µIU/mL; P  < 0.01) concentrations.  There was no effect of treatment on 
calculated RQUICKI for the first 13 d (P = 0.57).  Cows fed the Low diet had higher 
circulating NEFA after 24 (929 vs. 656 µEq/L; P = 0.03) and 48 h (1361 vs. 923 
µEq/L; P = 0.01) of feed deprivation.  There were no significant differences in basal 
plasma glucose levels throughout the trial (P > 0.20), and no significant differences in 
plasma insulin after 24 or 48 h of feed deprivation (P > 0.10). 
 
 Glucose tolerance tests and hyperinsulinemic-euglycemic clamps 
 Figure 4-3 illustrates the change in plasma glucose levels following glucose 
infusion; glucose clearance was slower in cows fed the Low diet and during feed 
deprivation.  Responses are quantified in Table 4-3.  The most apparent differences, as 
detailed in Table 4-3, were found between cows in either the fed versus feed-deprived 
state.  After 24 h of feed deprivation, cows had lower basal plasma glucose (55 vs. 68 
mg/dL; P < 0.001), lower minimum glucose during GTT (50 vs. 62 mg/dL; P < 
0.001), slower glucose clearance rate (1.5 vs. 2.3 %/min; P = 0.003), greater glucose 
 82 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2.  Daily dry matter intake.  Cows were fed one of two dietary treatments 
(High vs. Low plane of nutrition) for two weeks as represented by day of experiment.  
Values represent least squares means with error bars representing SEM; n = 6 for both 
High and Low.  The P value for effect of dietary treatment was P = < 0.0001; for day 
was P = 0.01; for diet by day interaction was P = 0.03. 
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Table 4-2.  Daily metabolites. For cows fed two dietary energy levels (High and Low) for 14 days and subjected to a 24 and 48 
       hour feed deprivation. 
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Low High SEM P Low High SEM P Low High SEM P
NEFA (µEq/L) 163.6  73.1  11.5    <0.01 928.9  656.4  74.9  0.03 1361.1  923.0  98.6  0.01
Glucose (mg/dL) 66.4  66.8  1.3  0.84 53.1  56.1  1.8  0.25 45.0  50.3  2.7  0.20
Insulin (µIU/mL) 5.2  11.1  1.2    <0.01    2.6  5.4  1.1  0.10 1.7  2.1  0.40 0.60
d 1 to 13 After 24 hr feed deprivation After 48 hr feed deprivation
Treatment Treatment Treatment
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Figure 4-3.  Plasma glucose responses to glucose tolerance test.  Cows were fed 
one of two dietary treatments for two weeks (High vs. Low; A) and subjected to an 
intravenous glucose tolerance test in fed state or after 24 h of feed deprivation (Fed vs. 
Feed deprived; B).  Values represent least squares means, incremental change from 
basal plasma levels by minute relative to glucose infusion.  Error bars represent SEM.  
Results detailed in Table 4-3. 
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     Table 4-3.  Effects of diet and feed deprivation on glucose response to i.v. glucose tolerance test. 
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Measurea High Low SEM P Fed FD SEM P
High
Fed
High
FD
Low
Fed
Low
FD SEM P
Basal
glucose
(mg/dL)     62.5     59.7     1.6 0.25    67.6    54.6      1.2 <0.001       68.9      56.1      66.4       53.1      1.7 0.67
Minimum
glucose
(mg/dL)     57.9     53.7     1.8 0.15    62.0   49.6      1.4 <0.001       65.3      50.5      58.7       48.8      2.0 0.07
Maximum
glucose
(mg/dL)   188.3   185.5     3.8 0.61  186.3 187.6      3.0 0.66       187.9    188.7    184.6     186.4      4.3 0.87
CR30 
(%/min)       2.0       1.8     0.15 0.39      2.3    1.5     0.15 0.003         2.4         1.6        2.1         1.5      0.20 0.64
T1/2 (min)     39.3     42.6     3.7 0.54    33.0  49.0       3.7 0.007       29.5        49.1      36.4       48.8      5.3 0.51
Tbasal (min)     90.2   105.3     6.6 0.12    68.8 126.7        6.6 <0.001       59.1      121.4      78.5     132.1      9.4 0.65
AUC30 2537 2732   11 0.25 2280 2989   85 <0.001    2148   2926   2412   3052  121 0.32
AUC60 3750 4213 168 0.07 3085 4878 168 <0.001    2779   4721   3392   5034  237 0.53
AUC90 4344 5032 260 0.09 3313 6063 243 <0.001    2009   5780   3718   6346  343 0.71
Diet Fed vs. Feed Deprived (FD) Diet*Fed/Feed Deprived (FD) Interaction
a Basal glucose = mean glucose concentration at -15 and -5 min prior to GTT; Minimum glucose = minimum glucose during GTT; Maximum glucose = maximum glucose 
during GTT; CR30 = clearance rate during the first 30 min of GTT; T1/2 = Time to reach half maximal glucose concentration; Tbasal = time to reach basal glucose 
concentration; AUC30 = area under the curve during the first 30 min of GTT [mg/dL x 30 min];  AUC60 = area under the curve during the first 60 min of GTT [mg/dL x 
60 min];  AUC90 = area under the curve during the first 90 min of GTT [mg/dL x 90 min]
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half-life (49 vs. 33 min; P = 0.007), longer time to return to basal (127 vs. 69 min; P < 
0.001), and greater AUC (4878 vs. 3085 mg/dL x 60 min; P < 0.001).  There were no 
differences among treatments in maximum glucose during GTT, as would be expected 
(P < 0.61).  There were no significant differences observed based on dietary treatment 
(P > 0.07), although AUC tended to be higher for cows fed the Low diet (4213 vs. 
3750 mg/dL x 60 min; P = 0.07) and the interaction of both dietary treatment and fed 
versus feed-deprived state was also insignificant (P > 0.07).    
 Similar to plasma responses in glucose, the most apparent differences in 
plasma insulin during GTTs were between the fed versus feed-deprived state (Figure 
4-4 and Table 4-4).  As depicted in Figure 4-4, insulin secretion in response to glucose 
infusion was dramatically lower for cows in the feed-deprived versus fed state.  Cows 
after 24 h of feed deprivation had lower basal insulin (4 vs. 8 µIU/mL; P = 0.08), had 
lower maximum insulin (37 vs. 160 µIU/mL; P < 0.001), and lower insulin AUC (995 
vs. 3967 µIU/mL x 60 min; P < 0.001; Table 4-4).  There were no differences in 
plasma insulin response during GTT based on dietary treatment (P > 0.21), nor 
interactions of dietary treatment and whether or not cows were in the Fed state (P > 
0.14).   
 There were significant differences based on dietary treatment as measured by 
changes in plasma levels of NEFA during the GTTs.  Illustrated in Figure 4-5, cows 
fed the Low diet had a greater overall reduction in plasma NEFA during GTT and 
cows after 24 h of feed deprivation had greater responses in plasma NEFA following 
glucose infusion.  These responses are quantified in Table 4-5.  Based on dietary 
treatment, cows that were fed the Low diet had higher basal NEFA prior to glucose 
infusion (636 vs. 386 µEq/L; P = 0.02), had higher minimum NEFA during GTT (272 
vs. 134 µEq/L; P = 0.04), greater NEFA clearance rate (7.1 vs. 4.5 %/min), and more  
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Figure 4-4.  Plasma insulin responses to glucose tolerance test.  Cows were fed one 
of two dietary treatments for two weeks (High vs. Low; A) and subjected to an 
intravenous glucose tolerance test in fed state or after 24 hours of feed deprivation 
(Fed vs. Feed deprived; B).  Values represent least squares means, incremental change 
from basal plasma levels by minute relative to glucose infusion.  Error bars represent 
SEM.  Results detailed in Table 4-4. 
-40
-20
0
20
40
60
80
100
120
140
160
0 50 100 150
In
cr
em
en
t i
n 
pl
as
m
a 
in
su
lin
 
(µ
IU
/m
L
)
Minutes relative to glucose infusion
Fed
Feed deprived
-40
-20
0
20
40
60
80
100
120
140
160
In
cr
em
en
t i
n 
pl
as
m
a 
in
su
lin
 
(µ
IU
/m
L
)
High
Low
A 
B 
  
 
 
 
 
   Table 4-4.  Effects of diet and feed deprivation on plasma insulin response to i.v. glucose tolerance test. 
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Measurea High Low SEM P Fed FD SEM P
High
Fed
High
FD
Low
Fed
Low
FD SEM P
Basal
insulin
(µIU/mL)        7.8        4.4       1.2 0.08        8.1     4.1        1.8 0.08       10.2         5.5        6.1         2.6       2.5 0.78
Maximum
insulin
(µIU/mL)    113.7      83.3     20.1 0.31    159.6   37.4      22.7 <0.001    186.2       41.3    133.0       33.6     32.1 0.25
AUC30  2220  1629   320 0.21  3166    682   320 <0.001  3756     683  2576    681            453 0.21
AUC60  2714  2237   507 0.53  3957    995   408 <0.001  4485     943  3428   1047   577 0.17
AUC90  2779  2453   533 0.68  4030  1202   415 <0.001  4468   1089  3591   1315   587 0.14
Diet Fed vs. Feed Deprived (FD) Diet*Fed/Feed Deprived (FD) Interaction
a Basal insulin = mean insulin concentration at -15 and -5 minutes prior to IVGTT; Maximum insulin = minimum insulin during IVGTT;  AUC30 = area under the curve 
during the first 30 min of IVGTT [µIU/mL x 30 min];  AUC60 = area under the curve during the first 60 min of IVGTT [µIU/mL x 60 min];  AUC90 = area under the 
curve during the first 90 min of IVGTT [µIU/mL x 90 min]
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Figure 4-5.  Plasma non-esterified fatty acid responses to glucose tolerance test.  
Cows were fed one of two dietary treatments for two weeks (High vs. Low; A) and 
subjected to an intravenous glucose tolerance test in fed state or after 24 h of feed 
deprivation (Fed vs. Feed deprived; B).  Values represent least squares means, 
incremental change from basal plasma levels by minute relative to glucose infusion.  
Error bars represent SEM.  Results detailed in Table 4-5. 
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    Table 4-5.  Effects of diet and feed deprivation on plasma NEFA response to i.v. glucose tolerance test. 
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Measurea High Low SEM P Fed FD SEM P
High
Fed
High
FD
Low
Fed
Low
FD SEM P
Basal
NEFA
(µEq/L)      386.4      625.5    54.8 0.02    219.3    792.6     43.4 <0.001     116.3      656.4      322.2      928.9     61.4 0.42
Minimum
NEFA
(µEq/L)      133.5      271.8    40.6 0.04      76.1    329.3     54.5 <0.001      60.3      206.8        91.9      451.7     14.9 0.07
CR60 
(%/min)          4.5          7.1      0.77 0.04        2.9        8.7       0.62 <0.001        1.6          7.4          4.2        10.0       0.89 0.95
T1/2 (min)        45.2        17.4    10.6 0.09      53.9        8.7     14.6 0.01       80.7          9.7        27.1          7.8     20.6 0.10
GSRN        59.5        67.4      3.8 0.18      58.4     68.4       4.4 0.03       50.3        68.6        66.4        68.3       6.2 0.07
AUC30   -5009   -7447   777 0.04 -2129 -10326   777 <0.001   -664   -9354   -3595 -11298         1099 0.66
AUC60 -12055 -19044 1789 0.01 -6258 -25238 1789 <0.001 -2326 -21785 -10189 -28690 2530 0.85
AUC90 -18978 -30739 2865 0.01 -9944 -39773 2865 <0.001 -3697 -34260 -16191 -45287 4052 0.86
Fed vs. Feed Deprived (FD) Diet*Fed/Feed Deprived (FD) Interaction
a Basal NEFA = mean NEFA concentration at -15 and -5 minutes prior to IVGTT; Minimum NEFA = minimumNEFA during IVGTT; CR60 = clearance rate during the 
first 60 min of IVGTT; GSRN = glucose-stimulated reduction of NEFA (% reduction from basal); T1/2 = Time to reach half maximal NEFA concentration; AUC30 = 
area under the curve during the first 30 min of IVGTT [µEq/L x 30 min];  AUC60 = area under the curve during the first 60 min of IVGTT [µEq/L x 60 min];  AUC90 = 
area under the curve during the first 90 min of IVGTT [µEq/L x 90 min]
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substantial AUC (-19044 vs. -12055 µEq/L x 60 min; P = 0.01).  There was also a 
tendency for cows fed the Low diet to have a faster NEFA half-life (17 vs. 45 min; P 
= 0.09).  All measured responses for cows in the fed versus feed-deprived state were 
significant such that feed-deprived cows had higher basal NEFA (793 vs. 219 µEq/L;  
P < 0.001), higher minimum NEFA (329 vs. 76; P < 0.001), greater NEFA clearance 
rate (8.7 vs. 2.9 %/min; P < 0.001), faster NEFA half-life (8.7 vs. 53.9 min; P = 0.01), 
greater glucose-stimulated reduction in NEFA (68.4 vs. 58.4 % reduction 
from basal; P = 0.03), and more substantial AUC (-25238 vs. -6258 µEq/L x 60 min; 
P < 0.001). There were no significant interactions of dietary treatment and whether or 
not cows were in the Fed state in plasma NEFA response to GTT (P < 0.07).   
 The responses measured during HEC take place during the steady-state, or 
“clamped” phase.  Metabolic responses to HEC are detailed in Table 4-6 and reflect 
significant differences in response values during steady-state for HEC performed 
during the fed versus feed-deprived state.  Feed-deprived cows required less glucose to 
maintain euglycemia (90 vs. 203 mL/hr; P < 0.001), had higher plasma NEFA during 
the clamp (330 vs. 63 µEq/L; P < 0.001), and greater NEFA suppression (69 vs. 41%; 
P < 0.001).  As expected, there was no difference in insulin concentration during the 
clamp across all treatments (P > 0.18).  In terms of dietary effects, there were no 
differences in glucose required to maintain euglycemia based on dietary treatment (P 
= 0.81), but there was a tendency for cows fed the Low diet to have greater NEFA 
suppression (60 vs. 50 %; P = 0.11).  There was a significant (P = 0.004) dietary and 
fed versus feed-deprived state interaction  observed in plasma NEFA during the HEC 
such that cows fed the High diet and in the Fed state had the lowest plasma NEFA (55 
µEq/L), cows fed the Low diet and in the feed-deprived state had the highest plasma 
NEFA (456  µEq/L ), and cows in the feed-deprived state previously receiving the 
High diet had intermediary NEFA levels (205 µEq/L ), as did cows receiving the Low  
  
 
 
 
 
Table 4-6.  Variables measured or calculated during steady-state hyperinsulinemic-euglycemic clamp. 
 
 
 
 
 
 
 
 
 
 
 
92 
Measurea High Low SEM P Fed FD SEM P
High
Fed
High
FD
Low
Fed
Low
FD SEM P
Dextrose infusion rate (mL/hr)   149.0     144.5      12.1    0.81       203.2   90.1     17.0 <0.001    195.0     102.9      211.6       77.4      25.3 0.25   
Insulin at clamp (µIU/mL)     34.9       55.1        9.7 0.18         46.9   43.1     10.7 0.66        40.6      29.1        53.2       53.2      15.1 0.40   
Plasma NEFA (µEq/L)   130.0     262.9      22.7 0.001       62.6 330.4     30.4 <0.001      55.1    204.9        70.1     455.8      42.8 0.004
NEFA Suppression (%)     49.9       60.1        4.3 0.11         41.1   68.9       4.3 <0.001      20.7      79.1        61.5       58.6        6.1 <0.001
a NEFA Suppression calculated as: (1-((NEFA at clamp (µEq/L) / basal NEFA)) x 100
Diet Fed vs. Feed Deprived (FD) Diet*Fed/Feed Deprived (FD) Interaction
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diet and in the Fed state (70 µEq/L ).  Suppression of NEFA during the clamp also had 
an interaction (P < 0.001) of diet and Fed state such that cows fed the High diet in the 
Fed state had 21% NEFA suppression, cows previously fed the High diet in the feed-
deprived state had 79% NEFA suppression, cows previously fed the Low diet in the 
feed-deprived state had 62% NEFA suppression and cows previously fed the Low diet 
in the feed-deprived state had 59% NEFA suppression.  Finally, there were no 
significant dietary and Fed versus feed-deprived state interactions related to either 
glucose required to maintain euglycemia or insulin concentration during the clamp (P 
> 0.25).   
 
Discussion 
 
 The original intent of this experiment was to determine the effects of dietary 
energy level on insulin sensitivity and responsiveness and the potential interaction of 
dietary energy (maintenance versus high) when cows are in negative energy balance.  
Due to a feed mixing error, the dietary energy level of the low energy level diet was 
much lower than originally anticipated.  Furthermore, the high forage level of the Low 
diet limited intake as shown in Figure 4-2.  The result was that cows fed the High diet 
were meeting 143% of calculated energy requirement and cows fed the Low diet were 
meeting 88% of calculated energy requirement based on CNCPS v. 6.1 (Tylutki et al., 
2008).  Though there were no significant differences in daily plasma glucose for cows 
fed both diets, the cows fed the High diet had two-times greater circulating insulin 
levels (Table 4-2), corresponding with previous results for cows on high planes of 
nutrition (Holtenius et al., 2003).   The result of the low dietary energy level (Table 4-
1) in conjunction with lower intake resulted in higher plasma NEFA for cows fed the 
Low diet (Table 4-2).   
` 
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 Based on prior work (Holtenius et al., 2003), and because cows in the current 
study fed the High diet had higher circulating levels of insulin but no difference in 
plasma glucose (versus cows fed the Low diet), we expected that cows fed the High 
diet would be more insulin resistant.  The RQUICKI calculation has been used to 
describe differences in apparent insulin resistance in ruminants (Holtenius and 
Holtenius, 2007).  Additionally, as seen in Chapter 3, RQUICKI may detect 
differences in insulin resistance based on day relative to calving.  However, despite 
this, there were no significant differences in calculated RQUICKI for the first two 
weeks in this experiment.  This may correlate with the lack of dietary differences as 
measured by responses to GTT in the Fed state (Table 4-3).  As discussed below, 
responses to GTT as measured by changes in fatty acid metabolism may be more 
meaningful in this experimental design.   
 In addition, the results using RQUICKI as a measure of insulin resistance in 
ruminants have been mixed.  Although Holtenius and Holtenius (2007) drew 
conclusions about insulin sensitivity using RQUICKI in healthy obese cows, strong 
correlations with insulin sensitivity measures in cows with metabolic disorders are 
lacking (Kerestes et al., 2009).  Bossaert et al. (2009) were able to correlate RQUICKI 
and GTT measures in calves, further illustrating the need for future evaluation of 
RQUICKI as a measure of insulin sensitivity.  It appears that RQUICKI may be an 
appropriate measure in some metabolic circumstances but may lack the ability to 
detect differences in others.  In this case, RQUICKI was unable to detect treatment 
differences.  It is worth repeating that treatment differences based on diet were less 
dramatic in the current study and may be the reason why differences in RQUICKI 
were not significant. 
 The high NEFA likely was a factor in the slower glucose clearance during 
GTTs (Figure 4-3; (Pires et al., 2007a)).  This shift in glucose clearance to the right (as 
` 
95 
 
observed in this trial as decreased glucose clearance rates, increased half-life, 
increased time to basal, and increased AUC) is assumed to involve decreased insulin 
sensitivity (Kahn, 1978).  Because a single glucose dose was used in this instance 
there is little that can be ultimately said about changes in responsiveness, although it is 
noted that there was no difference in peak plasma glucose levels for any of the 
treatment combinations.   It could be argued that this would implicate more changes in 
insulin sensitivity than responsiveness in these cows (Kahn, 1978).  Additionally, 
responses to GTT do involve coordinated responses related to both insulin as well as 
direct glucose effectiveness (Kahn, 1978; Muniyappa et al., 2008).    
 Compared to the results seen here, Pires et al. (2007b) reported similar changes 
in glucose clearance for cows that were treated with a tallow infusion for 11 h in order 
to increase plasma NEFA.  The authors were attempting to mimic the increase in 
plasma NEFA that occurs in early lactation in a similar manner to our feed deprivation 
situation, and admit that different physiological conditions exist in the experimentally 
induced negative energy balance versus early lactation.  However, elevation of NEFA 
is only one aspect that affects insulin resistance during late pregnancy and early 
lactation.  The effect of elevated NEFA on glucose clearance is illustrated in the 
dramatic differences in clearance of glucose in fed versus feed-deprived cows (Figure 
4-3).  In this experiment, the effect of a fed versus feed-deprived state was much larger 
than plane of nutrition prior to feed deprivation.   
 Interestingly, the plasma concentrations of NEFA that Pires et al. (2007b) 
reported in their study were nearly identical to those cows in the current study on the 
Low diet in the fed state.  This suggests that in the current study there was likely an 
element of insulin resistance due to low energy balance even during the fed state, 
which may account for the slightly slower glucose clearance in cows fed the Low diet 
as measured by AUC (Table 4-3).  Additionally, Pires et al. (2007a) also completed 
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GTT on cows following 48-h of feed deprivation that were treated or not with 
nicotinic acid in order to reduce NEFA.  Cows that were feed-deprived for 48 h and 
not treated with nicotinic acid had similar plasma NEFA as the cows in the current 
study on the High diet after feed deprivation.  Like this study, cows with higher NEFA 
had slower glucose clearance.  The difference, however, was that cows in the current 
study had much lower secretion of insulin.   
 Slower glucose clearance would suggest reduced insulin secretion, decreased 
sensitivity or responsiveness of tissues to insulin, or a combination of these.  Certainly 
for cows in the feed-deprived state, there was attenuated insulin secretion during the 
GTT (Figure 4-5).   Cows in the feed-deprived state had a much lower insulin AUC as 
well as lower maximum insulin secretion in response to glucose infusion.  Hove 
(1978) deprived lactating cows of feed for 48 h and subjected them to a GTT.  He 
noted a much lower insulin response to GTT, and that unlike non-ketotic cows, there 
was lack of a biphasic insulin response.  A similar biphasic response was seen in fed 
cows in this study (Figure 4-5).   Likewise, cows with metabolic acidosis are shown to 
have much lower insulin response to glucose challenge (Bigner et al., 1996).  In GTT 
performed in pregnant or nonpregant ewes, Regnault et al. (2004), determined that 
pregnant ewes had much lower insulin secretion compared to non-pregnant 
nonlactating ewes.  This corresponds with increasing rates of lipolysis in ewes as 
gestation progresses, which allows circulating NEFA to act as an alternate fuel source 
and promote insulin resistance of peripheral tissues in order to promote substrate use 
by the gravid uterus (Regnault et al., 2004).   Insulin deficiency that was produced 
artificially through the use of a somatostatin infusion in dogs showed evidence of the 
direct effects of hyperglycemia on fatty acid metabolism (Park et al., 1990). 
 There were additional differences in fatty acid metabolism in response to GTT 
in this experiment.  Despite having the lowest secretion of insulin during GTT in this 
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experiment, cows previously fed the Low diet and in a feed-deprived state had the 
greatest clearance rates of NEFA following glucose infusion (Table 4-4).  Previous 
reports of NEFA responses during GTT in cows that were supplemented with 
chromium  in an effort to improve insulin sensitivity showed no significant differences 
in NEFA clearance rates (Hayirli et al., 2001; Sumner et al., 2007).  Given that cows 
fed the Low diet or cows in the feed-deprived state experienced greater reduction in 
plasma NEFA during GTT, had greater NEFA clearance rate during GTT, and greater 
AUC, this may suggest that these cows had lower insulin resistance related to lipid 
metabolism despite having slower glucose clearance.  In a study performed in 
hypertensive adult sheep, there were no significant differences in glucose-associated 
insulin resistance but there was increased insulin sensitivity of the inhibition of 
lipolysis (Gatford et al., 2000).    
 Similar to Gatford et al. (2000), there were differences  in plasma NEFA 
during HEC steady-state observed in this experiment.  Not only did cows on the Low 
diet and those in a feed-deprived state have faster NEFA CR during GTT, but they 
also had a greater suppression of NEFA during HEC (Tables 4-4 and 4-6).  These 
differences were also noted without having significant differences in circulating 
insulin during the clamp.  One of the only reported prior instances of comparing both 
HEC and GTT in ruminant animals was done in calves (Hostettler-Allen et al., 1994).   
In the case of calves, the authors did little to compare data gleaned from the HEC and 
GTT, but did note changes in insulin resistance as measured by multiple methods.  For 
the current experiment, an overall average glucose infusion rate of 2.1 mg 
dextrose/min-1 kg BW-1, is slightly lower than doses required to maintain euglycemia 
in calves (Hostettler-Allen et al., 1994).  The authors concluded that calves are more 
sensitive to insulin than adult ruminants, as would be supported by comparing the 
results of this experiment.  When comparing results in unfed calves, there also seems 
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to be attenuated insulin secretion in response to glucose challenge (Hostettler-Allen et 
al., 1994).  Unfortunately, unlike in this trial, HEC and GTT were not preformed on 
the same animals.  The study described here may be the only trial completed in 
ruminants where HEC and GTT were performed on the same animals in both a fed and 
feed-deprived state. 
 An additional outcome of this experiment was the ability to compare the 
overall results obtained from the GTT and HEC.  Although the HEC is considered the 
“gold standard" for measuring insulin sensitivity (DeFronzo et al., 1979), a great deal 
of information can be obtained from the GTT at a much lower input of resources.  The 
benefit to using the HEC is that it allows one to measure glucose disposal rate without 
having the added effect of increased insulin section (DeFronzo et al., 1979).  One 
downfall to the HEC is that it requires steady-state to be reached at supraphysiological 
levels and therefore may not accurately reflect dynamic or acute changes that may be 
biologically relevant (i.e. in terms of responses to meals, feed deprivation, or acute 
stress; (Trout et al., 2007).  In this case, measures of insulin resistance between the 
GTT and HEC corresponded such that cows that were without feed for 48 h required a 
lower dextrose infusion rate to maintain euglycemia during the HEC (Table 4-6).  The 
corresponding measure during the GTT would be the slower glucose clearance for 
feed-deprived cows.  Neither the GTT nor HEC detected significant differences based 
on dietary treatment in insulin resistance (as measured by clearance rates and AUC 
during GTT and glucose infusion rates during HEC).   
 Both the GTT and HEC detected potential differences in fatty acid metabolism 
based on dietary treatment and whether or not cows were in the fed versus feed-
deprived state.  In the case of GTT, as described above, cows fed the Low diet had 
greater NEFA clearance and AUC in response to glucose infusion.  These observations 
correspond with greater NFEA suppression in cows fed the Low diet at steady-state 
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during the HEC.  Differences in fatty acid metabolism for cows that were either in the 
Fed versus feed-deprived state were also depicted in the HEC such that the cows in the 
feed-deprived state had greater NEFA suppression during HEC, corresponding with 
greater NEFA clearance rates and AUC during GTT.  The significant interaction of 
diet and Fed versus feed-deprived state as measured during the HEC by NEFA 
suppression had very similar relationships as corresponding measurements during 
GTT.  For glucose-stimulated reduction in NEFA during GTT, cows in the feed-
deprived state fed the High diet had the greatest NEFA suppression while cows in the 
Fed state fed the High diet had the lowest NEFA suppression.  Similarities in these 
responses between the HEC and GTT suggest that measures from GTT and HEC may 
be comparable. 
 
Conclusions 
 
 Although the original intent of this experiment was to determine the effect of 
plane of nutrition and feed deprivation on insulin and glucose metabolism in far-off 
dry cows, the overall effects of feed deprivation proved to be much greater than that of 
prior plane of nutrition.  Cows not consuming feed for 24 h had slower glucose 
clearance during GTT than those in the fed state.  In addition, cows without feed for 
48 h required less glucose to maintain euglycemia during HEC.  Furthermore, plasma 
NEFA responses were more intriguing, the most notable being the dramatic response 
in plasma NEFA (greater NEFA clearance rate and AUC) during GTT despite 
attenuated insulin secretion (as measured by AUC) in cows not consuming feed for 24 
h.  These responses correspond with greater NEFA suppression for cows in the feed-
deprived state during HEC.  While the effect of diet on circulating NEFA had an effect 
on metabolic responses (as seen in reduced glucose clearance and greater reduction in 
NEFA during GTT and HEC), there was less of an effect on glucose metabolism 
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directly.  For example, there was only a slight reduction in plasma glucose clearance 
during GTT for cows fed the Low versus High diet as measured by glucose AUC.  
Additionally, responses were for the most part void of interaction between dietary 
treatments and fed versus feed-deprived measures.   
 These results have implications from the standpoint of far-off dry cattle 
nutrition as well as methodological approaches.  In terms of dry cow nutrition, it is 
important to note that extreme negative energy balance will have an effect on glucose, 
insulin, and fatty acid metabolism.  Cows in this trial in negative energy balance had 
reduced glucose tolerance but potentially heightened response to glucose and insulin 
in terms of fatty acid metabolism.  After 24 h of feed removal, cows had much lower 
secretion of insulin, adding evidence that prolonged negative energy balance and 
increased NEFA may reduce the pancreas’ ability to secrete insulin as has been seen in 
ketotic and feed-deprived animals.  It further proves that prolonged negative energy 
balance should be avoided, as is often seen in early lactation.  The experiment also 
provided evidence for the use of GTT and HEC in experimental design since many 
variables measured between the two corresponded with each other.  While comparison 
of results in both situations may not be appropriate in some instances, it appears as 
though GTT might be a suitable candidate to answer experimental questions related to 
glucose, insulin, and fatty acid metabolism. 
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CHAPTER 5:  EFFECTS OF PLANE OF NUTRITION AND 2,4-
THIAZOLIDINEDIONE ON INSULIN RESPONSES AND ADIPOSE TISSUE 
GENE EXPRESSION IN DAIRY CATTLE DURING LATE GESTATION1 
 
Abstract  
 
 Specific mechanisms by which dry period dietary energy level and 
thiazolidinedione (TZD) administration affect transition cow metabolism are not 
known, but we hypothesize effects are mediated via changes in insulin, glucose, or 
fatty acid metabolism. The objective of this experiment was to determine the effects of 
the insulin-sensitizing agent TZD and dietary energy level on glucose and fatty acid 
metabolism during late gestation in dairy cows. Multiparous Holstein cows (n = 32) 
approximately 50 d prior to expected calving date were dried-off and assigned to one 
of two dietary energy levels for three weeks (High, 1.52 Mcal/kg NEL; or Low, 1.34, 
Mcal/kg NEL) and treated daily during the final two weeks with 4.0 mg TZD/kg BW 
(TZD) or saline (Saline) in a completely randomized design. Cows fed the Low diet 
had lower DMI (12.8 vs. 16.1 kg/d) and higher plasma NEFA (103.3 vs. 82.4µEq/L) 
than cows fed the High diet. Cows administered TZD had higher plasma glucose (62.5 
vs. 59.6 mg/dL) than saline controls and cows fed the High diet had higher plasma 
insulin (35.1 vs. 25.3 µIU/mL) compared to those fed the Low diet. After two weeks 
of TZD treatment, all cows were subjected to an intravenous glucose tolerance test 
(GTT; 0.25 g dextrose/kg BW) followed 110 min later by an insulin challenge (IC; 1.0  
 
 
 
1Research material published in part as conference proceedings in 2010 (Schoenberg and 
Overton, 2010)  
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µg/kg BW). There was a trend for cows fed the High diet to have lower area under the 
curve (AUC) for plasma glucose during GTT (1895 vs. 2410 mg/dLx90 min) than 
those fed the Low diet; however, cows fed the Low diet had more negative NEFA 
AUC (-4838 vs -2137 µEq/Lx90 min) and greater NEFA clearance rates (1.35 vs. 0.63 
%/min) during GTT, suggesting differential responses of tissue glucose and fatty acid 
metabolism in response to dietary energy level. During IC, TZD-treated cows tended 
to have more negative glucose AUC (-45.0 vs. -12.1 mg/dL x 15 min) than controls, 
suggesting that TZD-treated cows had greater responses to insulin. Interactions of diet 
and TZD were only significant for NEFA responses to IC such that cows fed the Low 
diet receiving TZD had a negative AUC (-80 µEq/L x 15 min), cows fed the High diet 
and treated with either saline or TZD had slightly positive AUC (65 and 67 µEq/L x 
15 min, respectively), and cows fed the Low diet receiving saline had the most 
positive AUC (517 µEq/L x 15 min).  These results indicate that energy level and 
insulin-sensitizing agents affect glucose and lipid metabolism during the dry period, 
which may have implications for the transition period. 
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Introduction  
 
 The transition period requires complex coordination of tissues in order to 
support the onset of lactation (Bauman and Currie, 1980).  Although the transition 
period was first defined by Grummer (1995) as the three weeks prior to and following 
calving, much research has focused on the role of nutrition during the far-off as well 
as the close-up dry periods.  Maximizing prepartum dry matter or energy intake had 
previously been recommended (Curtis et al., 1984, 1985), however, many research 
groups have reported potentially negative consequences of overfeeding cows during 
the dry period (Grummer, 1995; Holtenius et al., 1996; Dann et al., 1999; Agenas et 
al., 2003; Holtenius et al., 2003; Dann et al., 2005; Dann et al., 2006).  Many of the 
more recent experiments reported sharper decreases in DMI and more dramatic 
increases in NEFA prior to and post-calving for cows that were overfed during the dry 
period.  The consequences of excessive postpartum mobilization of adipose tissue are 
increased incidences of metabolic disorders such as ketosis and fatty liver due to 
prolonged negative energy balance (Grummer, 1993; Douglas et al., 2006).   
 Feeding a controlled energy diet throughout the dry period has been shown to 
limit body condition losses post-calving, especially if gain in body condition is limited 
(Richards et al., 2010).  Furthermore, recent data suggests that changes in energy 
metabolism may occur with overfeeding without observable changes in BCS.  In a 
group of non-pregnant dry cows that were fed either a low (NEL = 1.37 Mcal/kg) or 
moderate (NEL = 1.61 Mcal/kg) energy level, the cows that were fed the moderate 
energy level deposited greater than 70% more internal fat despite no significant 
differences in assigned BCS (Nikkhah et al., 2008).  Therefore, changes in BCS alone 
may not be enough to determine the effects of overfeeding on transition cow 
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metabolism.  An understanding of coordinated changes in whole-body metabolism 
during situations of overfeeding is necessary.   
 Insulin, in particular changes in tissue responses to insulin, may be a key factor 
in these alterations in energy metabolism in overfed cows.  Cows fed at 178% of 
calculated energy requirements during the entire dry period had greater insulin 
responses to glucose challenge, indicating insulin resistance (Holtenius et al., 2003).  
Dann et al. (2006) reported that cows fed at 150% of NRC-predicted energy 
requirements in the far-off dry period had higher NEFA and BHBA and lost more 
body weight post-calving despite having higher insulin levels during the dry period.  
The potential role for insulin resistance in overfed cows and how it could be mediated 
is not known. 
 The use of an insulin-sensitizing agent, TZD, in transition dairy cattle resulted 
in increased DMI and decreased NEFA during the transition period (Smith et al., 
2007; Smith et al., 2009).  This PPARγ ligand has insulin sensitizing-effects targeted 
to adipose tissue (Sundvold et al., 1997; Hammarstedt et al., 2005).  The first use of 
TZD in ruminants reversed TNFα-induced insulin resistance, further supporting its 
potential application during the transition period (Kushibiki et al., 2001). 
 Much of the research conducted on plane of nutrition in dry cows has focused 
on responses in BCS loss and corresponding metabolites; therefore, there is need for 
further study of adipose tissue metabolism.  Overfeeding during the dry period 
resulted in increased esterification rates in adipose tissue prepartum (concurrent with 
higher circulating insulin) and greater lipolytic rates (and thus higher NEFA) post-
partum (Rukkwamsuk et al., 1999b).  These changes in regulation partially explain the 
greater post-partum loss of body condition observed in cows overfed during the dry 
period.  Given these observations, there is a need to clarify the potential mechanisms 
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by which controlled plane of nutrition and insulin-sensitizing agents can positively 
affect the metabolic health of transition dairy cows. 
 Therefore, the objectives of this experiment were to determine the effects of 
dietary energy level and administration of an insulin-sensitizing agent (TZD) on 
glucose and fatty acid metabolism during the dry period.  Specifically, what effect 
would excessive energy balance have on plasma concentrations of glucose, insulin, 
and fatty acids, and what interactions would exist between dietary energy level and 
TZD administration?  In order to determine these effects, responses to glucose and 
insulin challenges and responses in gene expression in adipose tissue were measured.  
The hypothesis was that plane of nutrition would impact energy metabolism related to 
insulin resistance, with potential interactions of TZD treatment. 
 
Materials and methods 
Animals, treatments, and daily sampling 
 The animal phase of this experiment took place from November 2009 through 
February 2010.  All procedures involving animals were approved prior to the onset of 
the experiment by the Cornell University Institutional Animal Care and Use 
Committee.  The overall project design is depicted in Figure 5-1.  Holstein cows (n = 
32) entering second or greater lactation were selected from the Cornell Teaching and 
Research Center dairy herd and dried off at approximately 50 d before expected 
calving date and moved to individual tie stalls to begin the experiment within one 
week.  Based on actual calving dates, cows began the experiment an average of 48 (+/- 
8) d prior to calving.  Cows were assigned randomly to one of two dietary treatments:  
those fed a high plane of nutrition (High) or those fed a low plane of nutrition (Low), 
based on dietary energy level and the resulting DMI.  Table 5-1 details diet ingredients 
and chemical composition.  Diets were sampled and analyzed by Dairy One  
  
Figure 5-1.  Study design.  Figure represents overall study layout, by day. 
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 Table 5-1.  Experimental diet ingredients and chemical composition.   
Ingredient (% , DM basis) High Low
Corn silage, processed 62.7       32.3        
Wheat straw   7.0       33.4        
Soybean hulls     9.53       10.77      
Distillers grains (with solubles)     9.09       10.29      
AminoPlusTM 1     6.21        7.03    
Soybean meal     3.12        3.53    
Calcium Carbonate     1.23        1.39    
Molasses     0.68        0.86    
Salt 0.27    0.31    
Magnesium Oxide 0.05    0.06    
Selenium 0.06% 0.03    0.03    
Vitamin A, D, E premix2 0.03    0.03    
1100 DairyTM 3 0.03    0.03    
Zinc Sulfate 0.0003 0.0003
Vitamin E premix4 0.0003 0.0003
Nutrient High Low
NEL (Mcal/kg)      1.52 (0.02)           1.34 (0.05)   
CP (%) 13.5 (0.51)     14.0 (0.40)  
Soluble protein, % of CP 33.7 (0.58)     30.3 (1.53)  
Acid detergent insoluble CP (%) 0.70 (0.06)   0.80 (0.06)
Neutral detergent insoluble CP (%) 2.40 (0.21) 2.90 (0.06
ADF (%) 25.6 (1.55)    35.0 (1.87)  
NDF (%) 41.4 (0.45)    52.3 (0.75)  
Starch (%) 25.9 (0.66)    15.2 (0.70)  
NFC, 6 (%) 39.3 (0.99)    28.1 (0.68)  
Ether extract (%) 2.10 (0.25)   2.20 (0.30)
Ash (%) 6.10 (0.19)   6.40 (0.19)
Ca (%) 0.60 (0.08)   0.70 (0.04)
P (%) 0.30 (0.01)   0.30 (0.01)
K (%) 1.20 (0.08)   1.10 (0.03)
Mg (%) 0.20 (0.01)   0.20 (0.00)
Na (%) 0.20 (0.03)   0.20 (0.03)
Cl (%) 0.30 (0.01)   0.30 (0.02)
S (%) 0.20 (0.01)   0.20 (0.01)
DCAD7, mEq/100 g DM        17.7 (0.58)       15.0 (0.00)          
1Rumen undegradable protein supplement; AGP® Inc., Omaha, NE
2Contained 37, 113 IU/kg of vitamin A, 7, 216 IU/kg vitamin D, and 72, 165 IU/kg of vitamin E
3Cargill Animal Nutrit ion propietary blend, Elk River, MN
4Contained 499,400  IU/kg of vitamin E
Chemical Composition5 (DM basis, ± SD) of experimental diets.
5Calculated by Dairy One Cooperative (Ithaca, NY) using NRC (2001) equations from three 
composite samples of each diet
6Calculated as 100‐[(NDF‐ NDFCP) + CP + ash + ether extract] (NRC, 2001)
7Calculated as mEq [(Na + K) ‐ (Cl + S)]/100 g DM (NRC, 2001)
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Cooperative (Ithaca, NY) as described in Chapter 4 in addition to neutral detergent 
insoluble CP and acid detergent insoluble CP (Licitra et al., 1996), ether extract (EE; 
method 2003.05;(AOAC, 2000)), ash (method 942.05; AOAC, 2000), and starch 
(Application note 319, TSI Inc., Yellow Springs, OH).  Both diets were fed for ad 
libitum intake once per day at approximately 1000 h for a total of three weeks.  
 On d 7 of the experiment, cows were fitted with indwelling jugular catheters as 
described in Chapter 4.  Patency of the catheters (Micro-Renathane® Implantation 
tubing, 2.03 mm o.d. x 1.02 mm i.d.; Braintree Scientific Inc., Braintree, MA) was 
maintained with regular flushing with heparinized saline (10 units/ml for frequent 
sampling; 100-500 U/ml otherwise).  Heparinized saline with an antibiotic was used 
for overnight storage of catheters to prevent bacterial growth (Naxcel®; 4 mg/mL of 
saline; Pfizer Inc., New York, NY).  There were no observed infections or 
complications in cows with catheters installed for two weeks.   
 Body weights were determined for all cows before beginning the feeding 
period, and again once per week until the end of the trial.  Two individuals recorded  
BCS (Wildman et al., 1982) for all cows prior to the start of the experiment, and 
weekly until the conclusion of the trial.  The average BCS for both individuals was 
recorded as the BCS for each cow at a given time period.  Daily blood samples (10 ml) 
were collected at approximately 1200 h each day via coccygeal venipuncture prior to 
catheter insertion and via jugular catheter beginning on d eight.  Additionally, a blood 
sample was drawn prior to the start of the experiment to serve as a covariate for each 
animal.    
 Beginning on d 8 of the experiment, cows were infused with a TZD solution at 
a dose of 4 mg/kg body weight.  The BW used to calculate dose was an average of the 
two BW measurements collected on d 1 and 7 of the experimental period.    The TZD 
was solubilized into solution as follows.  All glassware and weighing tools were 
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sterilized via autoclave prior to preparation of the solution.  The crystalline TZD (2,4-
Thiazolidinedione, Technical grade, 90%; Sigma-Aldrich Corp.; St. Louis, MO) was 
weighed into sterilized glass bottles for each cow and 60 mL of sterile saline (0.9% 
wt:vol) was added to the bottle.  The bottles were then capped with rubber Wheaton 
stoppers and aluminum seals (AluminumSeal 20mm FlipCap; Wheaton Science 
Products; Millville, NJ), placed into a hot water bath (37°C) for 20 min, and vortexed 
until TZD remained in solution.  Storage of bottles overnight for the next day was 
devoid from light and at room temperature.  On the morning of dose administration, 
the aluminum seal on each bottle was opened and the TZD solution was removed 
through the rubber stopper via sterile needle and 60 mL syringe.  If syringes were 
exposed to extreme cold for a long period of time, TZD had a tendency to come out of 
solution at which time a warm water bath and shaking was sufficient to resolubilize 
the TZD.  Doses were administered to each cow at approximately 1300 h each day via 
jugular catheter.   
 
  Glucose tolerance tests and insulin challenges 
 At the end of the experiment (d 22), all cows were subjected to an intravenous 
GTT similar to those conducted previously (Pires et al., 2007a; Pires et al., 2007b) and 
described in Chapter 4.  Feed was removed at approximately 0700 h.  Briefly, 0.25 g 
of glucose (dextrose 50% wt/vol) per kilogram of BW was administered in under 
seven min from multiple 60 mL syringes approximately two h after feed removal.  
Blood samples (10 ml) were collected -15, -5, 0, 5, 10, 15, 20, 25, 30, 45, 60, and 90 
min relative to the glucose infusion into the catheter.  The “-15”, and “-5” min samples 
were time relative to the beginning of the glucose infusion.  The “0” sample was 
collected immediately following the conclusion of the glucose infusion and a 20 mL 
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saline flush.  The rest of the samples were timed and collected relative to the 
completion of the infusion. 
 At 110 min following glucose infusion, an insulin challenge (IC) was 
administered to each cow.  For the IC, cows received 1µg of insulin (insulin from 
bovine pancreas; ≥27 USP units/mg; Sigma Aldrich; St. Louis, MO) per kilogram of 
BW at a solution concentration of 0.2 mg/mL.  The total infusion volume averaged 
2.45 mL.  The insulin dose was followed immediately by 20 mL of saline flush.  
Blood samples were then collected at 5, 10, 15, 20, 25, 30, 45, 60, 75, 90, 120, and 
180 min following the insulin infusion. 
 
 Plasma analyses   
 Blood samples, regardless of collection methods, were transferred into glass 
test tubes containing sodium heparin (100 IU/mL blood).  Plasma was harvested 
following centrifugation (2,800 x g for 15 min at 4°C), snap-frozen in liquid N2, and 
stored at -20°C until analyses for metabolites and insulin.  Plasma concentrations of 
glucose were determined by enzymatic analysis (glucose oxidase) using a commercial 
kit (kit 510-A; Sigma Chemical).  Intra- and interassay coefficients of variation were 
4.9 and 8.0% respectively.  Plasma concentrations of NEFA were also analyzed by 
enzymatic analysis (NEFA-C; WAKO Pure Chemical Industries; Osaka, Japan).  
Intra- and interassay coefficients of variation were 4.1 and 9.7% respectively.  All 
spectrophotometric measurements were conducted using a Versamax tunable 
microplate reader (Molecular Devices, Sunnyvale, CA).  Plasma concentrations of 
insulin were determined by double-antibody radioimmunoassay (Porcine Insulin RIA 
Cat. #PI-12K; LINCO Research; Millipore; St. Charles, MO).  The methodology of 
the insulin kit is very similar to that of the RIA used to analyze plasma insulin in 
Chapter 4 (Ehrhardt RA et al., 2001) and has a reported specificity to bovine insulin of 
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90%.  Intra- and interassay coefficients of variation for the insulin assay were 1.7 and 
7.5%, respectively. 
 
     Adipose tissue biopsies 
 On d 23 of the experiment, adipose biopsies were collected from all cows.  The 
procedure used is similar to that described by Houseknecht and Bauman (1997).  The 
area below the spinal processes between the hips and the pins of the cow was palpated 
to locate an area with sufficient subcutaneous fat.  The area was brushed and clipped 
to remove excess hair and prepared with betadine surgical scrub (Betadine Surgical 
Scrub (7.5% povidone-iodine; Purdue Frederick; Stamford, CT) and 70% ethanol in 
water.  Cows were administered 20 mg of the sedative zylazine hydrochloride 
(Rompun 2%, Bayer Inc., Sarnia, Ontario, Canada).  A local anesthetic (Lidocaine 
HCL, 2%, 18cc) was injected subcutaneously around the biopsy site.  A 4-8 cm 
incision was made and a small biopsy (0.5-1.5 g) was removed using sterile forceps 
and scalpel. The incision was closed with 6-12 surgical skin staples using a surgical 
staple gun (Precise Vista Skin Stapler 35W; 3M; St. Paul, MN).  The wound was 
topically treated with a topical antiseptic (BluKoteTM aerosol spray; H.W. Naylor Co., 
Morris, NY).  Adipose tissue samples were rinsed with sterile saline, cleaned of 
connective tissue, cut into three aliquots, placed into plastic vials, and quenched in 
liquid N2.  Cows were monitored for 7 d for signs of infection or fever.  No cows 
experienced complications from the biopsies and the staples were removed after 7 
days. 
 
Quantitative RT-PCR 
 Adipose tissue gene expression was conducted as described in Chapter 3.  
Instead of using 18S as a reference gene, the quantitative gene expression data shown 
in the present chapter are in proportion to the geometric mean of the expression of 
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both 18S and β2-microglobulin. In addition to measuring expression of PPARγ, leptin, 
LPL, and FAS, gene expression of TNFα and adiponectin also were analyzed.  The 
primers used were previously noted in Chapter 3 and in Table 5-2.  Expression 
analysis for four cows (two on the Low TZD treatment combination, two on the Low 
Saline treatment combination) was not included due to poor quality of isolated RNA. 
 
 Calculations 
 Energy balance was calculated using NRC requirements during gestation 
(NRC, 2001) and NEL of feedstuffs as analyzed.   
 RQUICKI, the relative insulin sensitivity measure used in ruminants was 
calculated as the following (Holtenius and Holtenius, 2007): 
RQUICKI  = 1 / [log(Gb) + log(Ib) + log(NEFAb)] 
Where 
Gb = Basal glucose (mg/dL) 
Ib = Basal insulin (µU/mL) 
NEFAb = Basal NEFA (mmol/L) 
such that a lower RQUICKI suggests greater insulin resistance. 
 Responses to GTT and HEC were measured as area under the curve (AUC), 
calculated using incremental change and trapezoidal rule via SAS (v. 9.2).  Additional 
responses such as clearance rates, half-life, and time to reach basal concentrations 
were estimated using ProcNLIN of SAS (v. 9.2) as described in Chapter 4.  
 
 Statistical analysis 
 Statistical analysis was performed as analysis of variance (ANOVA) on 
measures conducted over time (plasma concentrations) using the MIXED procedure of 
SAS (2001) for a completely randomized design with repeated measures where  
appropriate.  The statistical model included fixed effects of covariate, treatment, time
  
 
 
 
 
 
Table 5-2.  Primer sequences for adipose tissue mRNA expression.  
 
 
113 Target Forward Primer Sequence Reverse Primer Sequence Source
TNFα CCCATCTACCAGGGAGGAGT GGCGATGATCCCAAAGTAGA (Komatsu et al., 2005)
Adiponectin GTGGCTCTGATTCCACACCT GCCATGACTGGGTAAGGCTA (Boisclair, Y.R., personal communication)
β-2-microglobulin CATCCAGCGTCCTCCAAAGAT CCCCATTCTTCAGCAAATCG (Harvatine and Bauman, 2006)
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and the interaction of treatment and time.  The random effect was cow nested within 
treatment.  For each variable, six covariance structures were evaluated (first-order 
autoregressive, heterogeneous first-order autoregressive, compound symmetry, 
heterogeneous compound symmetry, first-order ante-dependence, and unstructured) 
and the structure with the smallest Akaike’s information criterion was used for further 
analysis.  The method of Kenward-Rogers was used for calculation of denominator 
degrees of freedom.  Covariates were dropped from the statistical model if P > 0.15 
and the data were reanalyzed.  Significance was declared as P values ≤ 0.05; trends as 
0.15 ≥ P ≥ 0.05. 
  
Results 
 
Daily intake and plasma 
 There was a significant effect of diet on DMI during the last two weeks of the 
experiment such that cows fed the High diet consumed 16.1 (± 0.4) kg/d of DM and 
cows fed the Low diet consumed 12.8 (± 0.4)  kg/d of DM (P = < 0.0001).   Figure 5-2 
illustrates the diet effects on DMI throughout the entire trial.  There was trend for a 
diet by day interaction (P = 0.07) such that cows fed the High diet consistently ate 
more than cows fed the Low diet (16.1 vs. 12.8  kg/d) throughout the experiment, and 
cows fed the Low diet decreased intake slightly during week two of the experiment.  
There were no significant effects of TZD administration or interactions of TZD with 
dietary treatment, though the four treatment combinations are illustrated in Figure 5-2.  
The resulting energy balance for cows on each diet was 172 (± 3.5) % calculated 
energy balance for cows on the High diet and 119 (± 3.5) % for cows on the Low diet 
during the last two weeks of the trial (P < 0.0001; (NRC, 2001).  Consistent with the 
  
 
 
 
 
Figure 5-2.  Daily dry matter intake.  Cows were fed one of two dietary treatments (High vs. Low dietary energy level) for three 
weeks, and treated daily with either TZD or Saline for the final two weeks of the experiment.  Values represent least squares means 
with error bars representing SEM; n = 8 for each of the four treatment combinations.  The P value for the final two weeks for effect 
of diet was P < 0.0001; for TZD treatment was P = 0.71; for diet by TZD interaction was P = 0.24. 
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lack of a direct effect of TZD administration on DMI, there were no effects of TZD on 
calculated energy balance (P = 0.69), nor interaction of diet and TZD (P = 0.48).  
Cows fed the High diet gained 0.30 (± 0.07) units of BCS throughout the study and 
cows fed the Low diet gained 0.14 (± 0.07) (P = 0.11).  There was no effect of TZD (P 
= 0.43), nor a TZD by diet interaction (P = 0.95) on BCS change throughout the trial.   
 Figure 5-3 depicts data for plasma metabolites, insulin, and calculated 
RQUICKI based upon daily plasma samples collected during the experiment.  
Statistics for plasma glucose, NEFA, and insulin concentrations were completed using 
results from the last two weeks of the trial as that was the time period that cows were 
receiving both dietary as well as TZD or Saline treatment.  Administration of TZD 
increased plasma glucose (62.5 vs. 59.6 mg/dL; P = 0.03) compared to controls.  
There was no effect of diet on daily plasma glucose (P = 0.80).  There was no effect of 
TZD on plasma insulin concentrations (P = 0.47), but cows fed the High diet had 
greater plasma concentrations of insulin (35 vs. 25 µIU/mL; P = 0.03) than those fed 
the Low diet.  Cows fed the High diet also had lower plasma NEFA concentration (82 
vs. 103 µEq/L; P = <0.0001) than those fed the Low diet.  For the length of the trial, 
cows fed the High diet had lower RQUICKI (0.45 vs. 0.48; P = 0.03), but there was no 
effect of TZD (P = 0.16), nor interaction between diet and TZD (P = 0.89).   
 
 Glucose tolerance tests and insulin challenges 
 Figure 5-4 illustrates the change in plasma glucose levels following glucose 
infusion.  Slightly slower clearance of glucose is visually apparent for cows fed the 
Low diet and for cows administered Saline control compared to their corresponding 
treatments.  These differences are quantified in Table 5-3.   There was a trend (P = 
0.13) for a greater AUC for cows fed the Low diet versus the High diet, suggesting  
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Figure 5-3.  Daily plasma metabolites.  Cows were fed one of two dietary treatments 
(High vs. Low dietary energy level) for three weeks, and treated daily with either TZD or 
Saline for the final two weeks of the experiment.  RQUICKI =  1 / [log(glucose) + 
log(insulin) + log(NEFA)].  Values represent least squares means with error bars 
representing SEM; n = 16 for each treatment depicted.  The P values for each are shown on 
the graphs. 
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Figure 5-4.  Plasma glucose responses to glucose tolerance test.  Cows were fed 
one of two dietary treatments (High vs. Low dietary energy level; A) for three weeks, 
and treated daily with either TZD or Saline (B) for the final two weeks of the 
experiment.  Values represent least squares means with error bars representing SEM; n 
= 16 for each treatment depicted.  Results are detailed in Table 5-3.  
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Table 5-3.  Effects of diet and TZD-administration on glucose responses to i.v. glucose tolerance test. 
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Measurea High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
glucose
(mg/dL)      67.8      61.2     1.6 0.01     65.0    64.0         1.6 0.64        70.0       65.6       60.1       62.4      2.2 0.14
Minimum
glucose
(mg/dL)      57.3      54.7     2.0 0.38     55.6    56.4         2.0 0.79        57.9       56.7       53.4       56.0      2.8 0.50
Maximum
glucose
(mg/dL)    182.2    180.6     4.4 0.81   182.2 180.6        4.3 0.79      187.6     176.7     176.8     184.4      6.2 0.14
CR30 
(%/min)       2.61       2.5     0.13 0.53      2.51        2.59         0.13 0.67         2.66        2.56        2.37         2.62      0.18 0.35
T1/2 (min)     27.4     29.6     1.5 0.32    29.1  27.9      1.5 0.57       27.2       27.6       31.0       28.2      2.1 0.45
Tbasal (min)     49.3     55.1     2.8 0.16    53.8 50.6      2.8 0.43       49.9       48.8       57.8       52.4      3.9 0.59
AUC30 1826 1979   97 0.28 1998 1808   97 0.18    1946   1706   2049   1911  137 0.71
AUC60 2029 2418 178 0.13 2367 2080 178 0.26    2164   1893   2571   2266  252 0.95
AUC90 1895 2410 231 0.13 2289 2017 231 0.41    2021   1771   2558   2263  327 0.95
Diet TZD TZD*Diet Interaction
a Basal glucose = mean glucose concentration at -15 and -5 min prior to GTT; Minimum glucose = minimum glucose during GTT; Maximum glucose = maximum glucose during 
GTT; CR30 = clearance rate during the first 30 min of GTT; T1/2 = Time to reach half maximal glucose concentration; Tbasal = time to reach basal glucose concentration; AUC30 = 
area under the curve during the first 30 min of GTT [mg/dL x 30 min];  AUC60 = area under the curve during the first 60 min of GTT [mg/dL x 60 min];  AUC90 = area under the 
curve during the first 90 min of GTT [mg/dL x 90 min]
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slower glucose clearance.  Additional measures during GTT (minimum glucose, 
maximum glucose, clearance rate, half-life, and time to return to basal) were not  
significant based on dietary treatment.  Furthermore, there were no significant 
differences in any of the GTT measures in response to TZD administration. 
 Plasma insulin responses to GTT were nearly identical based upon dietary 
treatment, but there was potentially lower secretion of insulin in response to GTT in 
cows that were administered TZD (Figure 5-5).  These responses are quantified in 
Table 5-4.  The AUC for plasma insulin responses to glucose challenge tended to be 
lower for cows treated with TZD versus saline (4381 vs. 5711 µIU/mL x 60 min; P = 
0.15).  Additional measures of plasma insulin during GTT were not different between 
cows administered TZD or saline. Basal insulin concentration was higher for cows fed 
the High diet (19.3 vs. 14.3; P = 0.02), as was also reflected in daily plasma levels in 
Figure 5-3, but this was the only plasma insulin response measure during GTT that 
was different based on dietary treatment.  In addition, there were no interactions of 
diet and TZD administration on plasma insulin responses measured during GTT. 
 Differences in plasma NEFA responses during GTT appeared to be more 
dramatic in cows fed the Low diet versus those fed the High diet, as observed in 
Figure 5-6, while there were no obvious differences in plasma NEFA response to GTT 
due to TZD administration.  These responses are quantified in Table 5-5.  Responses 
in plasma NEFA during GTT were statistically different for several measures in 
response to dietary treatment.  Basal and minimum NEFA were lower for cows fed the 
High diet than cows fed the Low diet (92 vs. 142 µEq/L; P = 0.03 and 44 vs. 54 
µEq/L; P = 0.11, respectively).   Clearance rate of NEFA during GTT was faster for 
cows on the Low diet as seen in Figure 5-6.  (1.35 vs. 0.63 %/min; P = 0.01).  
Glucose-stimulated reduction in NEFA also was greater in cows fed the Low diet  
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Figure 5-5.  Plasma insulin responses to glucose tolerance test.  Cows were fed one 
of two dietary treatments (High vs. Low dietary energy level; A) for three weeks, and 
treated daily with either TZD or Saline (B) for the final two weeks of the experiment.  
Values represent least squares means with error bars representing SEM; n = 16 for 
each treatment depicted.  Results are detailed in Table 5-4.   
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Table 5-4.  Effects of diet and TZD-administration on plasma insulin response to i.v. glucose tolerance test. 
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Measure1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
insulin
(µIU/mL)      19.3          14.3        1.4 0.02      17.7   15.9        1.4 0.37       21.1       17.5      14.3      14.4       1.9 0.36
Maximum
insulin
(µIU/mL)    214.3    249.3      29.1 0.40    241.3 186.8      29.1 0.65     241.9     186.8    240.7     257.9     41.2 0.39
AUC30  4138  3933   487 0.77  4509   3562   483 0.18   5110   3166  3907  3958             688 0.16
AUC60  5124  4967   643 0.87  5711   4381   637 0.15   6407   3842  5016   4919   901 0.18
AUC90  5071  5018   657 0.96  5723   4367   656 0.15   6374   3768  5071   4965   921 0.19
Diet TZD TZD*Diet Interaction
1 Basal insulin = mean insulin concentration at -15 and -5 minutes prior to GTT; Maximum insulin = minimum insulin during GTT;  AUC30 = area under the curve during the first 
30 min of GTT [µIU/mL x 30 min];  AUC60 = area under the curve during the first 60 min of GTT [µIU/mL x 60 min];  AUC90 = area under the curve during the first 90 min of 
GTT [µIU/mL x 90 min]
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Figure 5-6.  Plasma NEFA responses to glucose tolerance test.  Cows were fed one 
of two dietary treatments (High vs. Low dietary energy level; A) for three weeks, and 
treated daily with either TZD or Saline (B) for the final two weeks of the experiment.  
Values represent least squares means with error bars representing SEM; n = 16 for 
each treatment depicted.  Results are detailed in Table 5-5. 
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Table 5-5.  Effects of diet and TZD-administration on plasma NEFA response to i.v. glucose tolerance test. 
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Measure1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
NEFA
(µEq/L)       92.2     142.4     14.8 0.03      119.2      115.4        14.7 0.86       87.0      97.5    151.4     133.3    21.0 0.50
Minimum
NEFA
(µEq/L)       44.0       54.0      4.2 0.11        50.6     47.4       4.2 0.59       43.7      44.2      57.4       50.5      5.9 0.54
CR60 
(%/min)        0.63        1.35      0.18 0.01         0.98    1.0      0.18 0.94        0.60        0.66        1.36        1.34      0.26 0.86
T1/2 (min)    136.3      92.2    31.4 0.33     145.6    83.0     31.4 0.17    203.4      69.1      87.7      96.8    44.5 0.12
GSRN      49.6      40.6     3.1 0.05      48.1    42.2      3.1 0.19      51.7      47.5      44.5      36.9      4.4 0.71
AUC30   -641 -1086 246 0.21   -819   -906 246 0.81   -501   -780 -1138 -1032   348 0.58
AUC60 -1827 -3247 586 0.09 -2432 -2642 586 0.80 -1534 -2120 -3331 -3165   829 0.95
AUC90 -2137 -4838 880 0.04 -3413 -3562 880 0.91 -1774 -2599 -5349 -4326 1244 0.49
1 Basal NEFA = mean NEFA concentration at -15 and -5 minutes prior to GTT; Minimum NEFA = minimum NEFA during GTT; CR60 = clearance rate during the first 60 min 
of GTT; GSRN = glucose-stimulated reduction of NEFA (% of basal); T1/2 = Time to reach half maximal NEFA concentration; AUC30 = area under the curve during the first 30 
min of GTT [µEq/L x 30 min];  AUC60 = area under the curve during the first 60 min of GTT [µEq/L x 60 min];  AUC90 = area under the curve during the first 90 min of GTT 
[µEq/L x 90 min]
Diet TZD TZD*Diet Interaction
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(40.6 vs. 49.6% of basal NEFA; P = 0.05).  Plasma NEFA response as measured by 
AUC was more significant for cows fed the Low diet (-4838 vs. -2137 µEq/L x 90  
min; P = 0.04).  There were no significant interactions of diet and TZD administration 
on plasma NEFA responses to GTT. 
 Figure 5-7 represents the changes in plasma glucose in response to IC.  The 
only differences in plasma glucose response to insulin challenge were tendencies in 
AUC for plasma glucose within 15 min post-insulin infusion (P = 0.08; Table 5-6).  
Within 15 min of insulin infusion, the AUC for plasma glucose for cows administered 
TZD was -45 mg/dL x 15 min while cows receiving saline had AUC of -12 mg/dL x 
15 min.  There were no additional differences in plasma glucose responses to insulin 
challenge based on either dietary or TZD administration; nor were there any 
significant interactions of the two. 
 There were no treatment differences in plasma insulin response to insulin 
challenge (Figure 5-8, Table 5-7).  As visually depicted in Figure 5-9, there were 
differences in plasma NEFA response during IC.  As detailed in Table 5-8,  cows 
administered TZD had more negative AUC during the minutes immediately following 
insulin infusion than cows administered Saline control (-6.4 vs. 291.1 µEq/L x 15 min; 
P = 0.04).  Additionally, there was significant interaction of TZD and dietary 
treatments for the same measurement (P = 0.04) such that cows fed the Low diet and 
receiving TZD had the most negative AUC (-228 µEq/L x 15 min) and cows on the 
Low diet not receiving TZD had the most positive AUC (979 µEq/L x 15 min) while 
cows fed the High diet that were receiving TZD or saline control had intermediary 
responses in AUC (26 and 149 µEq/L x 15 min, respectively).  No additional 
differences in plasma NEFA response to IC were observed, nor were additional 
interactions of dietary and TZD treatment. 
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Figure 5-7.  Plasma glucose responses to insulin challenge.  Cows were fed one of 
two dietary treatments (High vs. Low dietary energy level; A) for three weeks, and 
treated daily with either TZD or Saline (B) for the final two weeks of the experiment.  
Values represent least squares means with error bars representing SEM; n = 16 for 
each treatment depicted.  Results are detailed in Table 5-6. 
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Table 5-6.  Effects of diet and TZD-administration on plasma glucose response to i.v. insulin challenge. 
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Measure1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
glucose
(mg/dL)     64.5          59.1        1.5 0.02       60.9    62.7       1.5 0.43       64.6      64.3        57.2       61.1       2.2 0.33
Minimum
glucose
(mg/dL)     54.7      52.0        1.1 0.12       54.0  52.7      1.2 0.43       55.8      53.6        52.3       51.7       1.7 0.64
CR (%/min)       0.46       0.24        0.12 0.22        0.34        0.37      0.12 0.86         0.44        0.49         0.24         0.25       0.35   0.91
ISRG (% of 
basal)     81.2     85.1       2.1 0.21      83.8 82.6      2.1 0.68       80.4      82.0       87.1       83.1       2.9 0.34
AUC15    -34.2    -22.9     12.9 0.54    -12.1     -45.0    12.9 0.08      -19.0     -49.4       -5.3      -40.6     18.3 0.89
AUC30    -89.9    -65.4     28.4 0.55    -47.7   -107.6    28.4 0.15      -67.8   -111.9     -27.5    -103.3     40.1 0.70
AUC180   106.8   265.8   234.4 0.64   414.4     -41.8  234.4 0.18     153.3      60.4    675.5    -144.0   331.4 0.28
Diet TZD TZD*Diet Interaction
1 Basal glucose = mean glucose concentration at -15 and -5 minutes prior to IC; Minimum glucose = minimum glucose during IC;  CR = clearance rate of glucose during IC; ISRG = 
reduction of plasma glucose from basal levels; AUC15 = area under the curve during the first 15 min of IC [mg/dL x 15 min]; AUC30 = area under the curve during the first 30 min 
of IC [mg/dL x 30 min];  AUC180 = area under the curve during the first 180 min of IC [mg/dL x 180 min]
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Figure 5-8.  Plasma insulin responses to insulin challenge.  Cows were fed one of 
two dietary treatments (High vs. Low dietary energy level; A) for three weeks, and 
treated daily with either TZD or Saline (B) for the final two weeks of the experiment.  
Values represent least squares means with error bars representing SEM; n = 16 for 
each treatment depicted.  Results are detailed in Table 5-7. 
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Table 5-7.  Effects of diet and TZD-administration on plasma insulin response to i.v. insulin challenge. 
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Measure1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
insulin
(µIU/mL)     15.3           11.9        1.5 0.12      13.4    13.8       1.5 0.85      16.4      14.2      10.4     13.4      2.1 0.21
Minimum
insulin
(µIU/mL)     10.3        8.4        0.9 0.17       9.3   9.5      0.9 0.88      14.1        9.5       7.4       9.4      1.3 0.17
Maximum
insulin
(µIU/mL)    121.5    170.3      33.4 0.31   138.7     153.1     33.4 0.76    111.2     131.9    166.3    174.3    47.2   0.89
AUC15    490.4    673.7    162.3 0.43   579.3     584.8   162.3     0.98    450.3     530.5    708.2    639.1  229.5 0.98
AUC30    565.1    928.1    221.6 0.26   708.8     784.3   221.6 0.81    496.9     633.3    920.8    935.4  313.4 0.85
AUC180  1134  1312    485 0.80   859.1   1587   481.3 0.30    566.5   1702  1152   1472  685.8 0.55
1 Basal insulin = mean insulin concentration at -15 and -5 minutes prior to IC; Minimum insulin = minimum insulin during IC;  Maximum insulin = maximum insulin during IC; 
AUC15 = area under the curve during the first 15 min of IC [µIU/mL x 15 min]; AUC30 = area under the curve during the first 30 min of IC [µIU/mL x 30 min];  AUC180 = area 
under the curve during the first 180 min of IC [µIU/mL x 180 min]
Diet TZD TZD*Diet Interaction
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Figure 5-9.  Plasma NEFA responses to insulin challenge.  Cows were fed one of 
two dietary treatments (High vs. Low dietary energy level) for three weeks, and 
treated daily with either TZD or Saline for the final two weeks of the experiment.  
Values represent least squares means with error bars representing SEM; n = 8 for each 
treatment combination depicted.  Results are detailed in Table 5-8. 
  
 
 
 
Table 5-8.  Effects of diet and TZD-administration on plasma NEFA response to i.v. insulin challenge. 
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Measure1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Basal
NEFA
(µEq/L)    114.0          126.2       13.5 0.53     110.3   130.0       13.5 0.31      102.8      125.2     117.7     134.8     19.1 0.89
Minimum
NEFA
(µEq/L)      97.3      114.6       10.6 0.26     104.4  107.5      10.6 0.84        87.2      107.5     121.7     107.6     14.9 0.26
CR20 
(%/min)        1.8         2.6        0.45 0.21        2.0     2.4       0.45 0.56          1.0         2.4        3.0        2.2       0.63 0.08
T1/2 (min)      76.2       71.3       36.3 0.92      88.2    59.3     34.0 0.56        80.0       72.5      96.5      46.1     47.5 0.67
ISRN (% of 
basal)      85.9       93.6        5.2 0.30      92.4   87.2       5.2 0.48       80.6       91.4    104.3      83.0       7.3 0.04
AUC15      66.2     218.6      95.5 0.28    291.1       -6.4     95.1    0.04       65.2       67.3    517.1     -80.0   134.5 0.04
AUC30      87.5     375.6    241.6 0.41    563.9   -100.8   239.6 0.06     149.0       26.0    978.7   -227.5   338.8 0.12
AUC180 11634 17447  2046 0.06 15704 13378 2029 0.43   12483 10785 18924 15970 2870 0.83
Diet TZD TZD*Diet Interaction
1 Basal NEFA = mean NEFA concentration at -15 and -5 minutes prior to IC; Minimum NEFA = Minimum NEFA during IC;  CR20 = Clearance rate for NEFA for 20 minutes 
post-IC; T1/2 = Half-life for NEFA during IC; ISRN = Insulin-stimulated reduction of NEFA during IC; AUC15 = area under the curve during the first 15 min of IC [µEq/L x 15 
min]; AUC30 = area under the curve during the first 30 min of IC [µEq/L x 30 min];  AUC180 = area under the curve during the first 180 min of IC [µEq/L x 180 min]
  
 
Adipose tissue gene expression 
 Table 5-9 details the effects of dietary and TZD-treatment on adipose tissue 
mRNA expression.  There was a trend for cows fed the High diet to have greater 
expression of LPL (2.2 vs. 1.6 relative units; P = 0.10) and to have significantly 
greater expression of PPARγ (2.4 vs. 1.3 relative units; P = 0.02).  Additional 
differences based on dietary treatment or TZD administration or interactions of the 
two were not significant.   
 
Discussion 
 
 The diets in this experiment were designed to achieve different planes of 
nutrition despite both diets being fed for ad libitum intake.  As reported in Table 5-1 
and Figure 5-2, the combination of lower dietary energy concentration and higher 
forage content of the Low diet resulted in a 53% lower calculated energy balance for 
cows fed the Low diet.  The difference in calculated energy balance for cows fed the 
two dietary treatments were similar to past experimental conditions during the dry 
period (Dann et al., 2006).  Additionally, changes in BCS for cows fed the High diet 
were similar to those described in previous studies focused on changes in plane of 
nutrition during the dry period despite a dietary treatment period of only three weeks 
(Dann et al., 2006; Richards et al., 2010).   
 In previous studies with dairy cattle, prepartum TZD administration did not 
affect prepartum DMI (Smith et al., 2007; Smith et al., 2009).  In those studies, 
however, prepartum diets were of moderate energy level (1.60 Mcal NEL/kg), and in 
one case were limit-fed to meet only 130% of energy requirements in the prepartum 
period (Smith et al., 2007).  Additionally, cows were much closer to calving (3 weeks) 
  
 
 
 
 
 
 
 
Table 5-9.  Effects of diet and TZD-administration on adipose tissue mRNA expression. 
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Gene1 High Low SEM P Saline TZD SEM P
High
Saline
High
TZD
Low
Saline
Low
TZD SEM P
Adiponectin      0.26     0.23       0.02 0.34        0.24     0.26     0.02 0.66        0.26     0.27     0.23    0.24    0.03 0.99
Fatty acid synthase     24.3    18.0       3.2 0.21      23.2 19.1     3.3 0.40      26.3   22.3   20.2  15.9    5.0 0.97
Leptin       6.4   4.3       1.2 0.20        4.8   5.9     1.1 0.48        5.4     7.4     4.3    4.4    1.6 0.55
Lipoprotein Lipase       2.2   1.6       0.29 0.10        1.9  1.9      0.27 0.87        2.1     2.3     1.6    1.5    0.40 0.70
PPARγ       2.4   1.3       0.31 0.02        1.9  1.8      0.30 0.86        2.6     2.2     1.2    1.4    0.40 0.50
TNFα       4.4   4.4       0.60 0.98         4.4         4.4      0.60     0.99        3.8     5.0     5.0    3.8    0.90 0.18
Diet TZD TZD*Diet Interaction
1 Values expressed are relative mRNA abundance, in relationship to the geometric mean of two housekeeping genes (18S and β2-microglobulin)
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in those studies.  In the case of the current experiment, however, TZD administration 
might have had an effect on DMI in a very desirable manner.  Since TZD 
administration increased DMI by 1 kg DM/day for cows fed the Low diet, and 
decreased DMI by 0.5 kg DM/day for cows fed the High diet, this could have 
implications for cows overfed during the dry period, though the magnitude of change 
in DMI may not be biologically relevant, nor did it reach significance in this 
experiment.  Control of energy intake during the dry period has been shown to 
improve performance and metabolic health of dairy cattle postpartum (Dann et al., 
2006) 
 Because overfeeding energy to nonlactating cows has been shown to increase 
internal fat deposition independent of observable increases in body condition 
(Nikkhah et al., 2008), it could be hypothesized that cows on this experiment fed the 
High diet may have deposited more visceral adipose as well as increased body 
condition score.  Unfortunately, dissection of internal adipose stores was not 
completed in this experiment, so results can only be hypothesized.  Loss of BCS post-
calving was also not recorded in this experiment as cows were removed from the 
controlled experiment at approximately three weeks prior to calving.  Given the 
similarities with BCS changes from other experiments, had dietary treatments 
continued through early lactation, there might have been more dramatic loss of BCS 
for cows fed the High diet and for cows not treated with TZD (Dann et al., 2006; 
Smith et al., 2007; Smith et al., 2009).  In a previous study that administered TZD to 
cows prepartum, there were no significant differences in BCS prepartum, but cows 
treated with TZD lost less BCS postpartum which may parallel current results (Smith 
et al., 2009).   
 Administration of TZD increased plasma glucose (Figure 5-3A).  Results of 
TZD treatment on plasma glucose in ruminants have been mixed such that it either 
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tended to increase or did not increase plasma glucose during TZD administration 
(Smith et al., 2007; Smith et al., 2009).  In steers that were treated with TNFα and had 
elevated plasma glucose over control cows, there were decreases in plasma glucose 
with TZD administration (Kushibiki et al., 2001).  However, in that experiment, there 
was not a control group of cows that were administered TZD and so direct effects of 
TZD on circulating glucose concentrations is not possible.  It is possible that the 
effects of TZD administration on plasma glucose are dependent upon the degree or 
form of insulin resistance in treated animals. In agreement with previous results, TZD 
administration did not have an effect on plasma insulin (Figure 5-3B).  Also consistent 
with previous results, cows fed the High diet had increased plasma insulin throughout 
the experiment  (Holtenius et al., 2003; Dann et al., 2006).    
 The differences in plasma levels of insulin and NEFA resulted in cows fed the 
High diet having a lower overall RQUICKI, which would suggest greater insulin 
resistance in those cows (Holtenius and Holtenius, 2007).  Greater insulin resistance in 
cows overfed during the dry period has been measured directly in other studies and is 
suggested as a mechanism by which overfed cows have altered metabolic regulation 
during the transition period (Holtenius et al., 2003).  Similar to the cows evaluated via 
RQUICKI by Holtenius and Holtenius (2007), the cows in this experiment were 
relatively healthy and not under metabolic stress.  Effective and repeatable evaluation 
of insulin resistance using RQUICKI  in cows with metabolic disorders is lacking 
(Kerestes et al., 2009).  Bossaert et al. (2009) were able to correlate RQUICKI and 
GTT measures in calves, further illustrating the need for future evaluation of 
RQUICKI as a measure of insulin sensitivity.  It appears that RQUICKI may be an 
appropriate measure in some metabolic circumstances but may lack the ability to 
detect differences in others.  In this case, RQUICKI was able to detect dietary 
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treatment differences consistent with previous results, and results shown here in 
response to GTT and IC. 
 Unlike in Chapter 4, there were fewer differences in clearance of glucose 
during GTT in the current experiment (Figure 5-4, Table 5-3). The trend for smaller 
glucose AUC for cows fed the Low diet may be explained by the slightly higher 
NEFA in these cows.  More interesting, though not statistically significant, is the trend 
for cows administered TZD to have less insulin secretion in response to GTT (Table 5-
4).  Since differences were not observed in the rate of glucose clearance based on 
TZD-treatment, yet the TZD-treated cows had to secrete less insulin to clear the 
glucose, this suggests differences in glucose metabolism.  Cows that were receiving 
chromium-methionine as a means to improve glucose tolerance, had reduced secretion 
of insulin in response to a GTT similar to the one performed here (Hayirli et al., 2001). 
 Plasma insulin responses to GTT are nearly identical to those illustrated in the 
fed state in Chapter 4.  The lack of altered response in plasma insulin secretion due to 
dietary treatment is a reflection of the energy balance met by each of the dietary 
treatments.  In Chapter 4, the Low diet and feed-deprived state may have reduced 
normal insulin responses due to prolonged negative energy balance while in the 
current experiment cows fed the Low diet were predicted to be in positive energy 
balance.  As such, there did not appear to be affects on actual insulin secretion in the 
current study.  As discussed, the heightened negative energy balance in cows fed the 
Low diet and those undergoing feed removal in Chapter 4 may have resulted in 
reduced capability of the pancreas to secrete insulin.  Similar reduction of insulin 
responses have been seen in other instances of feed removal and acidotic cows (Hove, 
1978; Bigner et al., 1996).  Additional evidence for normal insulin secretion and 
metabolism in animals fed both the High and Low diets in the current study are the 
lack of differences in plasma insulin responses to insulin challenge (Table 5-7).  Given 
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that there were no differences in insulin responses as measured by AUC, one can 
assume that there were no differences in insulin clearance based on dietary or TZD 
treatment.  Differential responses to GTT and IC as measured by changes in plasma 
glucose and NEFA responses are more likely due then to tissue responses to insulin 
rather than changes in insulin secretion or clearance. 
 Additional differences were seen in plasma NEFA responses to GTT (Figure 5-
6, Table 5-5).  Based on differences in clearance rate, AUC, and glucose-stimulated-
reduction-of-NEFA, it appears as though cows fed the Low diet had more dramatic 
changes in fatty acid metabolism in response to a glucose infusion.  Bines and Morant 
(1983) hypothesized that thin cows had a more rapid rate of fatty acid synthesis, 
resulting in lower blood fatty acid precursors and more rapid absorption from the 
rumen as measured by responses to restricted and ad libitum feeding.  The authors also 
suggested that this may explain why thin cows have a greater ability to increase intake 
than fat cows.  A similar response was quantified by Rukkwamsuk, et al. (1999b) 
when they showed that despite having greater rates of esterification in adipose tissue 
prepartum, cows overfed during the dry period have higher rates of lipolysis 
postpartum (Rukkwamsuk et al., 1998).   
 In one of the few studies to report NEFA responses to GTT, cows were 
receiving chromium-methionine and there were no reported differences in NEFA 
responses to GTT (Hayirli et al., 2001).  Any reported differences by the authors were 
due to differences in basal levels of NEFA prior to administration of the GTT.  Results 
were similar for cows administered chromium propionate and then subjected to a 
similar GTT where no significant differences in plasma NEFA response to GTT were 
observed  (Sumner et al., 2007).  This could suggest that unlike during the use of 
chromium supplements as an insulin sensitizer, we are seeing additional differences in 
NEFA responses to GTT with TZD administration.  Therefore, TZD might be 
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additionally beneficial due to its effects on fatty acid metabolism independent of 
glucose metabolism.  This is consistent with the actions of TZD acting most directly 
on PPARγ specific to adipose tissue (Sundvold et al., 1997). 
 Despite having similar responses in plasma insulin to IC, there was a tendency 
for cows administered TZD to have more dramatic decreases in plasma glucose 
following insulin infusion (Figure 5-7, Table 5-6, and Figure 5-8).  Previous insulin 
challenges completed on cows administered TZD did not show significant differences 
in plasma glucose or insulin responses at two insulin challenge doses (Smith et al., 
2007).  The authors stated this as evidence that TZD does not alter the important 
adaptation of reduced glucose utilization by skeletal muscle in preparation for 
lactation.  Because TZD is a PPARγ  ligand and expression is low in skeletal muscle 
(Sundvold et al., 1997), this likely a valid conclusion.  Additionally, the cows in Smith 
et al. (2007) experiment were administered IC at 9 or 10 d prior to expected calving 
date, a time when insulin resistance of skeletal muscle is likely to be relatively high 
(Bauman and Currie, 1980).  In contrast, the cows in this experiment were three weeks 
prior to calving at the time of the IC, a period of time when effects on whole-body 
glucose metabolism might be more measurable. 
 While the most differences in plasma NEFA responses to GTT were attributed 
to dietary (vs. TZD) treatment, there were a greater differences in plasma NEFA 
response to IC attributed to TZD administration (vs. dietary treatment) (Figure 5-9, 
Table 5-8).  There were also instances of significant interactions of TZD and diet.  The 
result is that cows administered TZD appeared to have greater response in plasma 
NEFA to insulin, a response that may be further amplified in cows fed the Low diet.  
Furthermore, these differences were observed despite no significant differences in 
plasma insulin response during IC (Figure 5-8, Table 5-7).  This would suggest that 
differences in plasma NEFA responses to IC are not due to differences in insulin 
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secretion nor clearance and are more likely due to adipose tissue response to insulin.  
Therefore, cows treated with TZD, and especially cows also fed the Low diet, had 
greater ability of insulin to alter rates of either lipolysis or lipogenesis, or a 
combination. Treatment of human adipocytes in vitro with TZDs has been shown to 
enhance the effects of insulin on lipid metabolism (McTernan et al., 2002).  However, 
the ability of TZD to enhance these effects is lost under situations of chronic 
hyperinulinemia (McTernan et al., 2002).  This helps to explain how hyperinsulinemic 
individuals (both obese humans and overfed ruminants) can experience greater rates of 
lipolysis and/or body weight gain (McTernan et al., 2002; Dann et al., 2006) 
 Similar to results shown in Chapter 3, there were few effects of treatment on 
mRNA expression within subcutaneous adipose tissue.  As discussed previously, 
although TZD has been shown to increase expression of both LPL and FAS in 
nonruminants, the effects in ruminants are not yet known (Kageyama et al., 2003; 
Bogacka et al., 2004).  Because both of these genes have been implicated in changes 
in lipid metabolism occurring during milk fat depression (Harvatine et al., 2009), it 
was hypothesized that they may play roles in changes in insulin resistance mediated by 
TZD administration.  In this case, however, there did not appear to be significant 
effects.  In the case of LPL, it may not be a large factor in early lactation but instead 
may play a greater regulatory role in mid to late lactation (McNamara et al., 1987).  
There was a tendency for cows fed the High diet to have increased mRNA expression 
of LPL, which may be related to increased insulin concentration caused by dietary 
treatment (Faulconnier et al., 1996).    
 It is unknown why there was an effect of diet on PPARγ expression; however, 
it has been shown in human adipose tissue to be upregulated by insulin and 
downregulated by a low calorie diet (Vidal-Puig et al., 1997).  Although TZD 
administration was shown in Chapter 3 to upregulate PPARγ expression, the reason 
 140 
for a lack of an effect in the current study is unknown.  Unlike cows in this 
experiment, cows investigated in Chapter 3 were much closer to calving and fed a 
single, moderate dietary energy level.  It is possible that timing relative to calving 
and/or dietary energy level affect the potential for TZD to upregulate PPARγ in 
ruminants. There are additional factors beyond those investigated here that regulate 
changes in fatty acid metabolism due to TZD administration in dairy cattle.   
 
Conclusions 
 
 The results shown here indicate that changes in insulin resistance may be 
different in relation to glucose and fatty acid metabolism based on dietary treatment as 
well as the use of an insulin sensitizing agent.  While plasma glucose responses to 
GTT were more pronounced in cows fed a high plane of nutrition, cows fed a lower 
plane of nutrition had more dramatic responses in plasma NEFA.  These results may 
be similar to the growing body of evidence which suggests that overfed cows 
experience changes in energy metabolism that ultimately results in greater loss of 
body condition and lower DMI postcalving. 
 The author expected to see more significant interaction between dietary 
treatment and TZD-administration.  The reasons for the lack of interaction may have 
to do with the experimental design.  Rather than complicate measures in energy 
metabolism by completing the study close to calving, the experiment was conducted in 
the early dry period in the hopes that responses due to diet and TZD might be more 
easily characterized.  This may have resulted in a lack of response interaction.  In the 
future, it might be beneficial to carry a similar experimental design through the 
transition into early lactation, or to subject cows to a period of negative energy balance 
similar to the one completed in Chapter 4.   
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 The responses related to glucose and fatty acid metabolism observed in overfed 
dry cows needs to be further characterized.  From this study, it is clear that evaluation 
of dietary treatments and metabolic intervention needs to include measures of both 
glucose and fatty acid metabolism.  Responses may be differential for adipose tissue, 
and other insulin-dependent tissues in the body.  As suggested, differences between 
independent adipose tissue depots needs further exploration as well.   
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CHAPTER 6:  INTEGRATED SUMMARY AND CONCLUSIONS 
 
 The metabolic adaptations that support the onset of lactation include increased 
mobilization of fatty acids from adipose tissue and increased hepatic gluconeogenesis 
(Bell, 1995).  Orchestration of nutrient partitioning is necessary to meet new metabolic 
demands coinciding with a simultaneous decrease in dry matter intake around calving, 
which requires mobilization of body fat reserves (Bauman and Currie, 1980).  Insulin 
resistance during pregnancy and early lactation is a normal homeorhetic adaptation, 
the purpose of which is to spare glucose for the gravid uterus and mammary gland 
(Bauman and Currie, 1980).  However, extreme insulin resistance may contribute to  
excess mobilization of adipose tissue in early lactation which is detrimental to the 
metabolic health of dairy cattle (Drackley, 1999).   
 Recent evidence shows that cows that are overfed and gain excessive body 
condition during the dry period often experience prolonged negative energy balance in 
early lactation (Douglas et al., 2006; Dann et al., 2006).  Additionally, overfed cows 
were also determined to have increased insulin resistance as indicated by decrease 
clearance of glucose following glucose infusion (Holtenius et al., 2003).  Given these 
findings, there is potential to investigate the roles of insulin resistance in dry cows and 
what influence plane of nutrition and adipose tissue metabolism might have on 
metabolic health of these animals. 
 Previous work demonstrated that administration of insulin sensitizing agents to 
prepartum dairy cattle can have positive effects on transition cow metabolism (Smith 
et al., 2007; Smith et al., 2009).  One objective of this dissertation was to begin to 
explain the mechansism by which TZD administration may increase DMI and reduce 
NEFA in transition dairy cows.  In Chapter 3, plasma leptin was found to be linearly 
increased postpartum by prepartum TZD administration of 2.0 and 4.0 mg TZD/kg of 
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BW.  Plasma concentrations of TNFα were also shown to be linearly increased by 
increasing dose of TZD administration.  A calculated measure of insulin resistance, 
RQUICKI, suggested that cows administered TZD had increased insulin sensitivity.  
Also reported in Chapter 3 was the first evidence that TZD administration in 
ruminants upregulates PPARγ, as measured by mRNA levels.  There was no effect of 
TZD administration on adipose tissue mRNA expression for either LPL or FAS.  
These results implicate altered expression and plasma concentrations of leptin, plasma 
TNFα, but not LPL or FAS as potential mechanisms for the effects of TZD 
administration on transition dairy cattle. 
 An additional objective of this work was to further elucidate the role of insulin 
resistance in dry cows, and its potential influence on transition cow metabolism, 
especially during instances of altered plane of nutrition.  In Chapter 4, cows subjected 
to high and low planes of energy and then subjected to feed deprivation had different 
responses in glucose and fatty acid metabolism as measured by both GTT and HEC.  
For example, cows fed the diet with lower energy had slower clearance of glucose 
during GTT but more dramatic decreases in NEFA during GTT.  Overall, the effects 
of feed deprivation were much greater than prior plane of nutrition.  Cows that were 
deprived of feed for 24h had much slower clearance of glucose during GTT, 
suggesting greater insulin resistance.  In addition, following feed deprivation, cows 
had greatly attenuated insulin response to glucose infusion.  This highlights that not 
only plane of nutrition but also acute periods of negative energy balance, such as that 
which occurs around the time of calving, can have profound effects on insulin 
responses in dairy cattle.  The results also highlight that variables measured during 
GTT and HEC can be compared such as clearance rate during GTT and glucose 
infusion rate during HEC, and NEFA clearance rate during GTT and NEFA 
suppression during HEC. 
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 Finally, in Chapter 5, the effects of both plane of nutrition and the use of the 
insulin-sensitizing agent TZD were investigated.  This was the first experiment where 
TZD administration was combined with different dietary treatments.  Responses to 
treatment were measured using a combination GTT and IC approach, as well as 
measures of adipose tissue mRNA expression of various genes.  There were 
differential effects of plane of nutrition on glucose and fatty acid metabolism such that 
cows fed a lower energy level diet had tendency for smaller glucose AUC following 
GTT but more negative NEFA AUC and greater NEFA clearance.  Administration of 
TZD tended to decrease the amount of insulin secreted during GTT, suggesting greater 
insulin sensitivity.  The only significant interactions of plane of nutrition and TZD 
administration were that plasma NEFA responses happened more quickly and were 
greatest for cows treated with TZD and fed the lower plane of energy.  While TZD 
administration or diet did not affect FAS, leptin, TNFα, or adiponectin mRNA 
expression, the higher energy level diet increased mRNA of PPARγ and LPL.  It is 
possible that these effects and potential interactions of diet and TZD would be more 
dramatic closer to the time of calving.  Results from GTT and IC indicate that energy 
level and insulin-sensitizing agents affect glucose and lipid metabolism during the dry 
period, which may have implications for the transition period. 
 These experiments were the first to analyze plasma concentration of leptin and 
TNFα from dairy cattle treated with TZD.  This work began to explain potential 
metabolic outcomes of TZD administration in transition dairy cows.  Additionally, 
results in Chapter 4 illustrated the potential effects of negative energy balance on 
insulin responses and secretion.  It also provided comparison of measurements taken 
during GTT and HEC, illustrating that both can be used to determine changes in 
glucose and fatty acid metabolism in dairy cattle.  It appears that plane of energy may 
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not affect responses in cattle to TZD administration, at least during the far-off dry 
period.   
 In conclusion, the transition period continues to be a dynamic area of research 
in which additional work is required.  Future work should include additional 
characterization of insulin resistance during the dry period, including responses in 
additional adipokines.  There is opportunity to use GTT and IC in order to assess 
insulin responses in dairy cattle, and future use should involve accurate reporting of 
not only glucose and insulin responses to these challenges, but also NEFA in order to 
characterize changes in fatty acid metabolism.  There may also be opportunity to use 
RQUICKI as a relative measure of insulin resistance in dairy cattle, but additional 
testing is required to see if it is an appropriate measure in all circumstances.  In the 
future, potential application of TZD in transition dairy cattle may not depend on plane 
of nutrition, but further work should be completed during the transition period in order 
to solidify this conclusion.  Overall this work added to the body of evidence that 
suggests that insulin resistance in dry cows can potentially have large effects on 
transition cow metabolism. 
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